{
"animated_ranking_plot": "https://www.realrate-archive.com/us_chemicals/2012/animated_ranking.gif",
"company_details": [
{
"company_id": "0000084748",
"feature_distribution_plot": "https://www.realrate-archive.com/us_chemicals/2012/feature_distribution/feature_distribution_0000084748.svg",
"graph_url": "https://www.realrate-archive.com/us_chemicals/2012/graphs/IME_0000084748.svg",
"logo_url": "https://www.realrate-archive.com/us_chemicals/logos/0000084748.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_chemicals/logos/0000084748_256x256.png",
"name": "Rogers CORP",
"rank": 1,
"regression_plot": "https://www.realrate-archive.com/us_chemicals/2012/backtesting_correlation/regression_0000084748.svg",
"report_text": "The relative strengths and weaknesses of Rogers CORP are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Rogers CORP compared to the market average is the variable Stockholders Equity, increasing the Economic Capital Ratio by 57% points.The greatest weakness of Rogers CORP is the variable Assets, Noncurrent, reducing the Economic Capital Ratio by 1.3% points.
The company's Economic Capital Ratio, given in the ranking table, is 175%, being 47% points above the market average of 128%.",
"report_url": "https://www.realrate-archive.com/us_chemicals/2012/report/0000084748_2013_Rogers_CORP.pdf",
"shrinked_graph_json": {
"2011": {
"Liabilities, Current": "4.06",
"Liabilities": "34.9",
"Stockholders Equity": "37.1",
"ECR before LimitedLiability": "37.4",
"Other Liabilities": "3.12",
"Liabilities, Noncurrent": "29.3",
"Property, Plant and Equipment, Net": "-0.702",
"Assets": "3.07",
"Intangible Assets": "-1.52",
"Other Assets": "9.45",
"Assets, Noncurrent": "-1.60",
"Assets, Current": "0.166",
"Cost of Revenues": "0",
"Expenses": "0",
"Net Income": "0",
"Other Expenses": "0",
"Selling, General and Administrative Expense": "0",
"Other Revenues": "0",
"Revenues": "0",
"Other Compr. Net Income": "0",
"Comprehensive Net Income": "0",
"Other Net Income": "0",
"Revenues Y+3": "0",
"Economic Capital Ratio": "38.9",
"Revenues Y+2": "0",
"Revenues Y+1": "0",
"Revenues Y+5": "0",
"Revenues Y+4": "0"
},
"2012": {
"Other Liabilities": "2.15",
"Liabilities": "33.2",
"Stockholders Equity": "56.5",
"ECR before LimitedLiability": "46.9",
"Liabilities, Noncurrent": "26.1",
"Liabilities, Current": "6.73",
"Property, Plant and Equipment, Net": "-0.339",
"Assets": "8.80",
"Intangible Assets": "2.80",
"Other Assets": "3.38",
"Assets, Current": "2.91",
"Assets, Noncurrent": "-1.30",
"Other Expenses": "0",
"Expenses": "0",
"Net Income": "0",
"Cost of Revenues": "0",
"Selling, General and Administrative Expense": "0",
"Other Revenues": "0",
"Revenues": "0",
"Other Net Income": "0",
"Comprehensive Net Income": "0",
"Other Compr. Net Income": "0",
"Revenues Y+4": "0",
"Economic Capital Ratio": "47.0",
"Revenues Y+1": "0",
"Revenues Y+5": "0",
"Revenues Y+3": "0",
"Revenues Y+2": "0"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2012/plot_over_time/0000084748_strength_weakness.svg",
"table_records": {
"2011": {
"input_variables": {
"Assets, Current": "265,632",
"Assets, Noncurrent": "32,167",
"Cost of Revenues": "0",
"Intangible Assets": "0",
"Liabilities, Current": "78,797",
"Liabilities, Noncurrent": "0",
"Other Assets": "231,647",
"Other Compr. Net Income": "0",
"Other Expenses": "385,989",
"Other Liabilities": "0",
"Other Net Income": "-4,270",
"Other Revenues": "553,150",
"Property, Plant and Equipment, Net": "148,182",
"Revenues Y+1": "0",
"Revenues Y+2": "0",
"Revenues Y+3": "0",
"Revenues Y+4": "0",
"Revenues Y+5": "0",
"Selling, General and Administrative Expense": "125,836"
},
"output_variables": {
"Liabilities": "78,797",
"Assets": "677,628",
"Expenses": "511,825",
"Revenues": "553,150",
"Stockholders Equity": "598,831",
"Net Income": "37,055",
"Comprehensive Net Income": "37,055",
"BaseVar": "27,379,349",
"ECR before LimitedLiability": "128%",
"Economic Capital Ratio": "174%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "306,936",
"Assets, Noncurrent": "29,236",
"Cost of Revenues": "0",
"Intangible Assets": "158,329",
"Liabilities, Current": "84,505",
"Liabilities, Noncurrent": "0",
"Other Assets": "116,506",
"Other Compr. Net Income": "4,994",
"Other Expenses": "310,858",
"Other Liabilities": "0",
"Other Net Income": "-218",
"Other Revenues": "498,761",
"Property, Plant and Equipment, Net": "149,017",
"Revenues Y+1": "0",
"Revenues Y+2": "0",
"Revenues Y+3": "0",
"Revenues Y+4": "0",
"Revenues Y+5": "0",
"Selling, General and Administrative Expense": "119,000"
},
"output_variables": {
"Liabilities": "84,505",
"Assets": "760,024",
"Expenses": "429,858",
"Revenues": "498,761",
"Stockholders Equity": "675,519",
"Net Income": "68,685",
"Comprehensive Net Income": "73,679",
"BaseVar": "27,568,515",
"ECR before LimitedLiability": "130%",
"Economic Capital Ratio": "175%"
}
}
},
"top_rated": true,
"trend": 0.0,
"valuation": {
"past_accumulated_profits": 547170390.0,
"future_profits": 0.0,
"valuation_correction": 0.0,
"limited_liability_put_option": 191344399.55622676,
"fair_value": 738514789.5562267,
"market_value": 798268528.75
},
"valuation_plot": "https://www.realrate-archive.com/us_chemicals/2012/valuation/valuation_0000084748.svg",
"value": 1.748938851256089,
"company_index": "https://www.realrate-archive.com/us_chemicals/2012/industry_indexes/0000084748.svg",
"analysing_equity": "https://www.realrate-archive.com/us_chemicals/2012/analytics/equity/0000084748.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_chemicals/2012/analytics/profit_loss/0000084748.svg"
},
{
"company_id": "0000915913",
"feature_distribution_plot": "https://www.realrate-archive.com/us_chemicals/2012/feature_distribution/feature_distribution_0000915913.svg",
"graph_url": "https://www.realrate-archive.com/us_chemicals/2012/graphs/IME_0000915913.svg",
"logo_url": "https://www.realrate-archive.com/us_chemicals/logos/0000915913.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_chemicals/logos/0000915913_256x256.png",
"name": "Albemarle CORP",
"rank": 2,
"regression_plot": "https://www.realrate-archive.com/us_chemicals/2012/backtesting_correlation/regression_0000915913.svg",
"report_text": "The relative strengths and weaknesses of Albemarle CORP are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Albemarle CORP compared to the market average is the variable Stockholders Equity, increasing the Economic Capital Ratio by 47% points.The greatest weakness of Albemarle CORP is the variable Assets, Noncurrent, reducing the Economic Capital Ratio by 1.6% points.
The company's Economic Capital Ratio, given in the ranking table, is 175%, being 47% points above the market average of 128%.",
"report_url": "https://www.realrate-archive.com/us_chemicals/2012/report/0000915913_2013_Albemarle_CORP.pdf",
"shrinked_graph_json": {
"2011": {
"Liabilities, Current": "3.91",
"Liabilities": "36.1",
"Stockholders Equity": "32.9",
"ECR before LimitedLiability": "35.9",
"Other Liabilities": "3.26",
"Liabilities, Noncurrent": "30.5",
"Property, Plant and Equipment, Net": "1.87",
"Assets": "1.90",
"Intangible Assets": "0.849",
"Other Assets": "1.15",
"Assets, Noncurrent": "-2.04",
"Assets, Current": "0.351",
"Cost of Revenues": "0",
"Expenses": "0",
"Net Income": "0",
"Other Expenses": "0",
"Selling, General and Administrative Expense": "0",
"Other Revenues": "0",
"Revenues": "0",
"Other Compr. Net Income": "0",
"Comprehensive Net Income": "0",
"Other Net Income": "0",
"Revenues Y+3": "0",
"Economic Capital Ratio": "37.4",
"Revenues Y+2": "0",
"Revenues Y+1": "0",
"Revenues Y+5": "0",
"Revenues Y+4": "0"
},
"2012": {
"Other Liabilities": "2.65",
"Liabilities": "43.0",
"Stockholders Equity": "47.2",
"ECR before LimitedLiability": "46.7",
"Liabilities, Noncurrent": "31.6",
"Liabilities, Current": "12.3",
"Property, Plant and Equipment, Net": "2.41",
"Assets": "3.69",
"Intangible Assets": "0.191",
"Other Assets": "1.19",
"Assets, Current": "1.54",
"Assets, Noncurrent": "-1.64",
"Other Expenses": "0",
"Expenses": "0",
"Net Income": "0",
"Cost of Revenues": "0",
"Selling, General and Administrative Expense": "0",
"Other Revenues": "0",
"Revenues": "0",
"Other Net Income": "0",
"Comprehensive Net Income": "0",
"Other Compr. Net Income": "0",
"Revenues Y+4": "0",
"Economic Capital Ratio": "46.8",
"Revenues Y+1": "0",
"Revenues Y+5": "0",
"Revenues Y+3": "0",
"Revenues Y+2": "0"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2012/plot_over_time/0000915913_strength_weakness.svg",
"table_records": {
"2011": {
"input_variables": {
"Assets, Current": "1,355,620",
"Assets, Noncurrent": "116,871",
"Cost of Revenues": "0",
"Intangible Assets": "403,426",
"Liabilities, Current": "401,178",
"Liabilities, Noncurrent": "0",
"Other Assets": "198,427",
"Other Compr. Net Income": "0",
"Other Expenses": "2,059,534",
"Other Liabilities": "0",
"Other Net Income": "44,111",
"Other Revenues": "2,869,005",
"Property, Plant and Equipment, Net": "1,129,480",
"Revenues Y+1": "0",
"Revenues Y+2": "0",
"Revenues Y+3": "0",
"Revenues Y+4": "0",
"Revenues Y+5": "0",
"Selling, General and Administrative Expense": "389,219"
},
"output_variables": {
"Liabilities": "401,178",
"Assets": "3,203,824",
"Expenses": "2,448,753",
"Revenues": "2,869,005",
"Stockholders Equity": "2,802,646",
"Net Income": "464,363",
"Comprehensive Net Income": "464,363",
"BaseVar": "137,203,233",
"ECR before LimitedLiability": "126%",
"Economic Capital Ratio": "173%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "1,407,313",
"Assets, Noncurrent": "154,836",
"Cost of Revenues": "0",
"Intangible Assets": "371,430",
"Liabilities, Current": "385,009",
"Liabilities, Noncurrent": "0",
"Other Assets": "207,141",
"Other Compr. Net Income": "6,344",
"Other Expenses": "2,062,443",
"Other Liabilities": "0",
"Other Net Income": "39,296",
"Other Revenues": "2,745,420",
"Property, Plant and Equipment, Net": "1,296,571",
"Revenues Y+1": "0",
"Revenues Y+2": "0",
"Revenues Y+3": "0",
"Revenues Y+4": "0",
"Revenues Y+5": "0",
"Selling, General and Administrative Expense": "392,146"
},
"output_variables": {
"Liabilities": "385,009",
"Assets": "3,437,291",
"Expenses": "2,454,589",
"Revenues": "2,745,420",
"Stockholders Equity": "3,052,282",
"Net Income": "330,127",
"Comprehensive Net Income": "336,471",
"BaseVar": "154,400,947",
"ECR before LimitedLiability": "129%",
"Economic Capital Ratio": "175%"
}
}
},
"top_rated": true,
"trend": 0.0,
"valuation": {
"past_accumulated_profits": 2472348420.0,
"future_profits": 0.0,
"valuation_correction": 0.0,
"limited_liability_put_option": 867425742.5878645,
"fair_value": 3339774162.5878644,
"market_value": 4536904082.248449
},
"valuation_plot": "https://www.realrate-archive.com/us_chemicals/2012/valuation/valuation_0000915913.svg",
"value": 1.747520687851746,
"company_index": "https://www.realrate-archive.com/us_chemicals/2012/industry_indexes/0000915913.svg",
"analysing_equity": "https://www.realrate-archive.com/us_chemicals/2012/analytics/equity/0000915913.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_chemicals/2012/analytics/profit_loss/0000915913.svg"
},
{
"company_id": "0001101302",
"feature_distribution_plot": "https://www.realrate-archive.com/us_chemicals/2012/feature_distribution/feature_distribution_0001101302.svg",
"graph_url": "https://www.realrate-archive.com/us_chemicals/2012/graphs/IME_0001101302.svg",
"logo_url": "https://www.realrate-archive.com/us_chemicals/logos/0001101302.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_chemicals/logos/0001101302_256x256.png",
"name": "Entegris INC",
"rank": 3,
"regression_plot": "https://www.realrate-archive.com/us_chemicals/2012/backtesting_correlation/regression_0001101302.svg",
"report_text": "The relative strengths and weaknesses of Entegris INC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Entegris INC compared to the market average is the variable Liabilities, increasing the Economic Capital Ratio by 48% points.The greatest weakness of Entegris INC is the variable Assets, Noncurrent, reducing the Economic Capital Ratio by 2.4% points.
The company's Economic Capital Ratio, given in the ranking table, is 174%, being 46% points above the market average of 128%.",
"report_url": "https://www.realrate-archive.com/us_chemicals/2012/report/0001101302_2013_Entegris_INC.pdf",
"shrinked_graph_json": {
"2011": {
"Liabilities, Current": "6.70",
"Liabilities": "41.9",
"Stockholders Equity": "25.1",
"ECR before LimitedLiability": "35.5",
"Other Liabilities": "3.67",
"Liabilities, Noncurrent": "34.1",
"Property, Plant and Equipment, Net": "-2.44",
"Assets": "-0.840",
"Intangible Assets": "-0.441",
"Other Assets": "0.627",
"Assets, Noncurrent": "-2.90",
"Assets, Current": "6.29",
"Cost of Revenues": "0",
"Expenses": "0",
"Net Income": "0",
"Other Expenses": "0",
"Selling, General and Administrative Expense": "0",
"Other Revenues": "0",
"Revenues": "0",
"Other Compr. Net Income": "0",
"Comprehensive Net Income": "0",
"Other Net Income": "0",
"Revenues Y+3": "0",
"Economic Capital Ratio": "36.9",
"Revenues Y+2": "0",
"Revenues Y+1": "0",
"Revenues Y+5": "0",
"Revenues Y+4": "0"
},
"2012": {
"Other Liabilities": "2.91",
"Liabilities": "47.6",
"Stockholders Equity": "42.1",
"ECR before LimitedLiability": "46.2",
"Liabilities, Noncurrent": "34.3",
"Liabilities, Current": "14.7",
"Property, Plant and Equipment, Net": "-1.79",
"Assets": "1.63",
"Intangible Assets": "-0.946",
"Other Assets": "0.384",
"Assets, Current": "9.86",
"Assets, Noncurrent": "-2.42",
"Other Expenses": "0",
"Expenses": "0",
"Net Income": "0",
"Cost of Revenues": "0",
"Selling, General and Administrative Expense": "0",
"Other Revenues": "0",
"Revenues": "0",
"Other Net Income": "0",
"Comprehensive Net Income": "0",
"Other Compr. Net Income": "0",
"Revenues Y+4": "0",
"Economic Capital Ratio": "46.3",
"Revenues Y+1": "0",
"Revenues Y+5": "0",
"Revenues Y+3": "0",
"Revenues Y+2": "0"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2012/plot_over_time/0001101302_strength_weakness.svg",
"table_records": {
"2011": {
"input_variables": {
"Assets, Current": "502,999",
"Assets, Noncurrent": "5,707",
"Cost of Revenues": "423,329",
"Intangible Assets": "56,453",
"Liabilities, Current": "92,594",
"Liabilities, Noncurrent": "0",
"Other Assets": "28,950",
"Other Compr. Net Income": "0",
"Other Expenses": "15,328",
"Other Liabilities": "0",
"Other Net Income": "2,471",
"Other Revenues": "749,259",
"Property, Plant and Equipment, Net": "130,554",
"Revenues Y+1": "0",
"Revenues Y+2": "0",
"Revenues Y+3": "0",
"Revenues Y+4": "0",
"Revenues Y+5": "0",
"Selling, General and Administrative Expense": "188,827"
},
"output_variables": {
"Liabilities": "92,594",
"Assets": "724,663",
"Expenses": "627,484",
"Revenues": "749,259",
"Stockholders Equity": "632,069",
"Net Income": "124,246",
"Comprehensive Net Income": "124,246",
"BaseVar": "35,237,265",
"ECR before LimitedLiability": "125%",
"Economic Capital Ratio": "172%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "579,324",
"Assets, Noncurrent": "10,825",
"Cost of Revenues": "408,520",
"Intangible Assets": "47,207",
"Liabilities, Current": "93,263",
"Liabilities, Noncurrent": "0",
"Other Assets": "17,167",
"Other Compr. Net Income": "-3,035",
"Other Expenses": "40,746",
"Other Liabilities": "0",
"Other Net Income": "533",
"Other Revenues": "715,903",
"Property, Plant and Equipment, Net": "157,021",
"Revenues Y+1": "0",
"Revenues Y+2": "0",
"Revenues Y+3": "0",
"Revenues Y+4": "0",
"Revenues Y+5": "0",
"Selling, General and Administrative Expense": "198,345"
},
"output_variables": {
"Liabilities": "93,263",
"Assets": "811,544",
"Expenses": "647,611",
"Revenues": "715,903",
"Stockholders Equity": "718,281",
"Net Income": "68,825",
"Comprehensive Net Income": "65,790",
"BaseVar": "40,193,159",
"ECR before LimitedLiability": "129%",
"Economic Capital Ratio": "174%"
}
}
},
"top_rated": true,
"trend": 1.0,
"valuation": {
"past_accumulated_profits": 581807610.0,
"future_profits": 0.0,
"valuation_correction": 0.0,
"limited_liability_put_option": 206512673.96935296,
"fair_value": 788320283.969353,
"market_value": 1205819443.9925404
},
"valuation_plot": "https://www.realrate-archive.com/us_chemicals/2012/valuation/valuation_0001101302.svg",
"value": 1.7425158823248559,
"company_index": "https://www.realrate-archive.com/us_chemicals/2012/industry_indexes/0001101302.svg",
"analysing_equity": "https://www.realrate-archive.com/us_chemicals/2012/analytics/equity/0001101302.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_chemicals/2012/analytics/profit_loss/0001101302.svg"
},
{
"company_id": "0000310142",
"feature_distribution_plot": "https://www.realrate-archive.com/us_chemicals/2012/feature_distribution/feature_distribution_0000310142.svg",
"graph_url": "https://www.realrate-archive.com/us_chemicals/2012/graphs/IME_0000310142.svg",
"logo_url": "https://www.realrate-archive.com/us_chemicals/logos/0000310142.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_chemicals/logos/0000310142_256x256.png",
"name": "Sensient Technologies CORP",
"rank": 4,
"regression_plot": "https://www.realrate-archive.com/us_chemicals/2012/backtesting_correlation/regression_0000310142.svg",
"report_text": "The relative strengths and weaknesses of Sensient Technologies CORP are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Sensient Technologies CORP compared to the market average is the variable Stockholders Equity, increasing the Economic Capital Ratio by 45% points.The greatest weakness of Sensient Technologies CORP is the variable Assets, Noncurrent, reducing the Economic Capital Ratio by 2.1% points.
The company's Economic Capital Ratio, given in the ranking table, is 174%, being 46% points above the market average of 128%.",
"report_url": "https://www.realrate-archive.com/us_chemicals/2012/report/0000310142_2013_Sensient_Technologies_CORP.pdf",
"shrinked_graph_json": {
"2011": {
"Liabilities, Current": "3.66",
"Liabilities": "35.6",
"Stockholders Equity": "33.4",
"ECR before LimitedLiability": "35.9",
"Other Liabilities": "3.22",
"Liabilities, Noncurrent": "30.3",
"Property, Plant and Equipment, Net": "0.110",
"Assets": "2.13",
"Intangible Assets": "4.84",
"Other Assets": "-0.208",
"Assets, Noncurrent": "-2.24",
"Assets, Current": "0.530",
"Cost of Revenues": "0",
"Expenses": "0",
"Net Income": "0",
"Other Expenses": "0",
"Selling, General and Administrative Expense": "0",
"Other Revenues": "0",
"Revenues": "0",
"Other Compr. Net Income": "0",
"Comprehensive Net Income": "0",
"Other Net Income": "0",
"Revenues Y+3": "0",
"Economic Capital Ratio": "37.3",
"Revenues Y+2": "0",
"Revenues Y+1": "0",
"Revenues Y+5": "0",
"Revenues Y+4": "0"
},
"2012": {
"Other Liabilities": "2.75",
"Liabilities": "44.7",
"Stockholders Equity": "44.8",
"ECR before LimitedLiability": "46.2",
"Liabilities, Noncurrent": "32.6",
"Liabilities, Current": "13.0",
"Property, Plant and Equipment, Net": "0.266",
"Assets": "2.83",
"Intangible Assets": "3.63",
"Other Assets": "-0.0370",
"Assets, Current": "1.55",
"Assets, Noncurrent": "-2.07",
"Other Expenses": "0",
"Expenses": "0",
"Net Income": "0",
"Cost of Revenues": "0",
"Selling, General and Administrative Expense": "0",
"Other Revenues": "0",
"Revenues": "0",
"Other Net Income": "0",
"Comprehensive Net Income": "0",
"Other Compr. Net Income": "0",
"Revenues Y+4": "0",
"Economic Capital Ratio": "46.3",
"Revenues Y+1": "0",
"Revenues Y+5": "0",
"Revenues Y+3": "0",
"Revenues Y+2": "0"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2012/plot_over_time/0000310142_strength_weakness.svg",
"table_records": {
"2011": {
"input_variables": {
"Assets, Current": "706,870",
"Assets, Noncurrent": "38,730",
"Cost of Revenues": "0",
"Intangible Assets": "457,025",
"Liabilities, Current": "207,275",
"Liabilities, Noncurrent": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "1,051,476",
"Other Liabilities": "0",
"Other Net Income": "0",
"Other Revenues": "1,430,789",
"Property, Plant and Equipment, Net": "451,539",
"Revenues Y+1": "0",
"Revenues Y+2": "0",
"Revenues Y+3": "0",
"Revenues Y+4": "0",
"Revenues Y+5": "0",
"Selling, General and Administrative Expense": "258,829"
},
"output_variables": {
"Liabilities": "207,275",
"Assets": "1,654,164",
"Expenses": "1,310,305",
"Revenues": "1,430,789",
"Stockholders Equity": "1,446,889",
"Net Income": "120,484",
"Comprehensive Net Income": "120,484",
"BaseVar": "70,150,265",
"ECR before LimitedLiability": "126%",
"Economic Capital Ratio": "172%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "751,354",
"Assets, Noncurrent": "47,685",
"Cost of Revenues": "0",
"Intangible Assets": "462,896",
"Liabilities, Current": "204,236",
"Liabilities, Noncurrent": "0",
"Other Assets": "0",
"Other Compr. Net Income": "34,463",
"Other Expenses": "1,063,207",
"Other Liabilities": "0",
"Other Net Income": "0",
"Other Revenues": "1,459,050",
"Property, Plant and Equipment, Net": "514,708",
"Revenues Y+1": "0",
"Revenues Y+2": "0",
"Revenues Y+3": "0",
"Revenues Y+4": "0",
"Revenues Y+5": "0",
"Selling, General and Administrative Expense": "271,935"
},
"output_variables": {
"Liabilities": "204,236",
"Assets": "1,776,643",
"Expenses": "1,335,142",
"Revenues": "1,459,050",
"Stockholders Equity": "1,572,407",
"Net Income": "123,908",
"Comprehensive Net Income": "158,371",
"BaseVar": "83,218,783",
"ECR before LimitedLiability": "129%",
"Economic Capital Ratio": "174%"
}
}
},
"top_rated": true,
"trend": -1.0,
"valuation": {
"past_accumulated_profits": 1273649670.0,
"future_profits": 0.0,
"valuation_correction": 0.0,
"limited_liability_put_option": 452146289.9524128,
"fair_value": 1725795959.9524128,
"market_value": 1367587709.2306309
},
"valuation_plot": "https://www.realrate-archive.com/us_chemicals/2012/valuation/valuation_0000310142.svg",
"value": 1.742454698093536,
"company_index": "https://www.realrate-archive.com/us_chemicals/2012/industry_indexes/0000310142.svg",
"analysing_equity": "https://www.realrate-archive.com/us_chemicals/2012/analytics/equity/0000310142.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_chemicals/2012/analytics/profit_loss/0000310142.svg"
},
{
"company_id": "0001306830",
"feature_distribution_plot": "https://www.realrate-archive.com/us_chemicals/2012/feature_distribution/feature_distribution_0001306830.svg",
"graph_url": "https://www.realrate-archive.com/us_chemicals/2012/graphs/IME_0001306830.svg",
"logo_url": "https://www.realrate-archive.com/us_chemicals/logos/0001306830.png",
"logo_url_256x256": "https://www.realrate-archive.com/us_chemicals/logos/0001306830_256x256.png",
"name": "Celanese Corp",
"rank": 5,
"regression_plot": "https://www.realrate-archive.com/us_chemicals/2012/backtesting_correlation/regression_0001306830.svg",
"report_text": "The relative strengths and weaknesses of Celanese Corp are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Celanese Corp compared to the market average is the variable Stockholders Equity, increasing the Economic Capital Ratio by 45% points.The greatest weakness of Celanese Corp is the variable Assets, Noncurrent, reducing the Economic Capital Ratio by 1.8% points.
The company's Economic Capital Ratio, given in the ranking table, is 168%, being 40% points above the market average of 128%.",
"report_url": "https://www.realrate-archive.com/us_chemicals/2012/report/0001306830_2013_Celanese_Corp.pdf",
"shrinked_graph_json": {
"2011": {
"Liabilities, Current": "-3.46",
"Liabilities": "27.5",
"Stockholders Equity": "31.4",
"ECR before LimitedLiability": "29.8",
"Other Liabilities": "2.91",
"Liabilities, Noncurrent": "27.8",
"Property, Plant and Equipment, Net": "3.71",
"Assets": "3.83",
"Intangible Assets": "0.790",
"Other Assets": "4.01",
"Assets, Noncurrent": "-2.25",
"Assets, Current": "-1.66",
"Cost of Revenues": "0",
"Expenses": "0",
"Net Income": "0",
"Other Expenses": "0",
"Selling, General and Administrative Expense": "0",
"Other Revenues": "0",
"Revenues": "0",
"Other Compr. Net Income": "0",
"Comprehensive Net Income": "0",
"Other Net Income": "0",
"Revenues Y+3": "0",
"Economic Capital Ratio": "31.2",
"Revenues Y+2": "0",
"Revenues Y+1": "0",
"Revenues Y+5": "0",
"Revenues Y+4": "0"
},
"2012": {
"Other Liabilities": "2.34",
"Liabilities": "33.5",
"Stockholders Equity": "45.1",
"ECR before LimitedLiability": "40.3",
"Liabilities, Noncurrent": "28.4",
"Liabilities, Current": "4.06",
"Property, Plant and Equipment, Net": "3.37",
"Assets": "6.43",
"Intangible Assets": "0.306",
"Other Assets": "4.36",
"Assets, Current": "0.0238",
"Assets, Noncurrent": "-1.76",
"Other Expenses": "0",
"Expenses": "0",
"Net Income": "0",
"Cost of Revenues": "0",
"Selling, General and Administrative Expense": "0",
"Other Revenues": "0",
"Revenues": "0",
"Other Net Income": "0",
"Comprehensive Net Income": "0",
"Other Compr. Net Income": "0",
"Revenues Y+4": "0",
"Economic Capital Ratio": "40.4",
"Revenues Y+1": "0",
"Revenues Y+5": "0",
"Revenues Y+3": "0",
"Revenues Y+2": "0"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2012/plot_over_time/0001306830_strength_weakness.svg",
"table_records": {
"2011": {
"input_variables": {
"Assets, Current": "2,703,000",
"Assets, Noncurrent": "344,000",
"Cost of Revenues": "5,329,000",
"Intangible Assets": "957,000",
"Liabilities, Current": "1,385,000",
"Liabilities, Noncurrent": "0",
"Other Assets": "1,245,000",
"Other Compr. Net Income": "0",
"Other Expenses": "483,000",
"Other Liabilities": "0",
"Other Net Income": "288,000",
"Other Revenues": "6,763,000",
"Property, Plant and Equipment, Net": "3,269,000",
"Revenues Y+1": "0",
"Revenues Y+2": "0",
"Revenues Y+3": "0",
"Revenues Y+4": "0",
"Revenues Y+5": "0",
"Selling, General and Administrative Expense": "632,000"
},
"output_variables": {
"Liabilities": "1,385,000",
"Assets": "8,518,000",
"Expenses": "6,444,000",
"Revenues": "6,763,000",
"Stockholders Equity": "7,133,000",
"Net Income": "607,000",
"Comprehensive Net Income": "607,000",
"BaseVar": "345,734,328",
"ECR before LimitedLiability": "117%",
"Economic Capital Ratio": "166%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "2,839,000",
"Assets, Noncurrent": "463,000",
"Cost of Revenues": "5,226,000",
"Intangible Assets": "942,000",
"Liabilities, Current": "1,355,000",
"Liabilities, Noncurrent": "0",
"Other Assets": "1,406,000",
"Other Compr. Net Income": "0",
"Other Expenses": "301,000",
"Other Liabilities": "0",
"Other Net Income": "323,000",
"Other Revenues": "6,418,000",
"Property, Plant and Equipment, Net": "3,350,000",
"Revenues Y+1": "0",
"Revenues Y+2": "0",
"Revenues Y+3": "0",
"Revenues Y+4": "0",
"Revenues Y+5": "0",
"Selling, General and Administrative Expense": "609,000"
},
"output_variables": {
"Liabilities": "1,355,000",
"Assets": "9,000,000",
"Expenses": "6,136,000",
"Revenues": "6,418,000",
"Stockholders Equity": "7,645,000",
"Net Income": "605,000",
"Comprehensive Net Income": "605,000",
"BaseVar": "379,508,895",
"ECR before LimitedLiability": "120%",
"Economic Capital Ratio": "168%"
}
}
},
"top_rated": true,
"trend": 1.0,
"valuation": {
"past_accumulated_profits": 6192450000.0,
"future_profits": 0.0,
"valuation_correction": 0.0,
"limited_liability_put_option": 2522371118.7415705,
"fair_value": 8714821118.74157,
"market_value": 5563153599.209358
},
"valuation_plot": "https://www.realrate-archive.com/us_chemicals/2012/valuation/valuation_0001306830.svg",
"value": 1.6832102595348277,
"company_index": "https://www.realrate-archive.com/us_chemicals/2012/industry_indexes/0001306830.svg",
"analysing_equity": "https://www.realrate-archive.com/us_chemicals/2012/analytics/equity/0001306830.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_chemicals/2012/analytics/profit_loss/0001306830.svg"
},
{
"company_id": "0001200375",
"feature_distribution_plot": "https://www.realrate-archive.com/us_chemicals/2012/feature_distribution/feature_distribution_0001200375.svg",
"graph_url": "https://www.realrate-archive.com/us_chemicals/2012/graphs/IME_0001200375.svg",
"logo_url": "https://www.realrate-archive.com/us_chemicals/logos/0001200375.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_chemicals/logos/0001200375_256x256.png",
"name": "Codexis INC",
"rank": 6,
"regression_plot": "https://www.realrate-archive.com/us_chemicals/2012/backtesting_correlation/regression_0001200375.svg",
"report_text": "The relative strengths and weaknesses of Codexis INC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Codexis INC compared to the market average is the variable Liabilities, increasing the Economic Capital Ratio by 52% points.The greatest weakness of Codexis INC is the variable Property, Plant and Equipment, Net, reducing the Economic Capital Ratio by 4.3% points.
The company's Economic Capital Ratio, given in the ranking table, is 166%, being 38% points above the market average of 128%.",
"report_url": "https://www.realrate-archive.com/us_chemicals/2012/report/0001200375_2013_Codexis_INC.pdf",
"shrinked_graph_json": {
"2011": {
"Liabilities, Current": "-5.29",
"Liabilities": "30.5",
"Stockholders Equity": "15.1",
"ECR before LimitedLiability": "22.8",
"Other Liabilities": "3.36",
"Liabilities, Noncurrent": "31.9",
"Property, Plant and Equipment, Net": "-3.80",
"Assets": "-1.97",
"Intangible Assets": "1.40",
"Other Assets": "2.50",
"Assets, Noncurrent": "-4.32",
"Assets, Current": "3.74",
"Cost of Revenues": "0",
"Expenses": "0",
"Net Income": "0",
"Other Expenses": "0",
"Selling, General and Administrative Expense": "0",
"Other Revenues": "0",
"Revenues": "0",
"Other Compr. Net Income": "0",
"Comprehensive Net Income": "0",
"Other Net Income": "0",
"Revenues Y+3": "0",
"Economic Capital Ratio": "24.2",
"Revenues Y+2": "0",
"Revenues Y+1": "0",
"Revenues Y+5": "0",
"Revenues Y+4": "0"
},
"2012": {
"Other Liabilities": "3.31",
"Liabilities": "51.7",
"Stockholders Equity": "25.2",
"ECR before LimitedLiability": "38.3",
"Liabilities, Noncurrent": "38.9",
"Liabilities, Current": "13.7",
"Property, Plant and Equipment, Net": "-4.28",
"Assets": "-3.18",
"Intangible Assets": "0.749",
"Other Assets": "1.32",
"Assets, Current": "4.21",
"Assets, Noncurrent": "-3.70",
"Other Expenses": "0",
"Expenses": "0",
"Net Income": "0",
"Cost of Revenues": "0",
"Selling, General and Administrative Expense": "0",
"Other Revenues": "0",
"Revenues": "0",
"Other Net Income": "0",
"Comprehensive Net Income": "0",
"Other Compr. Net Income": "0",
"Revenues Y+4": "0",
"Economic Capital Ratio": "38.4",
"Revenues Y+1": "0",
"Revenues Y+5": "0",
"Revenues Y+3": "0",
"Revenues Y+2": "0"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2012/plot_over_time/0001200375_strength_weakness.svg",
"table_records": {
"2011": {
"input_variables": {
"Assets, Current": "79,232",
"Assets, Noncurrent": "972",
"Cost of Revenues": "0",
"Intangible Assets": "19,683",
"Liabilities, Current": "28,292",
"Liabilities, Noncurrent": "0",
"Other Assets": "11,859",
"Other Compr. Net Income": "-373",
"Other Expenses": "42,697",
"Other Liabilities": "0",
"Other Net Income": "273",
"Other Revenues": "123,865",
"Property, Plant and Equipment, Net": "24,176",
"Revenues Y+1": "0",
"Revenues Y+2": "0",
"Revenues Y+3": "0",
"Revenues Y+4": "0",
"Revenues Y+5": "0",
"Selling, General and Administrative Expense": "97,991"
},
"output_variables": {
"Liabilities": "28,292",
"Assets": "135,922",
"Expenses": "140,688",
"Revenues": "123,865",
"Stockholders Equity": "107,630",
"Net Income": "-16,550",
"Comprehensive Net Income": "-16,923",
"BaseVar": "6,779,051",
"ECR before LimitedLiability": "106%",
"Economic Capital Ratio": "159%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "59,769",
"Assets, Noncurrent": "2,237",
"Cost of Revenues": "0",
"Intangible Assets": "16,175",
"Liabilities, Current": "16,283",
"Liabilities, Noncurrent": "0",
"Other Assets": "5,134",
"Other Compr. Net Income": "0",
"Other Expenses": "31,243",
"Other Liabilities": "0",
"Other Net Income": "252",
"Other Revenues": "88,298",
"Property, Plant and Equipment, Net": "16,650",
"Revenues Y+1": "0",
"Revenues Y+2": "0",
"Revenues Y+3": "0",
"Revenues Y+4": "0",
"Revenues Y+5": "0",
"Selling, General and Administrative Expense": "88,164"
},
"output_variables": {
"Liabilities": "16,283",
"Assets": "99,965",
"Expenses": "119,407",
"Revenues": "88,298",
"Stockholders Equity": "83,682",
"Net Income": "-30,857",
"Comprehensive Net Income": "-30,857",
"BaseVar": "6,103,386",
"ECR before LimitedLiability": "117%",
"Economic Capital Ratio": "166%"
}
}
},
"top_rated": true,
"trend": 3.0,
"valuation": {
"past_accumulated_profits": 67782420.0,
"future_profits": 0.0,
"valuation_correction": -0.0,
"limited_liability_put_option": 28904807.31709853,
"fair_value": 96687227.31709853,
"market_value": 82990224.20250034
},
"valuation_plot": "https://www.realrate-archive.com/us_chemicals/2012/valuation/valuation_0001200375.svg",
"value": 1.6634647876453537,
"company_index": "https://www.realrate-archive.com/us_chemicals/2012/industry_indexes/0001200375.svg",
"analysing_equity": "https://www.realrate-archive.com/us_chemicals/2012/analytics/equity/0001200375.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_chemicals/2012/analytics/profit_loss/0001200375.svg"
},
{
"company_id": "0001282637",
"feature_distribution_plot": "https://www.realrate-archive.com/us_chemicals/2012/feature_distribution/feature_distribution_0001282637.svg",
"graph_url": "https://www.realrate-archive.com/us_chemicals/2012/graphs/IME_0001282637.svg",
"logo_url": "https://www.realrate-archive.com/us_chemicals/logos/0001282637.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_chemicals/logos/0001282637_256x256.png",
"name": "Newmarket CORP",
"rank": 7,
"regression_plot": "https://www.realrate-archive.com/us_chemicals/2012/backtesting_correlation/regression_0001282637.svg",
"report_text": "The relative strengths and weaknesses of Newmarket CORP are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Newmarket CORP compared to the market average is the variable Liabilities, increasing the Economic Capital Ratio by 83% points.The greatest weakness of Newmarket CORP is the variable Assets, reducing the Economic Capital Ratio by 13% points.
The company's Economic Capital Ratio, given in the ranking table, is 165%, being 37% points above the market average of 128%.",
"report_url": "https://www.realrate-archive.com/us_chemicals/2012/report/0001282637_2013_Newmarket_CORP.pdf",
"shrinked_graph_json": {
"2011": {
"Liabilities, Current": "18.3",
"Liabilities": "70.7",
"Stockholders Equity": "-27.3",
"ECR before LimitedLiability": "26.8",
"Other Liabilities": "6.13",
"Liabilities, Noncurrent": "54.1",
"Property, Plant and Equipment, Net": "-6.04",
"Assets": "-14.2",
"Intangible Assets": "-4.38",
"Other Assets": "1.49",
"Assets, Noncurrent": "-5.44",
"Assets, Current": "-6.20",
"Cost of Revenues": "0",
"Expenses": "0",
"Net Income": "0",
"Other Expenses": "0",
"Selling, General and Administrative Expense": "0",
"Other Revenues": "0",
"Revenues": "0",
"Other Compr. Net Income": "0",
"Comprehensive Net Income": "0",
"Other Net Income": "0",
"Revenues Y+3": "0",
"Economic Capital Ratio": "28.3",
"Revenues Y+2": "0",
"Revenues Y+1": "0",
"Revenues Y+5": "0",
"Revenues Y+4": "0"
},
"2012": {
"Other Liabilities": "5.21",
"Liabilities": "83.3",
"Stockholders Equity": "-8.40",
"ECR before LimitedLiability": "36.9",
"Liabilities, Noncurrent": "57.8",
"Liabilities, Current": "32.4",
"Property, Plant and Equipment, Net": "-6.31",
"Assets": "-13.0",
"Intangible Assets": "-4.40",
"Other Assets": "1.25",
"Assets, Current": "-3.51",
"Assets, Noncurrent": "-5.39",
"Other Expenses": "0",
"Expenses": "0",
"Net Income": "0",
"Cost of Revenues": "0",
"Selling, General and Administrative Expense": "0",
"Other Revenues": "0",
"Revenues": "0",
"Other Net Income": "0",
"Comprehensive Net Income": "0",
"Other Compr. Net Income": "0",
"Revenues Y+4": "0",
"Economic Capital Ratio": "36.9",
"Revenues Y+1": "0",
"Revenues Y+5": "0",
"Revenues Y+3": "0",
"Revenues Y+2": "0"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2012/plot_over_time/0001282637_strength_weakness.svg",
"table_records": {
"2011": {
"input_variables": {
"Assets, Current": "679,731",
"Assets, Noncurrent": "73,619",
"Cost of Revenues": "1,590,531",
"Intangible Assets": "0",
"Liabilities, Current": "216,024",
"Liabilities, Noncurrent": "0",
"Other Assets": "85,346",
"Other Compr. Net Income": "0",
"Other Expenses": "115,630",
"Other Liabilities": "0",
"Other Net Income": "56,704",
"Other Revenues": "2,149,558",
"Property, Plant and Equipment, Net": "352,966",
"Revenues Y+1": "0",
"Revenues Y+2": "0",
"Revenues Y+3": "0",
"Revenues Y+4": "0",
"Revenues Y+5": "0",
"Selling, General and Administrative Expense": "257,098"
},
"output_variables": {
"Liabilities": "216,024",
"Assets": "1,191,662",
"Expenses": "1,963,259",
"Revenues": "2,149,558",
"Stockholders Equity": "975,638",
"Net Income": "243,003",
"Comprehensive Net Income": "243,003",
"BaseVar": "105,994,777",
"ECR before LimitedLiability": "112%",
"Economic Capital Ratio": "163%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "735,495",
"Assets, Noncurrent": "72,007",
"Cost of Revenues": "1,585,779",
"Intangible Assets": "30,542",
"Liabilities, Current": "216,671",
"Liabilities, Noncurrent": "0",
"Other Assets": "61,095",
"Other Compr. Net Income": "-11,957",
"Other Expenses": "112,613",
"Other Liabilities": "0",
"Other Net Income": "-13,270",
"Other Revenues": "2,223,309",
"Property, Plant and Equipment, Net": "358,371",
"Revenues Y+1": "0",
"Revenues Y+2": "0",
"Revenues Y+3": "0",
"Revenues Y+4": "0",
"Revenues Y+5": "0",
"Selling, General and Administrative Expense": "272,054"
},
"output_variables": {
"Liabilities": "216,671",
"Assets": "1,257,510",
"Expenses": "1,970,446",
"Revenues": "2,223,309",
"Stockholders Equity": "1,040,839",
"Net Income": "239,593",
"Comprehensive Net Income": "227,636",
"BaseVar": "123,381,916",
"ECR before LimitedLiability": "114%",
"Economic Capital Ratio": "165%"
}
}
},
"top_rated": true,
"trend": 0.0,
"valuation": {
"past_accumulated_profits": 843079590.0,
"future_profits": 0.0,
"valuation_correction": 0.0,
"limited_liability_put_option": 372113593.401208,
"fair_value": 1215193183.401208,
"market_value": 2789369860.813698
},
"valuation_plot": "https://www.realrate-archive.com/us_chemicals/2012/valuation/valuation_0001282637.svg",
"value": 1.648634982273151,
"company_index": "https://www.realrate-archive.com/us_chemicals/2012/industry_indexes/0001282637.svg",
"analysing_equity": "https://www.realrate-archive.com/us_chemicals/2012/analytics/equity/0001282637.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_chemicals/2012/analytics/profit_loss/0001282637.svg"
},
{
"company_id": "0000896622",
"feature_distribution_plot": "https://www.realrate-archive.com/us_chemicals/2012/feature_distribution/feature_distribution_0000896622.svg",
"graph_url": "https://www.realrate-archive.com/us_chemicals/2012/graphs/IME_0000896622.svg",
"logo_url": "https://www.realrate-archive.com/us_chemicals/logos/0000896622.png",
"logo_url_256x256": "https://www.realrate-archive.com/us_chemicals/logos/0000896622_256x256.png",
"name": "Aptargroup INC",
"rank": 8,
"regression_plot": "https://www.realrate-archive.com/us_chemicals/2012/backtesting_correlation/regression_0000896622.svg",
"report_text": "The relative strengths and weaknesses of Aptargroup INC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Aptargroup INC compared to the market average is the variable Liabilities, increasing the Economic Capital Ratio by 42% points.The greatest weakness of Aptargroup INC is the variable Assets, Noncurrent, reducing the Economic Capital Ratio by 4.2% points.
The company's Economic Capital Ratio, given in the ranking table, is 161%, being 33% points above the market average of 128%.",
"report_url": "https://www.realrate-archive.com/us_chemicals/2012/report/0000896622_2013_Aptargroup_INC.pdf",
"shrinked_graph_json": {
"2011": {
"Liabilities, Current": "-8.23",
"Liabilities": "29.2",
"Stockholders Equity": "8.16",
"ECR before LimitedLiability": "18.1",
"Other Liabilities": "3.44",
"Liabilities, Noncurrent": "32.7",
"Property, Plant and Equipment, Net": "0.486",
"Assets": "-4.22",
"Intangible Assets": "0.0763",
"Other Assets": "-0.365",
"Assets, Noncurrent": "-5.04",
"Assets, Current": "0.883",
"Cost of Revenues": "0",
"Expenses": "0",
"Net Income": "0",
"Other Expenses": "0",
"Selling, General and Administrative Expense": "0",
"Other Revenues": "0",
"Revenues": "0",
"Other Compr. Net Income": "0",
"Comprehensive Net Income": "0",
"Other Net Income": "0",
"Revenues Y+3": "0",
"Economic Capital Ratio": "19.6",
"Revenues Y+2": "0",
"Revenues Y+1": "0",
"Revenues Y+5": "0",
"Revenues Y+4": "0"
},
"2012": {
"Other Liabilities": "2.95",
"Liabilities": "42.3",
"Stockholders Equity": "25.5",
"ECR before LimitedLiability": "33.2",
"Liabilities, Noncurrent": "35.4",
"Liabilities, Current": "6.15",
"Property, Plant and Equipment, Net": "0.892",
"Assets": "-1.69",
"Intangible Assets": "1.52",
"Other Assets": "-0.0205",
"Assets, Current": "0.689",
"Assets, Noncurrent": "-4.18",
"Other Expenses": "0",
"Expenses": "0",
"Net Income": "0",
"Cost of Revenues": "0",
"Selling, General and Administrative Expense": "0",
"Other Revenues": "0",
"Revenues": "0",
"Other Net Income": "0",
"Comprehensive Net Income": "0",
"Other Compr. Net Income": "0",
"Revenues Y+4": "0",
"Economic Capital Ratio": "33.3",
"Revenues Y+1": "0",
"Revenues Y+5": "0",
"Revenues Y+3": "0",
"Revenues Y+2": "0"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2012/plot_over_time/0000896622_strength_weakness.svg",
"table_records": {
"2011": {
"input_variables": {
"Assets, Current": "1,143,950",
"Assets, Noncurrent": "18,755",
"Cost of Revenues": "1,568,286",
"Intangible Assets": "238,063",
"Liabilities, Current": "518,849",
"Liabilities, Noncurrent": "0",
"Other Assets": "3,812",
"Other Compr. Net Income": "0",
"Other Expenses": "225,484",
"Other Liabilities": "0",
"Other Net Income": "-12,154",
"Other Revenues": "2,337,183",
"Property, Plant and Equipment, Net": "754,715",
"Revenues Y+1": "0",
"Revenues Y+2": "0",
"Revenues Y+3": "0",
"Revenues Y+4": "0",
"Revenues Y+5": "0",
"Selling, General and Administrative Expense": "347,629"
},
"output_variables": {
"Liabilities": "518,849",
"Assets": "2,159,295",
"Expenses": "2,141,399",
"Revenues": "2,337,183",
"Stockholders Equity": "1,640,446",
"Net Income": "183,630",
"Comprehensive Net Income": "183,630",
"BaseVar": "114,741,496",
"ECR before LimitedLiability": "99%",
"Economic Capital Ratio": "155%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "1,038,933",
"Assets, Noncurrent": "30,041",
"Cost of Revenues": "1,590,365",
"Intangible Assets": "403,512",
"Liabilities, Current": "455,323",
"Liabilities, Noncurrent": "0",
"Other Assets": "3,693",
"Other Compr. Net Income": "557",
"Other Expenses": "219,077",
"Other Liabilities": "0",
"Other Net Income": "-17,540",
"Other Revenues": "2,331,036",
"Property, Plant and Equipment, Net": "848,233",
"Revenues Y+1": "0",
"Revenues Y+2": "0",
"Revenues Y+3": "0",
"Revenues Y+4": "0",
"Revenues Y+5": "0",
"Selling, General and Administrative Expense": "341,634"
},
"output_variables": {
"Liabilities": "455,323",
"Assets": "2,324,412",
"Expenses": "2,151,076",
"Revenues": "2,331,036",
"Stockholders Equity": "1,869,089",
"Net Income": "162,420",
"Comprehensive Net Income": "162,977",
"BaseVar": "132,209,897",
"ECR before LimitedLiability": "109%",
"Economic Capital Ratio": "161%"
}
}
},
"top_rated": true,
"trend": 3.0,
"valuation": {
"past_accumulated_profits": 1513962090.0,
"future_profits": 0.0,
"valuation_correction": 0.0,
"limited_liability_put_option": 726993072.7368814,
"fair_value": 2240955162.7368813,
"market_value": 2613958093.6143494
},
"valuation_plot": "https://www.realrate-archive.com/us_chemicals/2012/valuation/valuation_0000896622.svg",
"value": 1.6123516541950087,
"company_index": "https://www.realrate-archive.com/us_chemicals/2012/industry_indexes/0000896622.svg",
"analysing_equity": "https://www.realrate-archive.com/us_chemicals/2012/analytics/equity/0000896622.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_chemicals/2012/analytics/profit_loss/0000896622.svg"
},
{
"company_id": "0000060714",
"feature_distribution_plot": "https://www.realrate-archive.com/us_chemicals/2012/feature_distribution/feature_distribution_0000060714.svg",
"graph_url": "https://www.realrate-archive.com/us_chemicals/2012/graphs/IME_0000060714.svg",
"logo_url": "https://www.realrate-archive.com/us_chemicals/logos/0000060714.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_chemicals/logos/0000060714_256x256.png",
"name": "LSB Industries INC",
"rank": 9,
"regression_plot": "https://www.realrate-archive.com/us_chemicals/2012/backtesting_correlation/regression_0000060714.svg",
"report_text": "The relative strengths and weaknesses of LSB Industries INC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of LSB Industries INC compared to the market average is the variable Liabilities, increasing the Economic Capital Ratio by 59% points.The greatest weakness of LSB Industries INC is the variable Assets, reducing the Economic Capital Ratio by 8.9% points.
The company's Economic Capital Ratio, given in the ranking table, is 160%, being 32% points above the market average of 128%.",
"report_url": "https://www.realrate-archive.com/us_chemicals/2012/report/0000060714_2013_LSB_Industries_INC.pdf",
"shrinked_graph_json": {
"2011": {
"Liabilities, Current": "11.1",
"Liabilities": "59.4",
"Stockholders Equity": "-15.5",
"ECR before LimitedLiability": "25.0",
"Other Liabilities": "5.29",
"Liabilities, Noncurrent": "47.8",
"Property, Plant and Equipment, Net": "-4.21",
"Assets": "-12.4",
"Intangible Assets": "-4.01",
"Other Assets": "-0.528",
"Assets, Noncurrent": "-5.90",
"Assets, Current": "-2.34",
"Cost of Revenues": "0",
"Expenses": "0",
"Net Income": "0",
"Other Expenses": "0",
"Selling, General and Administrative Expense": "0",
"Other Revenues": "0",
"Revenues": "0",
"Other Compr. Net Income": "0",
"Comprehensive Net Income": "0",
"Other Net Income": "0",
"Revenues Y+3": "0",
"Economic Capital Ratio": "26.4",
"Revenues Y+2": "0",
"Revenues Y+1": "0",
"Revenues Y+5": "0",
"Revenues Y+4": "0"
},
"2012": {
"Other Liabilities": "3.82",
"Liabilities": "58.5",
"Stockholders Equity": "8.87",
"ECR before LimitedLiability": "32.2",
"Liabilities, Noncurrent": "44.5",
"Liabilities, Current": "15.3",
"Property, Plant and Equipment, Net": "1.54",
"Assets": "-8.91",
"Intangible Assets": "-4.29",
"Other Assets": "-0.0909",
"Assets, Current": "-1.81",
"Assets, Noncurrent": "-5.48",
"Other Expenses": "0",
"Expenses": "0",
"Net Income": "0",
"Cost of Revenues": "0",
"Selling, General and Administrative Expense": "0",
"Other Revenues": "0",
"Revenues": "0",
"Other Net Income": "0",
"Comprehensive Net Income": "0",
"Other Compr. Net Income": "0",
"Revenues Y+4": "0",
"Economic Capital Ratio": "32.2",
"Revenues Y+1": "0",
"Revenues Y+5": "0",
"Revenues Y+3": "0",
"Revenues Y+2": "0"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2012/plot_over_time/0000060714_strength_weakness.svg",
"table_records": {
"2011": {
"input_variables": {
"Assets, Current": "328,106",
"Assets, Noncurrent": "7,632",
"Cost of Revenues": "582,238",
"Intangible Assets": "1,724",
"Liabilities, Current": "97,149",
"Liabilities, Noncurrent": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "57,036",
"Other Liabilities": "0",
"Other Net Income": "265",
"Other Revenues": "809,194",
"Property, Plant and Equipment, Net": "164,547",
"Revenues Y+1": "0",
"Revenues Y+2": "0",
"Revenues Y+3": "0",
"Revenues Y+4": "0",
"Revenues Y+5": "0",
"Selling, General and Administrative Expense": "86,343"
},
"output_variables": {
"Liabilities": "97,149",
"Assets": "502,009",
"Expenses": "725,617",
"Revenues": "809,194",
"Stockholders Equity": "404,860",
"Net Income": "83,842",
"Comprehensive Net Income": "83,842",
"BaseVar": "39,064,124",
"ECR before LimitedLiability": "109%",
"Economic Capital Ratio": "162%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "284,747",
"Assets, Noncurrent": "8,270",
"Cost of Revenues": "575,295",
"Intangible Assets": "1,724",
"Liabilities, Current": "117,083",
"Liabilities, Noncurrent": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "39,735",
"Other Liabilities": "0",
"Other Net Income": "780",
"Other Revenues": "762,842",
"Property, Plant and Equipment, Net": "281,871",
"Revenues Y+1": "0",
"Revenues Y+2": "0",
"Revenues Y+3": "0",
"Revenues Y+4": "0",
"Revenues Y+5": "0",
"Selling, General and Administrative Expense": "89,988"
},
"output_variables": {
"Liabilities": "117,083",
"Assets": "576,612",
"Expenses": "705,018",
"Revenues": "762,842",
"Stockholders Equity": "459,529",
"Net Income": "58,604",
"Comprehensive Net Income": "58,604",
"BaseVar": "43,039,871",
"ECR before LimitedLiability": "107%",
"Economic Capital Ratio": "160%"
}
}
},
"top_rated": false,
"trend": -1.0,
"valuation": {
"past_accumulated_profits": 372218490.0,
"future_profits": 0.0,
"valuation_correction": 0.0,
"limited_liability_put_option": 183278335.80366024,
"fair_value": 555496825.8036603,
"market_value": 767636211.515316
},
"valuation_plot": "https://www.realrate-archive.com/us_chemicals/2012/valuation/valuation_0000060714.svg",
"value": 1.6015592610690872,
"company_index": "https://www.realrate-archive.com/us_chemicals/2012/industry_indexes/0000060714.svg",
"analysing_equity": "https://www.realrate-archive.com/us_chemicals/2012/analytics/equity/0000060714.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_chemicals/2012/analytics/profit_loss/0000060714.svg"
},
{
"company_id": "0000069488",
"feature_distribution_plot": "https://www.realrate-archive.com/us_chemicals/2012/feature_distribution/feature_distribution_0000069488.svg",
"graph_url": "https://www.realrate-archive.com/us_chemicals/2012/graphs/IME_0000069488.svg",
"logo_url": "https://www.realrate-archive.com/us_chemicals/logos/0000069488.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_chemicals/logos/0000069488_256x256.png",
"name": "Myers Industries INC",
"rank": 10,
"regression_plot": "https://www.realrate-archive.com/us_chemicals/2012/backtesting_correlation/regression_0000069488.svg",
"report_text": "The relative strengths and weaknesses of Myers Industries INC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Myers Industries INC compared to the market average is the variable Liabilities, increasing the Economic Capital Ratio by 70% points.The greatest weakness of Myers Industries INC is the variable Assets, reducing the Economic Capital Ratio by 16% points.
The company's Economic Capital Ratio, given in the ranking table, is 155%, being 27% points above the market average of 128%.",
"report_url": "https://www.realrate-archive.com/us_chemicals/2012/report/0000069488_2013_Myers_Industries_INC.pdf",
"shrinked_graph_json": {
"2011": {
"Liabilities, Current": "6.63",
"Liabilities": "58.8",
"Stockholders Equity": "-31.5",
"ECR before LimitedLiability": "15.6",
"Other Liabilities": "5.55",
"Liabilities, Noncurrent": "50.3",
"Property, Plant and Equipment, Net": "-6.91",
"Assets": "-18.4",
"Intangible Assets": "-1.22",
"Other Assets": "-5.24",
"Assets, Noncurrent": "-4.27",
"Assets, Current": "-9.29",
"Cost of Revenues": "0",
"Expenses": "0",
"Net Income": "0",
"Other Expenses": "0",
"Selling, General and Administrative Expense": "0",
"Other Revenues": "0",
"Revenues": "0",
"Other Compr. Net Income": "0",
"Comprehensive Net Income": "0",
"Other Net Income": "0",
"Revenues Y+3": "0",
"Economic Capital Ratio": "17.0",
"Revenues Y+2": "0",
"Revenues Y+1": "0",
"Revenues Y+5": "0",
"Revenues Y+4": "0"
},
"2012": {
"Other Liabilities": "4.60",
"Liabilities": "70.4",
"Stockholders Equity": "-10.2",
"ECR before LimitedLiability": "27.3",
"Liabilities, Noncurrent": "52.6",
"Liabilities, Current": "20.7",
"Property, Plant and Equipment, Net": "-6.85",
"Assets": "-15.6",
"Intangible Assets": "-0.869",
"Other Assets": "-5.37",
"Assets, Current": "-5.95",
"Assets, Noncurrent": "-2.86",
"Other Expenses": "0",
"Expenses": "0",
"Net Income": "0",
"Cost of Revenues": "0",
"Selling, General and Administrative Expense": "0",
"Other Revenues": "0",
"Revenues": "0",
"Other Net Income": "0",
"Comprehensive Net Income": "0",
"Other Compr. Net Income": "0",
"Revenues Y+4": "0",
"Economic Capital Ratio": "27.4",
"Revenues Y+1": "0",
"Revenues Y+5": "0",
"Revenues Y+3": "0",
"Revenues Y+2": "0"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2012/plot_over_time/0000069488_strength_weakness.svg",
"table_records": {
"2011": {
"input_variables": {
"Assets, Current": "218,452",
"Assets, Noncurrent": "69,371",
"Cost of Revenues": "557,385",
"Intangible Assets": "61,933",
"Liabilities, Current": "110,656",
"Liabilities, Noncurrent": "0",
"Other Assets": "-61,933",
"Other Compr. Net Income": "0",
"Other Expenses": "173,764",
"Other Liabilities": "0",
"Other Net Income": "0",
"Other Revenues": "755,654",
"Property, Plant and Equipment, Net": "140,934",
"Revenues Y+1": "0",
"Revenues Y+2": "0",
"Revenues Y+3": "0",
"Revenues Y+4": "0",
"Revenues Y+5": "0",
"Selling, General and Administrative Expense": "0"
},
"output_variables": {
"Liabilities": "110,656",
"Assets": "428,757",
"Expenses": "731,149",
"Revenues": "755,654",
"Stockholders Equity": "318,101",
"Net Income": "24,505",
"Comprehensive Net Income": "24,505",
"BaseVar": "37,815,237",
"ECR before LimitedLiability": "96%",
"Economic Capital Ratio": "152%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "239,596",
"Assets, Noncurrent": "94,777",
"Cost of Revenues": "575,907",
"Intangible Assets": "86,895",
"Liabilities, Current": "114,477",
"Liabilities, Noncurrent": "0",
"Other Assets": "-86,895",
"Other Compr. Net Income": "3,349",
"Other Expenses": "185,319",
"Other Liabilities": "0",
"Other Net Income": "0",
"Other Revenues": "791,188",
"Property, Plant and Equipment, Net": "150,483",
"Revenues Y+1": "0",
"Revenues Y+2": "0",
"Revenues Y+3": "0",
"Revenues Y+4": "0",
"Revenues Y+5": "0",
"Selling, General and Administrative Expense": "0"
},
"output_variables": {
"Liabilities": "114,477",
"Assets": "484,856",
"Expenses": "761,226",
"Revenues": "791,188",
"Stockholders Equity": "370,379",
"Net Income": "29,962",
"Comprehensive Net Income": "33,311",
"BaseVar": "45,525,335",
"ECR before LimitedLiability": "100%",
"Economic Capital Ratio": "155%"
}
}
},
"top_rated": false,
"trend": 3.0,
"valuation": {
"past_accumulated_profits": 300006990.0,
"future_profits": 0.0,
"valuation_correction": 0.0,
"limited_liability_put_option": 165390872.28026128,
"fair_value": 465397862.2802613,
"market_value": 329107883.0142288
},
"valuation_plot": "https://www.realrate-archive.com/us_chemicals/2012/valuation/valuation_0000069488.svg",
"value": 1.5530526845018087,
"company_index": "https://www.realrate-archive.com/us_chemicals/2012/industry_indexes/0000069488.svg",
"analysing_equity": "https://www.realrate-archive.com/us_chemicals/2012/analytics/equity/0000069488.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_chemicals/2012/analytics/profit_loss/0000069488.svg"
},
{
"company_id": "0001337298",
"feature_distribution_plot": "https://www.realrate-archive.com/us_chemicals/2012/feature_distribution/feature_distribution_0001337298.svg",
"graph_url": "https://www.realrate-archive.com/us_chemicals/2012/graphs/IME_0001337298.svg",
"logo_url": "https://www.realrate-archive.com/us_chemicals/logos/0001337298.png",
"logo_url_256x256": "https://www.realrate-archive.com/us_chemicals/logos/0001337298_256x256.png",
"name": "Futurefuel Corp",
"rank": 11,
"regression_plot": "https://www.realrate-archive.com/us_chemicals/2012/backtesting_correlation/regression_0001337298.svg",
"report_text": "The relative strengths and weaknesses of Futurefuel Corp are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Futurefuel Corp compared to the market average is the variable Liabilities, increasing the Economic Capital Ratio by 30% points.The greatest weakness of Futurefuel Corp is the variable Other Assets, reducing the Economic Capital Ratio by 11% points.
The company's Economic Capital Ratio, given in the ranking table, is 151%, being 23% points above the market average of 128%.",
"report_url": "https://www.realrate-archive.com/us_chemicals/2012/report/0001337298_2013_Futurefuel_Corp.pdf",
"shrinked_graph_json": {
"2011": {
"Liabilities, Current": "5.99",
"Liabilities": "12.6",
"Stockholders Equity": "23.5",
"ECR before LimitedLiability": "16.4",
"Other Liabilities": "3.59",
"Liabilities, Noncurrent": "3.42",
"Property, Plant and Equipment, Net": "4.63",
"Assets": "6.62",
"Intangible Assets": "-2.65",
"Other Assets": "-10.1",
"Assets, Noncurrent": "10.8",
"Assets, Current": "11.7",
"Cost of Revenues": "0",
"Expenses": "0",
"Net Income": "0",
"Other Expenses": "0",
"Selling, General and Administrative Expense": "0",
"Other Revenues": "0",
"Revenues": "0",
"Other Compr. Net Income": "0",
"Comprehensive Net Income": "0",
"Other Net Income": "0",
"Revenues Y+3": "0",
"Economic Capital Ratio": "17.9",
"Revenues Y+2": "0",
"Revenues Y+1": "0",
"Revenues Y+5": "0",
"Revenues Y+4": "0"
},
"2012": {
"Other Liabilities": "4.12",
"Liabilities": "30.4",
"Stockholders Equity": "19.6",
"ECR before LimitedLiability": "22.9",
"Liabilities, Noncurrent": "11.4",
"Liabilities, Current": "16.8",
"Property, Plant and Equipment, Net": "2.53",
"Assets": "-1.13",
"Intangible Assets": "-4.07",
"Other Assets": "-10.9",
"Assets, Current": "8.39",
"Assets, Noncurrent": "10.6",
"Other Expenses": "0",
"Expenses": "0",
"Net Income": "0",
"Cost of Revenues": "0",
"Selling, General and Administrative Expense": "0",
"Other Revenues": "0",
"Revenues": "0",
"Other Net Income": "0",
"Comprehensive Net Income": "0",
"Other Compr. Net Income": "0",
"Revenues Y+4": "0",
"Economic Capital Ratio": "23.0",
"Revenues Y+1": "0",
"Revenues Y+5": "0",
"Revenues Y+3": "0",
"Revenues Y+2": "0"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2012/plot_over_time/0001337298_strength_weakness.svg",
"table_records": {
"2011": {
"input_variables": {
"Assets, Current": "242,525",
"Assets, Noncurrent": "142,719",
"Cost of Revenues": "0",
"Intangible Assets": "0",
"Liabilities, Current": "35,799",
"Liabilities, Noncurrent": "64,230",
"Other Assets": "-140,517",
"Other Compr. Net Income": "1,278",
"Other Expenses": "266,396",
"Other Liabilities": "-3,023",
"Other Net Income": "6,431",
"Other Revenues": "304,614",
"Property, Plant and Equipment, Net": "140,517",
"Revenues Y+1": "0",
"Revenues Y+2": "0",
"Revenues Y+3": "0",
"Revenues Y+4": "0",
"Revenues Y+5": "0",
"Selling, General and Administrative Expense": "10,140"
},
"output_variables": {
"Liabilities": "97,006",
"Assets": "385,244",
"Expenses": "276,536",
"Revenues": "304,614",
"Stockholders Equity": "288,238",
"Net Income": "34,509",
"Comprehensive Net Income": "35,787",
"BaseVar": "15,111,302",
"ECR before LimitedLiability": "97%",
"Economic Capital Ratio": "153%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "213,936",
"Assets, Noncurrent": "141,301",
"Cost of Revenues": "0",
"Intangible Assets": "0",
"Liabilities, Current": "36,234",
"Liabilities, Noncurrent": "62,556",
"Other Assets": "-138,865",
"Other Compr. Net Income": "-10,994",
"Other Expenses": "302,293",
"Other Liabilities": "-3,887",
"Other Net Income": "338,812",
"Other Revenues": "13,017",
"Property, Plant and Equipment, Net": "138,865",
"Revenues Y+1": "0",
"Revenues Y+2": "0",
"Revenues Y+3": "0",
"Revenues Y+4": "0",
"Revenues Y+5": "0",
"Selling, General and Administrative Expense": "3,444"
},
"output_variables": {
"Liabilities": "94,903",
"Assets": "355,237",
"Expenses": "305,737",
"Revenues": "13,017",
"Stockholders Equity": "260,334",
"Net Income": "46,092",
"Comprehensive Net Income": "35,098",
"BaseVar": "19,659,954",
"ECR before LimitedLiability": "94%",
"Economic Capital Ratio": "151%"
}
}
},
"top_rated": false,
"trend": 1.0,
"valuation": {
"past_accumulated_profits": 210870540.0,
"future_profits": 0.0,
"valuation_correction": 0.0,
"limited_liability_put_option": 128807459.92987879,
"fair_value": 339677999.9298788,
"market_value": 124499857.41162099
},
"valuation_plot": "https://www.realrate-archive.com/us_chemicals/2012/valuation/valuation_0001337298.svg",
"value": 1.5092104675428923,
"company_index": "https://www.realrate-archive.com/us_chemicals/2012/industry_indexes/0001337298.svg",
"analysing_equity": "https://www.realrate-archive.com/us_chemicals/2012/analytics/equity/0001337298.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_chemicals/2012/analytics/profit_loss/0001337298.svg"
},
{
"company_id": "0000744187",
"feature_distribution_plot": "https://www.realrate-archive.com/us_chemicals/2012/feature_distribution/feature_distribution_0000744187.svg",
"graph_url": "https://www.realrate-archive.com/us_chemicals/2012/graphs/IME_0000744187.svg",
"logo_url": "https://www.realrate-archive.com/us_chemicals/logos/0000000000.png",
"logo_url_256x256": "https://www.realrate-archive.com/us_chemicals/logos/0000000000_256x256.png",
"name": "REX American Resources Corp",
"rank": 12,
"regression_plot": "https://www.realrate-archive.com/us_chemicals/2012/backtesting_correlation/regression_0000744187.svg",
"report_text": "The relative strengths and weaknesses of REX American Resources Corp are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of REX American Resources Corp compared to the market average is the variable Liabilities, increasing the Economic Capital Ratio by 20% points.The greatest weakness of REX American Resources Corp is the variable Assets, Current, reducing the Economic Capital Ratio by 5.5% points.
The company's Economic Capital Ratio, given in the ranking table, is 139%, being 11% points above the market average of 128%.",
"report_url": "https://www.realrate-archive.com/us_chemicals/2012/report/0000744187_2013_REX_American_Resources_Corp.pdf",
"shrinked_graph_json": {
"2011": {
"Liabilities, Current": "10.8",
"Liabilities": "12.2",
"Stockholders Equity": "16.6",
"ECR before LimitedLiability": "12.3",
"Other Liabilities": "2.64",
"Liabilities, Noncurrent": "-1.18",
"Property, Plant and Equipment, Net": "8.36",
"Assets": "3.71",
"Intangible Assets": "-3.10",
"Other Assets": "0.314",
"Assets, Noncurrent": "2.16",
"Assets, Current": "-2.52",
"Cost of Revenues": "0",
"Expenses": "0",
"Net Income": "0",
"Other Expenses": "0",
"Selling, General and Administrative Expense": "0",
"Other Revenues": "0",
"Revenues": "0",
"Other Compr. Net Income": "0",
"Comprehensive Net Income": "0",
"Other Net Income": "0",
"Revenues Y+3": "0",
"Economic Capital Ratio": "13.8",
"Revenues Y+2": "0",
"Revenues Y+1": "0",
"Revenues Y+5": "0",
"Revenues Y+4": "0"
},
"2012": {
"Other Liabilities": "2.50",
"Liabilities": "20.4",
"Stockholders Equity": "9.51",
"ECR before LimitedLiability": "11.1",
"Liabilities, Noncurrent": "-0.136",
"Liabilities, Current": "18.3",
"Property, Plant and Equipment, Net": "11.6",
"Assets": "-2.77",
"Intangible Assets": "-5.12",
"Other Assets": "0.0371",
"Assets, Current": "-5.53",
"Assets, Noncurrent": "-0.690",
"Other Expenses": "0",
"Expenses": "0",
"Net Income": "0",
"Cost of Revenues": "0",
"Selling, General and Administrative Expense": "0",
"Other Revenues": "0",
"Revenues": "0",
"Other Net Income": "0",
"Comprehensive Net Income": "0",
"Other Compr. Net Income": "0",
"Revenues Y+4": "0",
"Economic Capital Ratio": "11.1",
"Revenues Y+1": "0",
"Revenues Y+5": "0",
"Revenues Y+3": "0",
"Revenues Y+2": "0"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2012/plot_over_time/0000744187_strength_weakness.svg",
"table_records": {
"2011": {
"input_variables": {
"Assets, Current": "125,849",
"Assets, Noncurrent": "73,256",
"Cost of Revenues": "270,777",
"Intangible Assets": "0",
"Liabilities, Current": "24,567",
"Liabilities, Noncurrent": "81,191",
"Other Assets": "6,806",
"Other Compr. Net Income": "0",
"Other Expenses": "27,000",
"Other Liabilities": "0",
"Other Net Income": "14,524",
"Other Revenues": "301,717",
"Property, Plant and Equipment, Net": "169,811",
"Revenues Y+1": "0",
"Revenues Y+2": "0",
"Revenues Y+3": "0",
"Revenues Y+4": "0",
"Revenues Y+5": "0",
"Selling, General and Administrative Expense": "9,722"
},
"output_variables": {
"Liabilities": "105,758",
"Assets": "375,722",
"Expenses": "307,499",
"Revenues": "301,717",
"Stockholders Equity": "269,964",
"Net Income": "8,742",
"Comprehensive Net Income": "8,742",
"BaseVar": "15,991,750",
"ECR before LimitedLiability": "91%",
"Economic Capital Ratio": "149%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "127,039",
"Assets, Noncurrent": "69,563",
"Cost of Revenues": "375,921",
"Intangible Assets": "0",
"Liabilities, Current": "37,241",
"Liabilities, Noncurrent": "118,965",
"Other Assets": "1,363",
"Other Compr. Net Income": "-5,428",
"Other Expenses": "19,416",
"Other Liabilities": "0",
"Other Net Income": "28,864",
"Other Revenues": "410,548",
"Property, Plant and Equipment, Net": "240,084",
"Revenues Y+1": "0",
"Revenues Y+2": "0",
"Revenues Y+3": "0",
"Revenues Y+4": "0",
"Revenues Y+5": "0",
"Selling, General and Administrative Expense": "10,377"
},
"output_variables": {
"Liabilities": "156,206",
"Assets": "438,049",
"Expenses": "405,714",
"Revenues": "410,548",
"Stockholders Equity": "281,843",
"Net Income": "33,698",
"Comprehensive Net Income": "28,270",
"BaseVar": "25,022,534",
"ECR before LimitedLiability": "77%",
"Economic Capital Ratio": "139%"
}
}
},
"top_rated": false,
"trend": 2.0,
"valuation": {
"past_accumulated_profits": 228292830.00000003,
"future_profits": 0.0,
"valuation_correction": 0.0,
"limited_liability_put_option": 184901712.5608164,
"fair_value": 413194542.5608164,
"market_value": 154743100.83401725
},
"valuation_plot": "https://www.realrate-archive.com/us_chemicals/2012/valuation/valuation_0000744187.svg",
"value": 1.3906304282195907,
"company_index": "https://www.realrate-archive.com/us_chemicals/2012/industry_indexes/0000744187.svg",
"analysing_equity": "https://www.realrate-archive.com/us_chemicals/2012/analytics/equity/0000744187.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_chemicals/2012/analytics/profit_loss/0000744187.svg"
},
{
"company_id": "0001392380",
"feature_distribution_plot": "https://www.realrate-archive.com/us_chemicals/2012/feature_distribution/feature_distribution_0001392380.svg",
"graph_url": "https://www.realrate-archive.com/us_chemicals/2012/graphs/IME_0001392380.svg",
"logo_url": "https://www.realrate-archive.com/us_chemicals/logos/0001392380.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_chemicals/logos/0001392380_256x256.png",
"name": "Gevo Inc",
"rank": 13,
"regression_plot": "https://www.realrate-archive.com/us_chemicals/2012/backtesting_correlation/regression_0001392380.svg",
"report_text": "The relative strengths and weaknesses of Gevo Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Gevo Inc compared to the market average is the variable Liabilities, Noncurrent, increasing the Economic Capital Ratio by 39% points.The greatest weakness of Gevo Inc is the variable Other Liabilities, reducing the Economic Capital Ratio by 34% points.
The company's Economic Capital Ratio, given in the ranking table, is 137%, being 9.0% points above the market average of 128%.",
"report_url": "https://www.realrate-archive.com/us_chemicals/2012/report/0001392380_2013_Gevo_Inc.pdf",
"shrinked_graph_json": {
"2011": {
"Liabilities, Current": "9.79",
"Liabilities": "23.6",
"Stockholders Equity": "-1.93",
"ECR before LimitedLiability": "8.84",
"Other Liabilities": "-23.4",
"Liabilities, Noncurrent": "32.8",
"Property, Plant and Equipment, Net": "-5.19",
"Assets": "-7.45",
"Intangible Assets": "-4.30",
"Other Assets": "-0.232",
"Assets, Noncurrent": "-6.54",
"Assets, Current": "11.9",
"Cost of Revenues": "0",
"Expenses": "0",
"Net Income": "0",
"Other Expenses": "0",
"Selling, General and Administrative Expense": "0",
"Other Revenues": "0",
"Revenues": "0",
"Other Compr. Net Income": "0",
"Comprehensive Net Income": "0",
"Other Net Income": "0",
"Revenues Y+3": "0",
"Economic Capital Ratio": "10.3",
"Revenues Y+2": "0",
"Revenues Y+1": "0",
"Revenues Y+5": "0",
"Revenues Y+4": "0"
},
"2012": {
"Other Liabilities": "-33.6",
"Liabilities": "36.7",
"Stockholders Equity": "-7.36",
"ECR before LimitedLiability": "8.95",
"Liabilities, Noncurrent": "39.2",
"Liabilities, Current": "24.3",
"Property, Plant and Equipment, Net": "2.16",
"Assets": "-14.5",
"Intangible Assets": "-6.83",
"Other Assets": "0.379",
"Assets, Current": "-3.58",
"Assets, Noncurrent": "-8.80",
"Other Expenses": "0",
"Expenses": "0",
"Net Income": "0",
"Cost of Revenues": "0",
"Selling, General and Administrative Expense": "0",
"Other Revenues": "0",
"Revenues": "0",
"Other Net Income": "0",
"Comprehensive Net Income": "0",
"Other Compr. Net Income": "0",
"Revenues Y+4": "0",
"Economic Capital Ratio": "9.02",
"Revenues Y+1": "0",
"Revenues Y+5": "0",
"Revenues Y+3": "0",
"Revenues Y+2": "0"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2012/plot_over_time/0001392380_strength_weakness.svg",
"table_records": {
"2011": {
"input_variables": {
"Assets, Current": "102,734",
"Assets, Noncurrent": "502",
"Cost of Revenues": "0",
"Intangible Assets": "0",
"Liabilities, Current": "16,117",
"Liabilities, Noncurrent": "24",
"Other Assets": "1,017",
"Other Compr. Net Income": "0",
"Other Expenses": "75,282",
"Other Liabilities": "24,752",
"Other Net Income": "-10,710",
"Other Revenues": "82,188",
"Property, Plant and Equipment, Net": "28,777",
"Revenues Y+1": "0",
"Revenues Y+2": "0",
"Revenues Y+3": "0",
"Revenues Y+4": "0",
"Revenues Y+5": "0",
"Selling, General and Administrative Expense": "127,544"
},
"output_variables": {
"Liabilities": "40,893",
"Assets": "133,030",
"Expenses": "202,826",
"Revenues": "82,188",
"Stockholders Equity": "92,137",
"Net Income": "-131,348",
"Comprehensive Net Income": "-131,348",
"BaseVar": "7,554,739",
"ECR before LimitedLiability": "86%",
"Economic Capital Ratio": "145%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "75,880",
"Assets, Noncurrent": "1,402",
"Cost of Revenues": "0",
"Intangible Assets": "0",
"Liabilities, Current": "16,769",
"Liabilities, Noncurrent": "512",
"Other Assets": "1,736",
"Other Compr. Net Income": "0",
"Other Expenses": "107,692",
"Other Liabilities": "40,999",
"Other Net Income": "15",
"Other Revenues": "106,573",
"Property, Plant and Equipment, Net": "77,093",
"Revenues Y+1": "0",
"Revenues Y+2": "0",
"Revenues Y+3": "0",
"Revenues Y+4": "0",
"Revenues Y+5": "0",
"Selling, General and Administrative Expense": "190,956"
},
"output_variables": {
"Liabilities": "58,280",
"Assets": "156,111",
"Expenses": "298,648",
"Revenues": "106,573",
"Stockholders Equity": "97,831",
"Net Income": "-192,060",
"Comprehensive Net Income": "-192,060",
"BaseVar": "11,887,312",
"ECR before LimitedLiability": "74%",
"Economic Capital Ratio": "137%"
}
}
},
"top_rated": false,
"trend": 2.0,
"valuation": {
"past_accumulated_profits": 79243110.0,
"future_profits": 0.0,
"valuation_correction": -0.0,
"limited_liability_put_option": 67565437.4143366,
"fair_value": 146808547.41433662,
"market_value": 0.0
},
"valuation_plot": "https://www.realrate-archive.com/us_chemicals/2012/valuation/valuation_0001392380.svg",
"value": 1.3695402084447257,
"company_index": "https://www.realrate-archive.com/us_chemicals/2012/industry_indexes/0001392380.svg",
"analysing_equity": "https://www.realrate-archive.com/us_chemicals/2012/analytics/equity/0001392380.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_chemicals/2012/analytics/profit_loss/0001392380.svg"
},
{
"company_id": "0000717605",
"feature_distribution_plot": "https://www.realrate-archive.com/us_chemicals/2012/feature_distribution/feature_distribution_0000717605.svg",
"graph_url": "https://www.realrate-archive.com/us_chemicals/2012/graphs/IME_0000717605.svg",
"logo_url": "https://www.realrate-archive.com/us_chemicals/logos/0000717605.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_chemicals/logos/0000717605_256x256.png",
"name": "Hexcel CORP DE",
"rank": 14,
"regression_plot": "https://www.realrate-archive.com/us_chemicals/2012/backtesting_correlation/regression_0000717605.svg",
"report_text": "The relative strengths and weaknesses of Hexcel CORP DE are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Hexcel CORP DE compared to the market average is the variable Liabilities, increasing the Economic Capital Ratio by 16% points.The greatest weakness of Hexcel CORP DE is the variable Assets, Noncurrent, reducing the Economic Capital Ratio by 6.6% points.
The company's Economic Capital Ratio, given in the ranking table, is 136%, being 8.2% points above the market average of 128%.",
"report_url": "https://www.realrate-archive.com/us_chemicals/2012/report/0000717605_2013_Hexcel_CORP_DE.pdf",
"shrinked_graph_json": {
"2011": {
"Liabilities, Current": "-0.998",
"Liabilities": "2.14",
"Stockholders Equity": "-3.25",
"ECR before LimitedLiability": "-5.04",
"Other Liabilities": "-3.31",
"Liabilities, Noncurrent": "6.29",
"Property, Plant and Equipment, Net": "13.1",
"Assets": "-2.70",
"Intangible Assets": "-4.66",
"Other Assets": "3.73",
"Assets, Noncurrent": "-6.76",
"Assets, Current": "-4.11",
"Cost of Revenues": "0",
"Expenses": "0",
"Net Income": "0",
"Other Expenses": "0",
"Selling, General and Administrative Expense": "0",
"Other Revenues": "0",
"Revenues": "0",
"Other Compr. Net Income": "0",
"Comprehensive Net Income": "0",
"Other Net Income": "0",
"Revenues Y+3": "0",
"Economic Capital Ratio": "-3.57",
"Revenues Y+2": "0",
"Revenues Y+1": "0",
"Revenues Y+5": "0",
"Revenues Y+4": "0"
},
"2012": {
"Other Liabilities": "-3.97",
"Liabilities": "15.8",
"Stockholders Equity": "8.79",
"ECR before LimitedLiability": "8.13",
"Liabilities, Noncurrent": "9.66",
"Liabilities, Current": "10.2",
"Property, Plant and Equipment, Net": "14.5",
"Assets": "-1.54",
"Intangible Assets": "-5.21",
"Other Assets": "2.86",
"Assets, Current": "-2.46",
"Assets, Noncurrent": "-6.62",
"Other Expenses": "0",
"Expenses": "0",
"Net Income": "0",
"Cost of Revenues": "0",
"Selling, General and Administrative Expense": "0",
"Other Revenues": "0",
"Revenues": "0",
"Other Net Income": "0",
"Comprehensive Net Income": "0",
"Other Compr. Net Income": "0",
"Revenues Y+4": "0",
"Economic Capital Ratio": "8.20",
"Revenues Y+1": "0",
"Revenues Y+5": "0",
"Revenues Y+3": "0",
"Revenues Y+2": "0"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2012/plot_over_time/0000717605_strength_weakness.svg",
"table_records": {
"2011": {
"input_variables": {
"Assets, Current": "524,300",
"Assets, Noncurrent": "17,600",
"Cost of Revenues": "0",
"Intangible Assets": "0",
"Liabilities, Current": "247,500",
"Liabilities, Noncurrent": "257,900",
"Other Assets": "112,100",
"Other Compr. Net Income": "0",
"Other Expenses": "1,100,500",
"Other Liabilities": "68,500",
"Other Net Income": "-4,900",
"Other Revenues": "1,392,400",
"Property, Plant and Equipment, Net": "722,100",
"Revenues Y+1": "0",
"Revenues Y+2": "0",
"Revenues Y+3": "0",
"Revenues Y+4": "0",
"Revenues Y+5": "0",
"Selling, General and Administrative Expense": "153,100"
},
"output_variables": {
"Liabilities": "573,900",
"Assets": "1,376,100",
"Expenses": "1,253,600",
"Revenues": "1,392,400",
"Stockholders Equity": "802,200",
"Net Income": "133,900",
"Comprehensive Net Income": "133,900",
"BaseVar": "67,916,919",
"ECR before LimitedLiability": "67%",
"Economic Capital Ratio": "132%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "575,700",
"Assets, Noncurrent": "17,200",
"Cost of Revenues": "0",
"Intangible Assets": "0",
"Liabilities, Current": "235,300",
"Liabilities, Noncurrent": "292,400",
"Other Assets": "95,800",
"Other Compr. Net Income": "8,600",
"Other Expenses": "1,255,600",
"Other Liabilities": "81,300",
"Other Net Income": "-1,100",
"Other Revenues": "1,587,700",
"Property, Plant and Equipment, Net": "914,400",
"Revenues Y+1": "0",
"Revenues Y+2": "0",
"Revenues Y+3": "0",
"Revenues Y+4": "0",
"Revenues Y+5": "0",
"Selling, General and Administrative Expense": "167,400"
},
"output_variables": {
"Liabilities": "609,000",
"Assets": "1,603,100",
"Expenses": "1,423,000",
"Revenues": "1,587,700",
"Stockholders Equity": "994,100",
"Net Income": "163,600",
"Comprehensive Net Income": "172,200",
"BaseVar": "88,908,376",
"ECR before LimitedLiability": "73%",
"Economic Capital Ratio": "136%"
}
}
},
"top_rated": false,
"trend": 4.0,
"valuation": {
"past_accumulated_profits": 805221000.0,
"future_profits": 0.0,
"valuation_correction": 0.0,
"limited_liability_put_option": 700497623.055158,
"fair_value": 1505718623.0551581,
"market_value": 2454591037.709755
},
"valuation_plot": "https://www.realrate-archive.com/us_chemicals/2012/valuation/valuation_0000717605.svg",
"value": 1.3613476995209601,
"company_index": "https://www.realrate-archive.com/us_chemicals/2012/industry_indexes/0000717605.svg",
"analysing_equity": "https://www.realrate-archive.com/us_chemicals/2012/analytics/equity/0000717605.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_chemicals/2012/analytics/profit_loss/0000717605.svg"
},
{
"company_id": "0000072162",
"feature_distribution_plot": "https://www.realrate-archive.com/us_chemicals/2012/feature_distribution/feature_distribution_0000072162.svg",
"graph_url": "https://www.realrate-archive.com/us_chemicals/2012/graphs/IME_0000072162.svg",
"logo_url": "https://www.realrate-archive.com/us_chemicals/logos/0000072162.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_chemicals/logos/0000072162_256x256.png",
"name": "NL Industries INC",
"rank": 15,
"regression_plot": "https://www.realrate-archive.com/us_chemicals/2012/backtesting_correlation/regression_0000072162.svg",
"report_text": "The relative strengths and weaknesses of NL Industries INC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of NL Industries INC compared to the market average is the variable Assets, Noncurrent, increasing the Economic Capital Ratio by 59% points.The greatest weakness of NL Industries INC is the variable Liabilities, Noncurrent, reducing the Economic Capital Ratio by 44% points.
The company's Economic Capital Ratio, given in the ranking table, is 130%, being 2.0% points above the market average of 128%.",
"report_url": "https://www.realrate-archive.com/us_chemicals/2012/report/0000072162_2013_NL_Industries_INC.pdf",
"shrinked_graph_json": {
"2011": {
"Liabilities, Current": "1.47",
"Liabilities": "-36.8",
"Stockholders Equity": "29.5",
"ECR before LimitedLiability": "-7.83",
"Other Liabilities": "1.03",
"Liabilities, Noncurrent": "-40.2",
"Property, Plant and Equipment, Net": "-2.60",
"Assets": "55.0",
"Intangible Assets": "1.27",
"Other Assets": "-3.31",
"Assets, Noncurrent": "61.8",
"Assets, Current": "-4.99",
"Cost of Revenues": "0",
"Expenses": "0",
"Net Income": "0",
"Other Expenses": "0",
"Selling, General and Administrative Expense": "0",
"Other Revenues": "0",
"Revenues": "0",
"Other Compr. Net Income": "0",
"Comprehensive Net Income": "0",
"Other Net Income": "0",
"Revenues Y+3": "0",
"Economic Capital Ratio": "-6.36",
"Revenues Y+2": "0",
"Revenues Y+1": "0",
"Revenues Y+5": "0",
"Revenues Y+4": "0"
},
"2012": {
"Other Liabilities": "0.700",
"Liabilities": "-37.4",
"Stockholders Equity": "38.8",
"ECR before LimitedLiability": "1.97",
"Liabilities, Noncurrent": "-43.9",
"Liabilities, Current": "3.98",
"Property, Plant and Equipment, Net": "-2.44",
"Assets": "57.4",
"Intangible Assets": "0.148",
"Other Assets": "-2.02",
"Assets, Current": "2.09",
"Assets, Noncurrent": "59.1",
"Other Expenses": "0",
"Expenses": "0",
"Net Income": "0",
"Cost of Revenues": "0",
"Selling, General and Administrative Expense": "0",
"Other Revenues": "0",
"Revenues": "0",
"Other Net Income": "0",
"Comprehensive Net Income": "0",
"Other Compr. Net Income": "0",
"Revenues Y+4": "0",
"Economic Capital Ratio": "2.04",
"Revenues Y+1": "0",
"Revenues Y+5": "0",
"Revenues Y+3": "0",
"Revenues Y+2": "0"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2012/plot_over_time/0000072162_strength_weakness.svg",
"table_records": {
"2011": {
"input_variables": {
"Assets, Current": "58,304",
"Assets, Noncurrent": "651,136",
"Cost of Revenues": "0",
"Intangible Assets": "47,553",
"Liabilities, Current": "40,806",
"Liabilities, Noncurrent": "294,444",
"Other Assets": "-47,553",
"Other Compr. Net Income": "103,105",
"Other Expenses": "158,293",
"Other Liabilities": "0",
"Other Net Income": "126,393",
"Other Revenues": "138,835",
"Property, Plant and Equipment, Net": "51,802",
"Revenues Y+1": "0",
"Revenues Y+2": "0",
"Revenues Y+3": "0",
"Revenues Y+4": "0",
"Revenues Y+5": "0",
"Selling, General and Administrative Expense": "24,280"
},
"output_variables": {
"Liabilities": "335,250",
"Assets": "761,242",
"Expenses": "182,573",
"Revenues": "138,835",
"Stockholders Equity": "425,992",
"Net Income": "82,655",
"Comprehensive Net Income": "185,760",
"BaseVar": "14,460,014",
"ECR before LimitedLiability": "63%",
"Economic Capital Ratio": "129%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "112,653",
"Assets, Noncurrent": "533,800",
"Cost of Revenues": "0",
"Intangible Assets": "27,156",
"Liabilities, Current": "25,126",
"Liabilities, Noncurrent": "267,914",
"Other Assets": "-27,156",
"Other Compr. Net Income": "0",
"Other Expenses": "148,551",
"Other Liabilities": "0",
"Other Net Income": "129,984",
"Other Revenues": "83,196",
"Property, Plant and Equipment, Net": "34,329",
"Revenues Y+1": "0",
"Revenues Y+2": "0",
"Revenues Y+3": "0",
"Revenues Y+4": "0",
"Revenues Y+5": "0",
"Selling, General and Administrative Expense": "17,747"
},
"output_variables": {
"Liabilities": "293,040",
"Assets": "680,782",
"Expenses": "166,298",
"Revenues": "83,196",
"Stockholders Equity": "387,742",
"Net Income": "46,882",
"Comprehensive Net Income": "46,882",
"BaseVar": "11,518,248",
"ECR before LimitedLiability": "65%",
"Economic Capital Ratio": "130%"
}
}
},
"top_rated": false,
"trend": 4.0,
"valuation": {
"past_accumulated_profits": 314071020.0,
"future_profits": 0.0,
"valuation_correction": 0.0,
"limited_liability_put_option": 318786259.10489005,
"fair_value": 632857279.1048901,
"market_value": 354835684.24980354
},
"valuation_plot": "https://www.realrate-archive.com/us_chemicals/2012/valuation/valuation_0000072162.svg",
"value": 1.299739129132203,
"company_index": "https://www.realrate-archive.com/us_chemicals/2012/industry_indexes/0000072162.svg",
"analysing_equity": "https://www.realrate-archive.com/us_chemicals/2012/analytics/equity/0000072162.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_chemicals/2012/analytics/profit_loss/0000072162.svg"
},
{
"company_id": "0001262823",
"feature_distribution_plot": "https://www.realrate-archive.com/us_chemicals/2012/feature_distribution/feature_distribution_0001262823.svg",
"graph_url": "https://www.realrate-archive.com/us_chemicals/2012/graphs/IME_0001262823.svg",
"logo_url": "https://www.realrate-archive.com/us_chemicals/logos/0001262823.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_chemicals/logos/0001262823_256x256.png",
"name": "Westlake CORP",
"rank": 16,
"regression_plot": "https://www.realrate-archive.com/us_chemicals/2012/backtesting_correlation/regression_0001262823.svg",
"report_text": "The relative strengths and weaknesses of Westlake CORP are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Westlake CORP compared to the market average is the variable Liabilities, Current, increasing the Economic Capital Ratio by 14% points.The greatest weakness of Westlake CORP is the variable Other Liabilities, reducing the Economic Capital Ratio by 9.1% points.
The company's Economic Capital Ratio, given in the ranking table, is 128%, being 0.43% points below the market average of 128%.",
"report_url": "https://www.realrate-archive.com/us_chemicals/2012/report/0001262823_2013_Westlake_CORP.pdf",
"shrinked_graph_json": {
"2011": {
"Liabilities, Current": "8.92",
"Liabilities": "2.35",
"Stockholders Equity": "-12.5",
"ECR before LimitedLiability": "-10.4",
"Other Liabilities": "-9.14",
"Liabilities, Noncurrent": "2.03",
"Property, Plant and Equipment, Net": "1.73",
"Assets": "-8.13",
"Intangible Assets": "-5.49",
"Other Assets": "0.907",
"Assets, Noncurrent": "-6.15",
"Assets, Current": "0.947",
"Cost of Revenues": "0",
"Expenses": "0",
"Net Income": "0",
"Other Expenses": "0",
"Selling, General and Administrative Expense": "0",
"Other Revenues": "0",
"Revenues": "0",
"Other Compr. Net Income": "0",
"Comprehensive Net Income": "0",
"Other Net Income": "0",
"Revenues Y+3": "0",
"Economic Capital Ratio": "-8.94",
"Revenues Y+2": "0",
"Revenues Y+1": "0",
"Revenues Y+5": "0",
"Revenues Y+4": "0"
},
"2012": {
"Other Liabilities": "-9.11",
"Liabilities": "10.3",
"Stockholders Equity": "0",
"ECR before LimitedLiability": "-0.500",
"Liabilities, Noncurrent": "4.43",
"Liabilities, Current": "14.3",
"Property, Plant and Equipment, Net": "5.61",
"Assets": "-4.47",
"Intangible Assets": "-6.14",
"Other Assets": "-0.124",
"Assets, Current": "4.35",
"Assets, Noncurrent": "-6.41",
"Other Expenses": "0",
"Expenses": "0",
"Net Income": "0",
"Cost of Revenues": "0",
"Selling, General and Administrative Expense": "0",
"Other Revenues": "0",
"Revenues": "0",
"Other Net Income": "0",
"Comprehensive Net Income": "0",
"Other Compr. Net Income": "0",
"Revenues Y+4": "0",
"Economic Capital Ratio": "-0.427",
"Revenues Y+1": "0",
"Revenues Y+5": "0",
"Revenues Y+3": "0",
"Revenues Y+2": "0"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2012/plot_over_time/0001262823_strength_weakness.svg",
"table_records": {
"2011": {
"input_variables": {
"Assets, Current": "1,756,156",
"Assets, Noncurrent": "182,316",
"Cost of Revenues": "0",
"Intangible Assets": "0",
"Liabilities, Current": "364,595",
"Liabilities, Noncurrent": "815,123",
"Other Assets": "96,283",
"Other Compr. Net Income": "0",
"Other Expenses": "3,254,300",
"Other Liabilities": "330,791",
"Other Net Income": "5,628",
"Other Revenues": "3,619,848",
"Property, Plant and Equipment, Net": "1,232,066",
"Revenues Y+1": "0",
"Revenues Y+2": "0",
"Revenues Y+3": "0",
"Revenues Y+4": "0",
"Revenues Y+5": "0",
"Selling, General and Administrative Expense": "112,210"
},
"output_variables": {
"Liabilities": "1,510,509",
"Assets": "3,266,821",
"Expenses": "3,366,510",
"Revenues": "3,619,848",
"Stockholders Equity": "1,756,312",
"Net Income": "258,966",
"Comprehensive Net Income": "258,966",
"BaseVar": "178,953,968",
"ECR before LimitedLiability": "60%",
"Economic Capital Ratio": "126%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "1,751,413",
"Assets, Noncurrent": "150,735",
"Cost of Revenues": "0",
"Intangible Assets": "0",
"Liabilities, Current": "398,510",
"Liabilities, Noncurrent": "815,140",
"Other Assets": "0",
"Other Compr. Net Income": "-1,770",
"Other Expenses": "3,076,744",
"Other Liabilities": "326,290",
"Other Net Income": "12,867",
"Other Revenues": "3,571,041",
"Property, Plant and Equipment, Net": "1,510,048",
"Revenues Y+1": "0",
"Revenues Y+2": "0",
"Revenues Y+3": "0",
"Revenues Y+4": "0",
"Revenues Y+5": "0",
"Selling, General and Administrative Expense": "121,609"
},
"output_variables": {
"Liabilities": "1,539,940",
"Assets": "3,412,196",
"Expenses": "3,198,353",
"Revenues": "3,571,041",
"Stockholders Equity": "1,872,256",
"Net Income": "385,555",
"Comprehensive Net Income": "383,785",
"BaseVar": "199,686,271",
"ECR before LimitedLiability": "61%",
"Economic Capital Ratio": "128%"
}
}
},
"top_rated": false,
"trend": 4.0,
"valuation": {
"past_accumulated_profits": 1516527360.0,
"future_profits": 0.0,
"valuation_correction": 0.0,
"limited_liability_put_option": 1640561214.7164671,
"fair_value": 3157088574.716467,
"market_value": 4376171045.652863
},
"valuation_plot": "https://www.realrate-archive.com/us_chemicals/2012/valuation/valuation_0001262823.svg",
"value": 1.2750411437474525,
"company_index": "https://www.realrate-archive.com/us_chemicals/2012/industry_indexes/0001262823.svg",
"analysing_equity": "https://www.realrate-archive.com/us_chemicals/2012/analytics/equity/0001262823.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_chemicals/2012/analytics/profit_loss/0001262823.svg"
},
{
"company_id": "0000038264",
"feature_distribution_plot": "https://www.realrate-archive.com/us_chemicals/2012/feature_distribution/feature_distribution_0000038264.svg",
"graph_url": "https://www.realrate-archive.com/us_chemicals/2012/graphs/IME_0000038264.svg",
"logo_url": "https://www.realrate-archive.com/us_chemicals/logos/0000038264.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_chemicals/logos/0000038264_256x256.png",
"name": "Forward Industries Inc",
"rank": 17,
"regression_plot": "https://www.realrate-archive.com/us_chemicals/2012/backtesting_correlation/regression_0000038264.svg",
"report_text": "The relative strengths and weaknesses of Forward Industries Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Forward Industries Inc compared to the market average is the variable Liabilities, increasing the Economic Capital Ratio by 52% points.The greatest weakness of Forward Industries Inc is the variable Stockholders Equity, reducing the Economic Capital Ratio by 43% points.
The company's Economic Capital Ratio, given in the ranking table, is 126%, being 1.8% points below the market average of 128%.",
"report_url": "https://www.realrate-archive.com/us_chemicals/2012/report/0000038264_2013_Forward_Industries_Inc.pdf",
"shrinked_graph_json": {
"2011": {
"Liabilities, Current": "9.33",
"Liabilities": "43.7",
"Stockholders Equity": "12.9",
"ECR before LimitedLiability": "30.1",
"Other Liabilities": "-0.441",
"Liabilities, Noncurrent": "36.9",
"Property, Plant and Equipment, Net": "-6.67",
"Assets": "-4.20",
"Intangible Assets": "-2.63",
"Other Assets": "-0.331",
"Assets, Noncurrent": "-3.99",
"Assets, Current": "19.5",
"Cost of Revenues": "0",
"Expenses": "0",
"Net Income": "0",
"Other Expenses": "0",
"Selling, General and Administrative Expense": "0",
"Other Revenues": "0",
"Revenues": "0",
"Other Compr. Net Income": "0",
"Comprehensive Net Income": "0",
"Other Net Income": "0",
"Revenues Y+3": "0",
"Economic Capital Ratio": "31.5",
"Revenues Y+2": "0",
"Revenues Y+1": "0",
"Revenues Y+5": "0",
"Revenues Y+4": "0"
},
"2012": {
"Other Liabilities": "-9.05",
"Liabilities": "52.3",
"Stockholders Equity": "-43.4",
"ECR before LimitedLiability": "-1.87",
"Liabilities, Noncurrent": "52.2",
"Liabilities, Current": "15.7",
"Property, Plant and Equipment, Net": "-23.7",
"Assets": "-32.6",
"Intangible Assets": "-11.4",
"Other Assets": "-0.252",
"Assets, Current": "6.98",
"Assets, Noncurrent": "-14.8",
"Other Expenses": "0",
"Expenses": "0",
"Net Income": "0",
"Cost of Revenues": "0",
"Selling, General and Administrative Expense": "0",
"Other Revenues": "0",
"Revenues": "0",
"Other Net Income": "0",
"Comprehensive Net Income": "0",
"Other Compr. Net Income": "0",
"Revenues Y+4": "0",
"Economic Capital Ratio": "-1.80",
"Revenues Y+1": "0",
"Revenues Y+5": "0",
"Revenues Y+3": "0",
"Revenues Y+2": "0"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2012/plot_over_time/0000038264_strength_weakness.svg",
"table_records": {
"2011": {
"input_variables": {
"Assets, Current": "21,869",
"Assets, Noncurrent": "89",
"Cost of Revenues": "0",
"Intangible Assets": "0",
"Liabilities, Current": "2,948",
"Liabilities, Noncurrent": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "25,736",
"Other Liabilities": "630",
"Other Net Income": "58",
"Other Revenues": "22,777",
"Property, Plant and Equipment, Net": "302",
"Revenues Y+1": "0",
"Revenues Y+2": "0",
"Revenues Y+3": "0",
"Revenues Y+4": "0",
"Revenues Y+5": "0",
"Selling, General and Administrative Expense": "0"
},
"output_variables": {
"Liabilities": "3,578",
"Assets": "22,260",
"Expenses": "25,736",
"Revenues": "22,777",
"Stockholders Equity": "18,683",
"Net Income": "-2,901",
"Comprehensive Net Income": "-2,901",
"BaseVar": "1,239,471",
"ECR before LimitedLiability": "117%",
"Economic Capital Ratio": "167%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "16,933",
"Assets, Noncurrent": "40",
"Cost of Revenues": "0",
"Intangible Assets": "0",
"Liabilities, Current": "5,937",
"Liabilities, Noncurrent": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "32,682",
"Other Liabilities": "1,987",
"Other Net Income": "-6,355",
"Other Revenues": "29,403",
"Property, Plant and Equipment, Net": "139",
"Revenues Y+1": "0",
"Revenues Y+2": "0",
"Revenues Y+3": "0",
"Revenues Y+4": "0",
"Revenues Y+5": "0",
"Selling, General and Administrative Expense": "0"
},
"output_variables": {
"Liabilities": "7,924",
"Assets": "17,112",
"Expenses": "32,682",
"Revenues": "29,403",
"Stockholders Equity": "9,188",
"Net Income": "-9,634",
"Comprehensive Net Income": "-9,634",
"BaseVar": "2,002,055",
"ECR before LimitedLiability": "59%",
"Economic Capital Ratio": "126%"
}
}
},
"top_rated": false,
"trend": -12.0,
"valuation": {
"past_accumulated_profits": 7442250.03,
"future_profits": 0.0,
"valuation_correction": -0.0,
"limited_liability_put_option": 8346392.362227618,
"fair_value": 15788642.392227618,
"market_value": 9888325.545405865
},
"valuation_plot": "https://www.realrate-archive.com/us_chemicals/2012/valuation/valuation_0000038264.svg",
"value": 1.2612932412817086,
"company_index": "https://www.realrate-archive.com/us_chemicals/2012/industry_indexes/0000038264.svg",
"analysing_equity": "https://www.realrate-archive.com/us_chemicals/2012/analytics/equity/0000038264.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_chemicals/2012/analytics/profit_loss/0000038264.svg"
},
{
"company_id": "0001257640",
"feature_distribution_plot": "https://www.realrate-archive.com/us_chemicals/2012/feature_distribution/feature_distribution_0001257640.svg",
"graph_url": "https://www.realrate-archive.com/us_chemicals/2012/graphs/IME_0001257640.svg",
"logo_url": "https://www.realrate-archive.com/us_chemicals/logos/0001257640.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_chemicals/logos/0001257640_256x256.png",
"name": "Kronos Worldwide INC",
"rank": 18,
"regression_plot": "https://www.realrate-archive.com/us_chemicals/2012/backtesting_correlation/regression_0001257640.svg",
"report_text": "The relative strengths and weaknesses of Kronos Worldwide INC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Kronos Worldwide INC compared to the market average is the variable Assets, Current, increasing the Economic Capital Ratio by 13% points.The greatest weakness of Kronos Worldwide INC is the variable Liabilities, Noncurrent, reducing the Economic Capital Ratio by 6.7% points.
The company's Economic Capital Ratio, given in the ranking table, is 125%, being 3.3% points below the market average of 128%.",
"report_url": "https://www.realrate-archive.com/us_chemicals/2012/report/0001257640_2013_Kronos_Worldwide_INC.pdf",
"shrinked_graph_json": {
"2011": {
"Liabilities, Current": "-0.394",
"Liabilities": "-5.35",
"Stockholders Equity": "-10.9",
"ECR before LimitedLiability": "-14.0",
"Other Liabilities": "2.63",
"Liabilities, Noncurrent": "-7.71",
"Property, Plant and Equipment, Net": "-2.91",
"Assets": "-4.49",
"Intangible Assets": "-5.34",
"Other Assets": "-0.662",
"Assets, Noncurrent": "5.53",
"Assets, Current": "-0.418",
"Cost of Revenues": "0",
"Expenses": "0",
"Net Income": "0",
"Other Expenses": "0",
"Selling, General and Administrative Expense": "0",
"Other Revenues": "0",
"Revenues": "0",
"Other Compr. Net Income": "0",
"Comprehensive Net Income": "0",
"Other Net Income": "0",
"Revenues Y+3": "0",
"Economic Capital Ratio": "-12.5",
"Revenues Y+2": "0",
"Revenues Y+1": "0",
"Revenues Y+5": "0",
"Revenues Y+4": "0"
},
"2012": {
"Other Liabilities": "2.16",
"Liabilities": "3.05",
"Stockholders Equity": "1.29",
"ECR before LimitedLiability": "-3.38",
"Liabilities, Noncurrent": "-6.71",
"Liabilities, Current": "7.29",
"Property, Plant and Equipment, Net": "-3.26",
"Assets": "-0.636",
"Intangible Assets": "-5.94",
"Other Assets": "-0.119",
"Assets, Current": "13.0",
"Assets, Noncurrent": "-1.44",
"Other Expenses": "0",
"Expenses": "0",
"Net Income": "0",
"Cost of Revenues": "0",
"Selling, General and Administrative Expense": "0",
"Other Revenues": "0",
"Revenues": "0",
"Other Net Income": "0",
"Comprehensive Net Income": "0",
"Other Compr. Net Income": "0",
"Revenues Y+4": "0",
"Economic Capital Ratio": "-3.30",
"Revenues Y+1": "0",
"Revenues Y+5": "0",
"Revenues Y+3": "0",
"Revenues Y+2": "0"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2012/plot_over_time/0001257640_strength_weakness.svg",
"table_records": {
"2011": {
"input_variables": {
"Assets, Current": "865,000",
"Assets, Noncurrent": "473,400",
"Cost of Revenues": "0",
"Intangible Assets": "0",
"Liabilities, Current": "328,000",
"Liabilities, Noncurrent": "571,600",
"Other Assets": "0",
"Other Compr. Net Income": "-33,500",
"Other Expenses": "1,432,700",
"Other Liabilities": "0",
"Other Net Income": "5,400",
"Other Revenues": "1,943,300",
"Property, Plant and Equipment, Net": "485,500",
"Revenues Y+1": "0",
"Revenues Y+2": "0",
"Revenues Y+3": "0",
"Revenues Y+4": "0",
"Revenues Y+5": "0",
"Selling, General and Administrative Expense": "195,000"
},
"output_variables": {
"Liabilities": "899,600",
"Assets": "1,823,900",
"Expenses": "1,627,700",
"Revenues": "1,943,300",
"Stockholders Equity": "924,300",
"Net Income": "321,000",
"Comprehensive Net Income": "287,500",
"BaseVar": "92,520,841",
"ECR before LimitedLiability": "55%",
"Economic Capital Ratio": "123%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "1,223,400",
"Assets, Noncurrent": "281,100",
"Cost of Revenues": "0",
"Intangible Assets": "0",
"Liabilities, Current": "328,400",
"Liabilities, Noncurrent": "636,500",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "1,568,800",
"Other Liabilities": "0",
"Other Net Income": "-5,600",
"Other Revenues": "1,976,300",
"Property, Plant and Equipment, Net": "522,500",
"Revenues Y+1": "0",
"Revenues Y+2": "0",
"Revenues Y+3": "0",
"Revenues Y+4": "0",
"Revenues Y+5": "0",
"Selling, General and Administrative Expense": "183,400"
},
"output_variables": {
"Liabilities": "964,900",
"Assets": "2,027,000",
"Expenses": "1,752,200",
"Revenues": "1,976,300",
"Stockholders Equity": "1,062,100",
"Net Income": "218,500",
"Comprehensive Net Income": "218,500",
"BaseVar": "110,045,369",
"ECR before LimitedLiability": "58%",
"Economic Capital Ratio": "125%"
}
}
},
"top_rated": false,
"trend": 5.0,
"valuation": {
"past_accumulated_profits": 860301000.0,
"future_profits": 0.0,
"valuation_correction": 0.0,
"limited_liability_put_option": 1004072515.4869819,
"fair_value": 1864373515.4869819,
"market_value": 1014925928.9985399
},
"valuation_plot": "https://www.realrate-archive.com/us_chemicals/2012/valuation/valuation_0001257640.svg",
"value": 1.2462806347050248,
"company_index": "https://www.realrate-archive.com/us_chemicals/2012/industry_indexes/0001257640.svg",
"analysing_equity": "https://www.realrate-archive.com/us_chemicals/2012/analytics/equity/0001257640.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_chemicals/2012/analytics/profit_loss/0001257640.svg"
},
{
"company_id": "0000790051",
"feature_distribution_plot": "https://www.realrate-archive.com/us_chemicals/2012/feature_distribution/feature_distribution_0000790051.svg",
"graph_url": "https://www.realrate-archive.com/us_chemicals/2012/graphs/IME_0000790051.svg",
"logo_url": "https://www.realrate-archive.com/us_chemicals/logos/0000790051.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_chemicals/logos/0000790051_256x256.png",
"name": "Carlisle Companies INC",
"rank": 19,
"regression_plot": "https://www.realrate-archive.com/us_chemicals/2012/backtesting_correlation/regression_0000790051.svg",
"report_text": "The relative strengths and weaknesses of Carlisle Companies INC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Carlisle Companies INC compared to the market average is the variable Intangible Assets, increasing the Economic Capital Ratio by 25% points.The greatest weakness of Carlisle Companies INC is the variable Assets, Noncurrent, reducing the Economic Capital Ratio by 8.3% points.
The company's Economic Capital Ratio, given in the ranking table, is 124%, being 4.1% points below the market average of 128%.",
"report_url": "https://www.realrate-archive.com/us_chemicals/2012/report/0000790051_2013_Carlisle_Companies_INC.pdf",
"shrinked_graph_json": {
"2011": {
"Liabilities, Current": "-1.94",
"Liabilities": "-8.03",
"Stockholders Equity": "-13.7",
"ECR before LimitedLiability": "-17.2",
"Other Liabilities": "2.60",
"Liabilities, Noncurrent": "-8.77",
"Property, Plant and Equipment, Net": "-7.55",
"Assets": "-5.23",
"Intangible Assets": "25.0",
"Other Assets": "-0.326",
"Assets, Noncurrent": "-8.43",
"Assets, Current": "-5.38",
"Cost of Revenues": "0",
"Expenses": "0",
"Net Income": "0",
"Other Expenses": "0",
"Selling, General and Administrative Expense": "0",
"Other Revenues": "0",
"Revenues": "0",
"Other Compr. Net Income": "0",
"Comprehensive Net Income": "0",
"Other Net Income": "0",
"Revenues Y+3": "0",
"Economic Capital Ratio": "-15.7",
"Revenues Y+2": "0",
"Revenues Y+1": "0",
"Revenues Y+5": "0",
"Revenues Y+4": "0"
},
"2012": {
"Other Liabilities": "2.36",
"Liabilities": "7.72",
"Stockholders Equity": "-3.48",
"ECR before LimitedLiability": "-4.16",
"Liabilities, Noncurrent": "-7.59",
"Liabilities, Current": "12.4",
"Property, Plant and Equipment, Net": "-8.15",
"Assets": "-5.60",
"Intangible Assets": "24.7",
"Other Assets": "-0.132",
"Assets, Current": "-4.91",
"Assets, Noncurrent": "-8.29",
"Other Expenses": "0",
"Expenses": "0",
"Net Income": "0",
"Cost of Revenues": "0",
"Selling, General and Administrative Expense": "0",
"Other Revenues": "0",
"Revenues": "0",
"Other Net Income": "0",
"Comprehensive Net Income": "0",
"Other Compr. Net Income": "0",
"Revenues Y+4": "0",
"Economic Capital Ratio": "-4.08",
"Revenues Y+1": "0",
"Revenues Y+5": "0",
"Revenues Y+3": "0",
"Revenues Y+2": "0"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2012/plot_over_time/0000790051_strength_weakness.svg",
"table_records": {
"2011": {
"input_variables": {
"Assets, Current": "1,214,100",
"Assets, Noncurrent": "19,000",
"Cost of Revenues": "2,547,400",
"Intangible Assets": "1,324,400",
"Liabilities, Current": "613,500",
"Liabilities, Noncurrent": "1,024,300",
"Other Assets": "20,100",
"Other Compr. Net Income": "-6,900",
"Other Expenses": "68,700",
"Other Liabilities": "0",
"Other Net Income": "-22,800",
"Other Revenues": "3,224,500",
"Property, Plant and Equipment, Net": "560,300",
"Revenues Y+1": "0",
"Revenues Y+2": "0",
"Revenues Y+3": "0",
"Revenues Y+4": "0",
"Revenues Y+5": "0",
"Selling, General and Administrative Expense": "405,300"
},
"output_variables": {
"Liabilities": "1,637,800",
"Assets": "3,137,900",
"Expenses": "3,021,400",
"Revenues": "3,224,500",
"Stockholders Equity": "1,500,100",
"Net Income": "180,300",
"Comprehensive Net Income": "173,400",
"BaseVar": "160,862,597",
"ECR before LimitedLiability": "51%",
"Economic Capital Ratio": "119%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "1,205,300",
"Assets, Noncurrent": "38,600",
"Cost of Revenues": "2,731,700",
"Intangible Assets": "1,576,300",
"Liabilities, Current": "470,600",
"Liabilities, Noncurrent": "1,198,600",
"Other Assets": "0",
"Other Compr. Net Income": "9,500",
"Other Expenses": "144,200",
"Other Liabilities": "0",
"Other Net Income": "-22,600",
"Other Revenues": "3,629,400",
"Property, Plant and Equipment, Net": "637,100",
"Revenues Y+1": "0",
"Revenues Y+2": "0",
"Revenues Y+3": "0",
"Revenues Y+4": "0",
"Revenues Y+5": "0",
"Selling, General and Administrative Expense": "460,700"
},
"output_variables": {
"Liabilities": "1,669,200",
"Assets": "3,457,300",
"Expenses": "3,336,600",
"Revenues": "3,629,400",
"Stockholders Equity": "1,788,100",
"Net Income": "270,200",
"Comprehensive Net Income": "279,700",
"BaseVar": "205,996,390",
"ECR before LimitedLiability": "57%",
"Economic Capital Ratio": "124%"
}
}
},
"top_rated": false,
"trend": 5.0,
"valuation": {
"past_accumulated_profits": 1448361000.0,
"future_profits": 0.0,
"valuation_correction": 0.0,
"limited_liability_put_option": 1726184182.2834725,
"fair_value": 3174545182.2834725,
"market_value": 3125506950.4642334
},
"valuation_plot": "https://www.realrate-archive.com/us_chemicals/2012/valuation/valuation_0000790051.svg",
"value": 1.2384844171592597,
"company_index": "https://www.realrate-archive.com/us_chemicals/2012/industry_indexes/0000790051.svg",
"analysing_equity": "https://www.realrate-archive.com/us_chemicals/2012/analytics/equity/0000790051.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_chemicals/2012/analytics/profit_loss/0000790051.svg"
},
{
"company_id": "0000105770",
"feature_distribution_plot": "https://www.realrate-archive.com/us_chemicals/2012/feature_distribution/feature_distribution_0000105770.svg",
"graph_url": "https://www.realrate-archive.com/us_chemicals/2012/graphs/IME_0000105770.svg",
"logo_url": "https://www.realrate-archive.com/us_chemicals/logos/0000105770.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_chemicals/logos/0000105770_256x256.png",
"name": "WEST Pharmaceutical Services INC",
"rank": 20,
"regression_plot": "https://www.realrate-archive.com/us_chemicals/2012/backtesting_correlation/regression_0000105770.svg",
"report_text": "The relative strengths and weaknesses of WEST Pharmaceutical Services INC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of WEST Pharmaceutical Services INC compared to the market average is the variable Property, Plant and Equipment, Net, increasing the Economic Capital Ratio by 10% points.The greatest weakness of WEST Pharmaceutical Services INC is the variable Liabilities, Noncurrent, reducing the Economic Capital Ratio by 16% points.
The company's Economic Capital Ratio, given in the ranking table, is 118%, being 9.8% points below the market average of 128%.",
"report_url": "https://www.realrate-archive.com/us_chemicals/2012/report/0000105770_2013_WEST_Pharmaceutical_Services_INC.pdf",
"shrinked_graph_json": {
"2011": {
"Liabilities, Current": "-2.54",
"Liabilities": "-17.5",
"Stockholders Equity": "-6.56",
"ECR before LimitedLiability": "-18.3",
"Other Liabilities": "0.496",
"Liabilities, Noncurrent": "-15.2",
"Property, Plant and Equipment, Net": "10.0",
"Assets": "4.39",
"Intangible Assets": "1.72",
"Other Assets": "5.77",
"Assets, Noncurrent": "-6.62",
"Assets, Current": "-4.17",
"Cost of Revenues": "0",
"Expenses": "0",
"Net Income": "0",
"Other Expenses": "0",
"Selling, General and Administrative Expense": "0",
"Other Revenues": "0",
"Revenues": "0",
"Other Compr. Net Income": "0",
"Comprehensive Net Income": "0",
"Other Net Income": "0",
"Revenues Y+3": "0",
"Economic Capital Ratio": "-16.8",
"Revenues Y+2": "0",
"Revenues Y+1": "0",
"Revenues Y+5": "0",
"Revenues Y+4": "0"
},
"2012": {
"Other Liabilities": "0.310",
"Liabilities": "-12.0",
"Stockholders Equity": "2.70",
"ECR before LimitedLiability": "-9.91",
"Liabilities, Noncurrent": "-15.5",
"Liabilities, Current": "2.87",
"Property, Plant and Equipment, Net": "10.4",
"Assets": "9.05",
"Intangible Assets": "0.172",
"Other Assets": "6.01",
"Assets, Current": "0.638",
"Assets, Noncurrent": "-6.73",
"Other Expenses": "0",
"Expenses": "0",
"Net Income": "0",
"Cost of Revenues": "0",
"Selling, General and Administrative Expense": "0",
"Other Revenues": "0",
"Revenues": "0",
"Other Net Income": "0",
"Comprehensive Net Income": "0",
"Other Compr. Net Income": "0",
"Revenues Y+4": "0",
"Economic Capital Ratio": "-9.84",
"Revenues Y+1": "0",
"Revenues Y+5": "0",
"Revenues Y+3": "0",
"Revenues Y+2": "0"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2012/plot_over_time/0000105770_strength_weakness.svg",
"table_records": {
"2011": {
"input_variables": {
"Assets, Current": "472,000",
"Assets, Noncurrent": "28,700",
"Cost of Revenues": "853,000",
"Intangible Assets": "163,500",
"Liabilities, Current": "243,200",
"Liabilities, Noncurrent": "479,400",
"Other Assets": "141,300",
"Other Compr. Net Income": "-40,200",
"Other Expenses": "51,200",
"Other Liabilities": "21,600",
"Other Net Income": "7,600",
"Other Revenues": "1,192,300",
"Property, Plant and Equipment, Net": "593,600",
"Revenues Y+1": "0",
"Revenues Y+2": "0",
"Revenues Y+3": "0",
"Revenues Y+4": "0",
"Revenues Y+5": "0",
"Selling, General and Administrative Expense": "220,200"
},
"output_variables": {
"Liabilities": "744,200",
"Assets": "1,399,100",
"Expenses": "1,124,400",
"Revenues": "1,192,300",
"Stockholders Equity": "654,900",
"Net Income": "75,500",
"Comprehensive Net Income": "35,300",
"BaseVar": "60,781,246",
"ECR before LimitedLiability": "50%",
"Economic Capital Ratio": "118%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "557,300",
"Assets, Noncurrent": "24,500",
"Cost of Revenues": "878,700",
"Intangible Assets": "163,100",
"Liabilities, Current": "261,800",
"Liabilities, Noncurrent": "552,500",
"Other Assets": "150,100",
"Other Compr. Net Income": "0",
"Other Expenses": "50,700",
"Other Liabilities": "20,800",
"Other Net Income": "-5,000",
"Other Revenues": "1,266,400",
"Property, Plant and Equipment, Net": "669,000",
"Revenues Y+1": "0",
"Revenues Y+2": "0",
"Revenues Y+3": "0",
"Revenues Y+4": "0",
"Revenues Y+5": "0",
"Selling, General and Administrative Expense": "251,300"
},
"output_variables": {
"Liabilities": "835,100",
"Assets": "1,564,000",
"Expenses": "1,180,700",
"Revenues": "1,266,400",
"Stockholders Equity": "728,900",
"Net Income": "80,700",
"Comprehensive Net Income": "80,700",
"BaseVar": "72,481,527",
"ECR before LimitedLiability": "49%",
"Economic Capital Ratio": "118%"
}
}
},
"top_rated": false,
"trend": 5.0,
"valuation": {
"past_accumulated_profits": 590409000.0,
"future_profits": 0.0,
"valuation_correction": 0.0,
"limited_liability_put_option": 826154270.339066,
"fair_value": 1416563270.339066,
"market_value": 1727543902.542057
},
"valuation_plot": "https://www.realrate-archive.com/us_chemicals/2012/valuation/valuation_0000105770.svg",
"value": 1.1809122340369858,
"company_index": "https://www.realrate-archive.com/us_chemicals/2012/industry_indexes/0000105770.svg",
"analysing_equity": "https://www.realrate-archive.com/us_chemicals/2012/analytics/equity/0000105770.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_chemicals/2012/analytics/profit_loss/0000105770.svg"
},
{
"company_id": "0000002969",
"feature_distribution_plot": "https://www.realrate-archive.com/us_chemicals/2012/feature_distribution/feature_distribution_0000002969.svg",
"graph_url": "https://www.realrate-archive.com/us_chemicals/2012/graphs/IME_0000002969.svg",
"logo_url": "https://www.realrate-archive.com/us_chemicals/logos/0000002969.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_chemicals/logos/0000002969_256x256.png",
"name": "Air Products Chemicals Inc",
"rank": 21,
"regression_plot": "https://www.realrate-archive.com/us_chemicals/2012/backtesting_correlation/regression_0000002969.svg",
"report_text": "The relative strengths and weaknesses of Air Products Chemicals Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Air Products Chemicals Inc compared to the market average is the variable Assets, Noncurrent, increasing the Economic Capital Ratio by 44% points.The greatest weakness of Air Products Chemicals Inc is the variable Liabilities, reducing the Economic Capital Ratio by 33% points.
The company's Economic Capital Ratio, given in the ranking table, is 112%, being 15% points below the market average of 128%.",
"report_url": "https://www.realrate-archive.com/us_chemicals/2012/report/0000002969_2013_Air_Products_Chemicals_Inc.pdf",
"shrinked_graph_json": {
"2011": {
"Liabilities, Current": "-5.04",
"Liabilities": "-34.2",
"Stockholders Equity": "-0.797",
"ECR before LimitedLiability": "-24.0",
"Other Liabilities": "1.64",
"Liabilities, Noncurrent": "-30.1",
"Property, Plant and Equipment, Net": "23.8",
"Assets": "22.2",
"Intangible Assets": "0.332",
"Other Assets": "-25.0",
"Assets, Noncurrent": "42.7",
"Assets, Current": "-5.64",
"Cost of Revenues": "0",
"Expenses": "0",
"Net Income": "0",
"Other Expenses": "0",
"Selling, General and Administrative Expense": "0",
"Other Revenues": "0",
"Revenues": "0",
"Other Compr. Net Income": "0",
"Comprehensive Net Income": "0",
"Other Net Income": "0",
"Revenues Y+3": "0",
"Economic Capital Ratio": "-22.5",
"Revenues Y+2": "0",
"Revenues Y+1": "0",
"Revenues Y+5": "0",
"Revenues Y+4": "0"
},
"2012": {
"Other Liabilities": "1.23",
"Liabilities": "-32.9",
"Stockholders Equity": "8.82",
"ECR before LimitedLiability": "-15.5",
"Liabilities, Noncurrent": "-31.8",
"Liabilities, Current": "-2.11",
"Property, Plant and Equipment, Net": "23.5",
"Assets": "34.0",
"Intangible Assets": "4.38",
"Other Assets": "-26.2",
"Assets, Current": "-2.81",
"Assets, Noncurrent": "44.0",
"Other Expenses": "0",
"Expenses": "0",
"Net Income": "0",
"Cost of Revenues": "0",
"Selling, General and Administrative Expense": "0",
"Other Revenues": "0",
"Revenues": "0",
"Other Net Income": "0",
"Comprehensive Net Income": "0",
"Other Compr. Net Income": "0",
"Revenues Y+4": "0",
"Economic Capital Ratio": "-15.5",
"Revenues Y+1": "0",
"Revenues Y+5": "0",
"Revenues Y+3": "0",
"Revenues Y+2": "0"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2012/plot_over_time/0000002969_strength_weakness.svg",
"table_records": {
"2011": {
"input_variables": {
"Assets, Current": "3,189,800",
"Assets, Noncurrent": "11,100,900",
"Cost of Revenues": "7,098,300",
"Intangible Assets": "1,056,700",
"Liabilities, Current": "2,342,000",
"Liabilities, Noncurrent": "6,010,000",
"Other Assets": "-8,279,400",
"Other Compr. Net Income": "0",
"Other Expenses": "539,300",
"Other Liabilities": "0",
"Other Net Income": "285,900",
"Other Revenues": "9,673,700",
"Property, Plant and Equipment, Net": "7,222,700",
"Revenues Y+1": "0",
"Revenues Y+2": "0",
"Revenues Y+3": "0",
"Revenues Y+4": "0",
"Revenues Y+5": "0",
"Selling, General and Administrative Expense": "1,060,500"
},
"output_variables": {
"Liabilities": "8,352,000",
"Assets": "14,290,700",
"Expenses": "8,698,100",
"Revenues": "9,673,700",
"Stockholders Equity": "5,938,700",
"Net Income": "1,261,500",
"Comprehensive Net Income": "1,261,500",
"BaseVar": "482,475,390",
"ECR before LimitedLiability": "42%",
"Economic Capital Ratio": "113%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "3,415,800",
"Assets, Noncurrent": "13,526,000",
"Cost of Revenues": "7,051,900",
"Intangible Assets": "2,360,000",
"Liabilities, Current": "2,689,900",
"Liabilities, Noncurrent": "7,236,100",
"Other Assets": "-10,600,600",
"Other Compr. Net Income": "0",
"Other Expenses": "748,200",
"Other Liabilities": "0",
"Other Net Income": "454,900",
"Other Revenues": "9,611,700",
"Property, Plant and Equipment, Net": "8,240,600",
"Revenues Y+1": "0",
"Revenues Y+2": "0",
"Revenues Y+3": "0",
"Revenues Y+4": "0",
"Revenues Y+5": "0",
"Selling, General and Administrative Expense": "1,073,200"
},
"output_variables": {
"Liabilities": "9,926,000",
"Assets": "16,941,800",
"Expenses": "8,873,300",
"Revenues": "9,611,700",
"Stockholders Equity": "7,015,800",
"Net Income": "1,193,300",
"Comprehensive Net Income": "1,193,300",
"BaseVar": "564,012,388",
"ECR before LimitedLiability": "42%",
"Economic Capital Ratio": "112%"
}
}
},
"top_rated": false,
"trend": 5.0,
"valuation": {
"past_accumulated_profits": 5682798000.0,
"future_profits": 0.0,
"valuation_correction": 0.0,
"limited_liability_put_option": 9424440482.740288,
"fair_value": 15107238482.740288,
"market_value": 12574186577.571589
},
"valuation_plot": "https://www.realrate-archive.com/us_chemicals/2012/valuation/valuation_0000002969.svg",
"value": 1.124560885724941,
"company_index": "https://www.realrate-archive.com/us_chemicals/2012/industry_indexes/0000002969.svg",
"analysing_equity": "https://www.realrate-archive.com/us_chemicals/2012/analytics/equity/0000002969.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_chemicals/2012/analytics/profit_loss/0000002969.svg"
},
{
"company_id": "0000738214",
"feature_distribution_plot": "https://www.realrate-archive.com/us_chemicals/2012/feature_distribution/feature_distribution_0000738214.svg",
"graph_url": "https://www.realrate-archive.com/us_chemicals/2012/graphs/IME_0000738214.svg",
"logo_url": "https://www.realrate-archive.com/us_chemicals/logos/0000738214.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_chemicals/logos/0000738214_256x256.png",
"name": "Aemetis INC",
"rank": 22,
"regression_plot": "https://www.realrate-archive.com/us_chemicals/2012/backtesting_correlation/regression_0000738214.svg",
"report_text": "The relative strengths and weaknesses of Aemetis INC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Aemetis INC compared to the market average is the variable Liabilities, increasing the Economic Capital Ratio by 38% points.The greatest weakness of Aemetis INC is the variable Stockholders Equity, reducing the Economic Capital Ratio by 63% points.
The company's Economic Capital Ratio, given in the ranking table, is 111%, being 17% points below the market average of 128%.",
"report_url": "https://www.realrate-archive.com/us_chemicals/2012/report/0000738214_2013_Aemetis_INC.pdf",
"shrinked_graph_json": {
"2012": {
"Other Liabilities": "4.91",
"Liabilities": "38.1",
"Stockholders Equity": "-63.2",
"ECR before LimitedLiability": "-16.7",
"Liabilities, Noncurrent": "38.0",
"Liabilities, Current": "-3.24",
"Property, Plant and Equipment, Net": "4.38",
"Assets": "-44.0",
"Intangible Assets": "-14.0",
"Other Assets": "1.89",
"Assets, Current": "-34.2",
"Assets, Noncurrent": "-19.7",
"Other Expenses": "0",
"Expenses": "0",
"Net Income": "0",
"Cost of Revenues": "0",
"Selling, General and Administrative Expense": "0",
"Other Revenues": "0",
"Revenues": "0",
"Other Net Income": "0",
"Comprehensive Net Income": "0",
"Other Compr. Net Income": "0",
"Revenues Y+4": "0",
"Economic Capital Ratio": "-16.7",
"Revenues Y+1": "0",
"Revenues Y+5": "0",
"Revenues Y+3": "0",
"Revenues Y+2": "0"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2012/plot_over_time/0000738214_strength_weakness.svg",
"table_records": {
"2012": {
"input_variables": {
"Assets, Current": "6,845",
"Assets, Noncurrent": "0",
"Cost of Revenues": "197,975",
"Intangible Assets": "2,768",
"Liabilities, Current": "57,835",
"Liabilities, Noncurrent": "0",
"Other Assets": "3,365",
"Other Compr. Net Income": "-75",
"Other Expenses": "16,577",
"Other Liabilities": "0",
"Other Net Income": "33,455",
"Other Revenues": "189,048",
"Property, Plant and Equipment, Net": "83,893",
"Revenues Y+1": "0",
"Revenues Y+2": "0",
"Revenues Y+3": "0",
"Revenues Y+4": "0",
"Revenues Y+5": "0",
"Selling, General and Administrative Expense": "12,234"
},
"output_variables": {
"Liabilities": "57,835",
"Assets": "96,872",
"Expenses": "226,786",
"Revenues": "189,048",
"Stockholders Equity": "39,037",
"Net Income": "-4,282",
"Comprehensive Net Income": "-4,357",
"BaseVar": "13,140,243",
"ECR before LimitedLiability": "41%",
"Economic Capital Ratio": "111%"
}
}
},
"top_rated": false,
"trend": null,
"valuation": {
"past_accumulated_profits": 31619934.360000003,
"future_profits": 0.0,
"valuation_correction": -0.0,
"limited_liability_put_option": 54454540.47274328,
"fair_value": 86074474.83274329,
"market_value": 79203331.31341337
},
"valuation_plot": "https://www.realrate-archive.com/us_chemicals/2012/valuation/valuation_0000738214.svg",
"value": 1.1127392222322718,
"company_index": "https://www.realrate-archive.com/us_chemicals/2012/industry_indexes/0000738214.svg",
"analysing_equity": "https://www.realrate-archive.com/us_chemicals/2012/analytics/equity/0000738214.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_chemicals/2012/analytics/profit_loss/0000738214.svg"
},
{
"company_id": "0000051253",
"feature_distribution_plot": "https://www.realrate-archive.com/us_chemicals/2012/feature_distribution/feature_distribution_0000051253.svg",
"graph_url": "https://www.realrate-archive.com/us_chemicals/2012/graphs/IME_0000051253.svg",
"logo_url": "https://www.realrate-archive.com/us_chemicals/logos/0000000000.png",
"logo_url_256x256": "https://www.realrate-archive.com/us_chemicals/logos/0000000000_256x256.png",
"name": "International Flavors Fragrances INC",
"rank": 23,
"regression_plot": "https://www.realrate-archive.com/us_chemicals/2012/backtesting_correlation/regression_0000051253.svg",
"report_text": "The relative strengths and weaknesses of International Flavors Fragrances INC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of International Flavors Fragrances INC compared to the market average is the variable Assets, Current, increasing the Economic Capital Ratio by 8.2% points.The greatest weakness of International Flavors Fragrances INC is the variable Liabilities, Noncurrent, reducing the Economic Capital Ratio by 21% points.
The company's Economic Capital Ratio, given in the ranking table, is 109%, being 18% points below the market average of 128%.",
"report_url": "https://www.realrate-archive.com/us_chemicals/2012/report/0000051253_2013_International_Flavors_Fragrances_INC.pdf",
"shrinked_graph_json": {
"2011": {
"Liabilities, Current": "-2.87",
"Liabilities": "-23.9",
"Stockholders Equity": "-17.4",
"ECR before LimitedLiability": "-28.4",
"Other Liabilities": "2.21",
"Liabilities, Noncurrent": "-23.2",
"Property, Plant and Equipment, Net": "-5.51",
"Assets": "-0.201",
"Intangible Assets": "10.5",
"Other Assets": "2.70",
"Assets, Noncurrent": "-5.74",
"Assets, Current": "-0.0642",
"Cost of Revenues": "0",
"Expenses": "0",
"Net Income": "0",
"Other Expenses": "0",
"Selling, General and Administrative Expense": "0",
"Other Revenues": "0",
"Revenues": "0",
"Other Compr. Net Income": "0",
"Comprehensive Net Income": "0",
"Other Net Income": "0",
"Revenues Y+3": "0",
"Economic Capital Ratio": "-27.0",
"Revenues Y+2": "0",
"Revenues Y+1": "0",
"Revenues Y+5": "0",
"Revenues Y+4": "0"
},
"2012": {
"Other Liabilities": "1.78",
"Liabilities": "-17.5",
"Stockholders Equity": "-6.33",
"ECR before LimitedLiability": "-18.6",
"Liabilities, Noncurrent": "-21.2",
"Liabilities, Current": "1.48",
"Property, Plant and Equipment, Net": "-5.35",
"Assets": "5.62",
"Intangible Assets": "7.61",
"Other Assets": "3.17",
"Assets, Current": "8.24",
"Assets, Noncurrent": "-6.02",
"Other Expenses": "0",
"Expenses": "0",
"Net Income": "0",
"Cost of Revenues": "0",
"Selling, General and Administrative Expense": "0",
"Other Revenues": "0",
"Revenues": "0",
"Other Net Income": "0",
"Comprehensive Net Income": "0",
"Other Compr. Net Income": "0",
"Revenues Y+4": "0",
"Economic Capital Ratio": "-18.5",
"Revenues Y+1": "0",
"Revenues Y+5": "0",
"Revenues Y+3": "0",
"Revenues Y+2": "0"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2012/plot_over_time/0000051253_strength_weakness.svg",
"table_records": {
"2011": {
"input_variables": {
"Assets, Current": "1,317,220",
"Assets, Noncurrent": "179,833",
"Cost of Revenues": "0",
"Intangible Assets": "708,345",
"Liabilities, Current": "564,566",
"Liabilities, Noncurrent": "1,293,608",
"Other Assets": "152,118",
"Other Compr. Net Income": "-99,958",
"Other Expenses": "1,857,397",
"Other Liabilities": "0",
"Other Net Income": "0",
"Other Revenues": "2,788,018",
"Property, Plant and Equipment, Net": "608,065",
"Revenues Y+1": "0",
"Revenues Y+2": "0",
"Revenues Y+3": "0",
"Revenues Y+4": "0",
"Revenues Y+5": "0",
"Selling, General and Administrative Expense": "663,755"
},
"output_variables": {
"Liabilities": "1,858,174",
"Assets": "2,965,581",
"Expenses": "2,521,152",
"Revenues": "2,788,018",
"Stockholders Equity": "1,107,407",
"Net Income": "266,866",
"Comprehensive Net Income": "166,908",
"BaseVar": "139,006,019",
"ECR before LimitedLiability": "37%",
"Economic Capital Ratio": "108%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "1,572,559",
"Assets, Noncurrent": "159,520",
"Cost of Revenues": "0",
"Intangible Assets": "702,270",
"Liabilities, Current": "622,732",
"Liabilities, Noncurrent": "1,374,313",
"Other Assets": "160,610",
"Other Compr. Net Income": "-28,316",
"Other Expenses": "1,880,064",
"Other Liabilities": "0",
"Other Net Income": "0",
"Other Revenues": "2,821,446",
"Property, Plant and Equipment, Net": "654,641",
"Revenues Y+1": "0",
"Revenues Y+2": "0",
"Revenues Y+3": "0",
"Revenues Y+4": "0",
"Revenues Y+5": "0",
"Selling, General and Administrative Expense": "687,248"
},
"output_variables": {
"Liabilities": "1,997,045",
"Assets": "3,249,600",
"Expenses": "2,567,312",
"Revenues": "2,821,446",
"Stockholders Equity": "1,252,555",
"Net Income": "254,134",
"Comprehensive Net Income": "225,818",
"BaseVar": "160,096,404",
"ECR before LimitedLiability": "39%",
"Economic Capital Ratio": "109%"
}
}
},
"top_rated": false,
"trend": 6.0,
"valuation": {
"past_accumulated_profits": 1014569550.0000001,
"future_profits": 0.0,
"valuation_correction": 0.0,
"limited_liability_put_option": 1856185901.200688,
"fair_value": 2870755451.200688,
"market_value": 4030350215.340324
},
"valuation_plot": "https://www.realrate-archive.com/us_chemicals/2012/valuation/valuation_0000051253.svg",
"value": 1.0943204471431507,
"company_index": "https://www.realrate-archive.com/us_chemicals/2012/industry_indexes/0000051253.svg",
"analysing_equity": "https://www.realrate-archive.com/us_chemicals/2012/analytics/equity/0000051253.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_chemicals/2012/analytics/profit_loss/0000051253.svg"
},
{
"company_id": "0001120970",
"feature_distribution_plot": "https://www.realrate-archive.com/us_chemicals/2012/feature_distribution/feature_distribution_0001120970.svg",
"graph_url": "https://www.realrate-archive.com/us_chemicals/2012/graphs/IME_0001120970.svg",
"logo_url": "https://www.realrate-archive.com/us_chemicals/logos/0001120970.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_chemicals/logos/0001120970_256x256.png",
"name": "Comstock Inc",
"rank": 24,
"regression_plot": "https://www.realrate-archive.com/us_chemicals/2012/backtesting_correlation/regression_0001120970.svg",
"report_text": "The relative strengths and weaknesses of Comstock Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Comstock Inc compared to the market average is the variable Assets, increasing the Economic Capital Ratio by 36% points.The greatest weakness of Comstock Inc is the variable Liabilities, reducing the Economic Capital Ratio by 46% points.
The company's Economic Capital Ratio, given in the ranking table, is 109%, being 19% points below the market average of 128%.",
"report_url": "https://www.realrate-archive.com/us_chemicals/2012/report/0001120970_2013_Comstock_Inc.pdf",
"shrinked_graph_json": {
"2011": {
"Liabilities, Current": "-20.8",
"Liabilities": "-29.1",
"Stockholders Equity": "34.4",
"ECR before LimitedLiability": "-1.08",
"Other Liabilities": "1.12",
"Liabilities, Noncurrent": "-8.23",
"Property, Plant and Equipment, Net": "13.1",
"Assets": "54.4",
"Intangible Assets": "-1.85",
"Other Assets": "13.8",
"Assets, Noncurrent": "-2.69",
"Assets, Current": "13.0",
"Cost of Revenues": "0",
"Expenses": "0",
"Net Income": "0",
"Other Expenses": "0",
"Selling, General and Administrative Expense": "0",
"Other Revenues": "0",
"Revenues": "0",
"Other Compr. Net Income": "0",
"Comprehensive Net Income": "0",
"Other Net Income": "0",
"Revenues Y+3": "0",
"Economic Capital Ratio": "0.390",
"Revenues Y+2": "0",
"Revenues Y+1": "0",
"Revenues Y+5": "0",
"Revenues Y+4": "0"
},
"2012": {
"Other Liabilities": "0.931",
"Liabilities": "-45.7",
"Stockholders Equity": "12.5",
"ECR before LimitedLiability": "-18.7",
"Liabilities, Noncurrent": "-12.4",
"Liabilities, Current": "-31.4",
"Property, Plant and Equipment, Net": "22.7",
"Assets": "36.3",
"Intangible Assets": "-3.46",
"Other Assets": "22.0",
"Assets, Current": "7.60",
"Assets, Noncurrent": "-4.65",
"Other Expenses": "0",
"Expenses": "0",
"Net Income": "0",
"Cost of Revenues": "0",
"Selling, General and Administrative Expense": "0",
"Other Revenues": "0",
"Revenues": "0",
"Other Net Income": "0",
"Comprehensive Net Income": "0",
"Other Compr. Net Income": "0",
"Revenues Y+4": "0",
"Economic Capital Ratio": "-18.6",
"Revenues Y+1": "0",
"Revenues Y+5": "0",
"Revenues Y+3": "0",
"Revenues Y+2": "0"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2012/plot_over_time/0001120970_strength_weakness.svg",
"table_records": {
"2011": {
"input_variables": {
"Assets, Current": "11,009",
"Assets, Noncurrent": "165",
"Cost of Revenues": "0",
"Intangible Assets": "0",
"Liabilities, Current": "6,045",
"Liabilities, Noncurrent": "4,331",
"Other Assets": "6,417",
"Other Compr. Net Income": "0",
"Other Expenses": "15,952",
"Other Liabilities": "0",
"Other Net Income": "3,872",
"Other Revenues": "473",
"Property, Plant and Equipment, Net": "9,384",
"Revenues Y+1": "0",
"Revenues Y+2": "0",
"Revenues Y+3": "0",
"Revenues Y+4": "0",
"Revenues Y+5": "0",
"Selling, General and Administrative Expense": "0"
},
"output_variables": {
"Liabilities": "10,376",
"Assets": "26,974",
"Expenses": "15,952",
"Revenues": "473",
"Stockholders Equity": "16,598",
"Net Income": "-11,606",
"Comprehensive Net Income": "-11,606",
"BaseVar": "531,237",
"ECR before LimitedLiability": "72%",
"Economic Capital Ratio": "136%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "14,360",
"Assets, Noncurrent": "85",
"Cost of Revenues": "0",
"Intangible Assets": "0",
"Liabilities, Current": "18,162",
"Liabilities, Noncurrent": "11,308",
"Other Assets": "12,929",
"Other Compr. Net Income": "0",
"Other Expenses": "35,458",
"Other Liabilities": "0",
"Other Net Income": "-443",
"Other Revenues": "5,139",
"Property, Plant and Equipment, Net": "20,491",
"Revenues Y+1": "0",
"Revenues Y+2": "0",
"Revenues Y+3": "0",
"Revenues Y+4": "0",
"Revenues Y+5": "0",
"Selling, General and Administrative Expense": "0"
},
"output_variables": {
"Liabilities": "29,470",
"Assets": "47,865",
"Expenses": "35,458",
"Revenues": "5,139",
"Stockholders Equity": "18,395",
"Net Income": "-30,762",
"Comprehensive Net Income": "-30,762",
"BaseVar": "1,231,676",
"ECR before LimitedLiability": "39%",
"Economic Capital Ratio": "109%"
}
}
},
"top_rated": false,
"trend": -7.0,
"valuation": {
"past_accumulated_profits": 14899595.22,
"future_profits": 0.0,
"valuation_correction": -0.0,
"limited_liability_put_option": 27368569.349929526,
"fair_value": 42268164.569929525,
"market_value": 99317942.28
},
"valuation_plot": "https://www.realrate-archive.com/us_chemicals/2012/valuation/valuation_0001120970.svg",
"value": 1.0931253002521597,
"company_index": "https://www.realrate-archive.com/us_chemicals/2012/industry_indexes/0001120970.svg",
"analysing_equity": "https://www.realrate-archive.com/us_chemicals/2012/analytics/equity/0001120970.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_chemicals/2012/analytics/profit_loss/0001120970.svg"
},
{
"company_id": "0000110621",
"feature_distribution_plot": "https://www.realrate-archive.com/us_chemicals/2012/feature_distribution/feature_distribution_0000110621.svg",
"graph_url": "https://www.realrate-archive.com/us_chemicals/2012/graphs/IME_0000110621.svg",
"logo_url": "https://www.realrate-archive.com/us_chemicals/logos/0000110621.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_chemicals/logos/0000110621_256x256.png",
"name": "RPM International INC DE",
"rank": 25,
"regression_plot": "https://www.realrate-archive.com/us_chemicals/2012/backtesting_correlation/regression_0000110621.svg",
"report_text": "The relative strengths and weaknesses of RPM International INC DE are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of RPM International INC DE compared to the market average is the variable Intangible Assets, increasing the Economic Capital Ratio by 15% points.The greatest weakness of RPM International INC DE is the variable Stockholders Equity, reducing the Economic Capital Ratio by 17% points.
The company's Economic Capital Ratio, given in the ranking table, is 108%, being 20% points below the market average of 128%.",
"report_url": "https://www.realrate-archive.com/us_chemicals/2012/report/0000110621_2013_RPM_International_INC_DE.pdf",
"shrinked_graph_json": {
"2011": {
"Liabilities, Current": "-4.44",
"Liabilities": "-20.3",
"Stockholders Equity": "-17.1",
"ECR before LimitedLiability": "-26.2",
"Other Liabilities": "2.31",
"Liabilities, Noncurrent": "-17.9",
"Property, Plant and Equipment, Net": "-10.7",
"Assets": "-1.95",
"Intangible Assets": "17.7",
"Other Assets": "-0.714",
"Assets, Noncurrent": "-7.40",
"Assets, Current": "4.98",
"Cost of Revenues": "0",
"Expenses": "0",
"Net Income": "0",
"Other Expenses": "0",
"Selling, General and Administrative Expense": "0",
"Other Revenues": "0",
"Revenues": "0",
"Other Compr. Net Income": "0",
"Comprehensive Net Income": "0",
"Other Net Income": "0",
"Revenues Y+3": "0",
"Economic Capital Ratio": "-24.7",
"Revenues Y+2": "0",
"Revenues Y+1": "0",
"Revenues Y+5": "0",
"Revenues Y+4": "0"
},
"2012": {
"Other Liabilities": "2.23",
"Liabilities": "-5.56",
"Stockholders Equity": "-17.4",
"ECR before LimitedLiability": "-20.3",
"Liabilities, Noncurrent": "-14.3",
"Liabilities, Current": "5.80",
"Property, Plant and Equipment, Net": "-13.7",
"Assets": "-9.45",
"Intangible Assets": "15.4",
"Other Assets": "-0.163",
"Assets, Current": "1.47",
"Assets, Noncurrent": "-7.76",
"Other Expenses": "0",
"Expenses": "0",
"Net Income": "0",
"Cost of Revenues": "0",
"Selling, General and Administrative Expense": "0",
"Other Revenues": "0",
"Revenues": "0",
"Other Net Income": "0",
"Comprehensive Net Income": "0",
"Other Compr. Net Income": "0",
"Revenues Y+4": "0",
"Economic Capital Ratio": "-20.2",
"Revenues Y+1": "0",
"Revenues Y+5": "0",
"Revenues Y+3": "0",
"Revenues Y+2": "0"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2012/plot_over_time/0000110621_strength_weakness.svg",
"table_records": {
"2011": {
"input_variables": {
"Assets, Current": "1,867,970",
"Assets, Noncurrent": "112,676",
"Cost of Revenues": "0",
"Intangible Assets": "1,144,356",
"Liabilities, Current": "735,289",
"Liabilities, Noncurrent": "1,392,372",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "2,138,286",
"Other Liabilities": "0",
"Other Net Income": "2,397",
"Other Revenues": "3,397,523",
"Property, Plant and Equipment, Net": "390,027",
"Revenues Y+1": "0",
"Revenues Y+2": "0",
"Revenues Y+3": "0",
"Revenues Y+4": "0",
"Revenues Y+5": "0",
"Selling, General and Administrative Expense": "1,058,466"
},
"output_variables": {
"Liabilities": "2,127,661",
"Assets": "3,515,029",
"Expenses": "3,196,752",
"Revenues": "3,397,523",
"Stockholders Equity": "1,387,368",
"Net Income": "203,168",
"Comprehensive Net Income": "203,168",
"BaseVar": "169,403,971",
"ECR before LimitedLiability": "40%",
"Economic Capital Ratio": "110%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "1,737,319",
"Assets, Noncurrent": "210,696",
"Cost of Revenues": "0",
"Intangible Assets": "1,194,966",
"Liabilities, Current": "725,140",
"Liabilities, Noncurrent": "1,522,690",
"Other Assets": "0",
"Other Compr. Net Income": "-201,793",
"Other Expenses": "2,401,724",
"Other Liabilities": "0",
"Other Net Income": "9,599",
"Other Revenues": "3,781,602",
"Property, Plant and Equipment, Net": "418,832",
"Revenues Y+1": "0",
"Revenues Y+2": "0",
"Revenues Y+3": "0",
"Revenues Y+4": "0",
"Revenues Y+5": "0",
"Selling, General and Administrative Expense": "1,155,714"
},
"output_variables": {
"Liabilities": "2,247,830",
"Assets": "3,561,813",
"Expenses": "3,557,438",
"Revenues": "3,781,602",
"Stockholders Equity": "1,313,983",
"Net Income": "233,763",
"Comprehensive Net Income": "31,970",
"BaseVar": "222,394,124",
"ECR before LimitedLiability": "37%",
"Economic Capital Ratio": "108%"
}
}
},
"top_rated": false,
"trend": 2.0,
"valuation": {
"past_accumulated_profits": 1064326230.0000001,
"future_profits": 0.0,
"valuation_correction": 0.0,
"limited_liability_put_option": 2064565130.143434,
"fair_value": 3128891360.143434,
"market_value": 2924046253.518471
},
"valuation_plot": "https://www.realrate-archive.com/us_chemicals/2012/valuation/valuation_0000110621.svg",
"value": 1.0771372217340835,
"company_index": "https://www.realrate-archive.com/us_chemicals/2012/industry_indexes/0000110621.svg",
"analysing_equity": "https://www.realrate-archive.com/us_chemicals/2012/analytics/equity/0000110621.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_chemicals/2012/analytics/profit_loss/0000110621.svg"
},
{
"company_id": "0001309402",
"feature_distribution_plot": "https://www.realrate-archive.com/us_chemicals/2012/feature_distribution/feature_distribution_0001309402.svg",
"graph_url": "https://www.realrate-archive.com/us_chemicals/2012/graphs/IME_0001309402.svg",
"logo_url": "https://www.realrate-archive.com/us_chemicals/logos/0001309402.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_chemicals/logos/0001309402_256x256.png",
"name": "Green Plains Inc",
"rank": 26,
"regression_plot": "https://www.realrate-archive.com/us_chemicals/2012/backtesting_correlation/regression_0001309402.svg",
"report_text": "The relative strengths and weaknesses of Green Plains Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Green Plains Inc compared to the market average is the variable Liabilities, increasing the Economic Capital Ratio by 35% points.The greatest weakness of Green Plains Inc is the variable Stockholders Equity, reducing the Economic Capital Ratio by 75% points.
The company's Economic Capital Ratio, given in the ranking table, is 107%, being 21% points below the market average of 128%.",
"report_url": "https://www.realrate-archive.com/us_chemicals/2012/report/0001309402_2013_Green_Plains_Inc.pdf",
"shrinked_graph_json": {
"2011": {
"Liabilities, Current": "17.9",
"Liabilities": "32.6",
"Stockholders Equity": "-86.6",
"ECR before LimitedLiability": "-30.3",
"Other Liabilities": "1.90",
"Liabilities, Noncurrent": "25.0",
"Property, Plant and Equipment, Net": "-13.9",
"Assets": "-48.7",
"Intangible Assets": "-12.8",
"Other Assets": "-1.92",
"Assets, Noncurrent": "-20.2",
"Assets, Current": "-32.4",
"Cost of Revenues": "0",
"Expenses": "0",
"Net Income": "0",
"Other Expenses": "0",
"Selling, General and Administrative Expense": "0",
"Other Revenues": "0",
"Revenues": "0",
"Other Compr. Net Income": "0",
"Comprehensive Net Income": "0",
"Other Net Income": "0",
"Revenues Y+3": "0",
"Economic Capital Ratio": "-28.8",
"Revenues Y+2": "0",
"Revenues Y+1": "0",
"Revenues Y+5": "0",
"Revenues Y+4": "0"
},
"2012": {
"Other Liabilities": "0.835",
"Liabilities": "34.8",
"Stockholders Equity": "-75.0",
"ECR before LimitedLiability": "-20.9",
"Liabilities, Noncurrent": "33.3",
"Liabilities, Current": "29.0",
"Property, Plant and Equipment, Net": "-18.8",
"Assets": "-49.7",
"Intangible Assets": "-16.0",
"Other Assets": "-0.396",
"Assets, Current": "-29.9",
"Assets, Noncurrent": "-21.4",
"Other Expenses": "0",
"Expenses": "0",
"Net Income": "0",
"Cost of Revenues": "0",
"Selling, General and Administrative Expense": "0",
"Other Revenues": "0",
"Revenues": "0",
"Other Net Income": "0",
"Comprehensive Net Income": "0",
"Other Compr. Net Income": "0",
"Revenues Y+4": "0",
"Economic Capital Ratio": "-20.8",
"Revenues Y+1": "0",
"Revenues Y+5": "0",
"Revenues Y+3": "0",
"Revenues Y+2": "0"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2012/plot_over_time/0001309402_strength_weakness.svg",
"table_records": {
"2011": {
"input_variables": {
"Assets, Current": "576,420",
"Assets, Noncurrent": "26,742",
"Cost of Revenues": "3,381,480",
"Intangible Assets": "40,877",
"Liabilities, Current": "360,965",
"Liabilities, Noncurrent": "498,536",
"Other Assets": "0",
"Other Compr. Net Income": "-2,533",
"Other Expenses": "23,686",
"Other Liabilities": "55,970",
"Other Net Income": "-37,114",
"Other Revenues": "3,553,712",
"Property, Plant and Equipment, Net": "776,789",
"Revenues Y+1": "0",
"Revenues Y+2": "0",
"Revenues Y+3": "0",
"Revenues Y+4": "0",
"Revenues Y+5": "0",
"Selling, General and Administrative Expense": "73,219"
},
"output_variables": {
"Liabilities": "915,471",
"Assets": "1,420,828",
"Expenses": "3,478,385",
"Revenues": "3,553,712",
"Stockholders Equity": "505,357",
"Net Income": "38,213",
"Comprehensive Net Income": "35,680",
"BaseVar": "179,747,543",
"ECR before LimitedLiability": "35%",
"Economic Capital Ratio": "106%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "568,035",
"Assets, Noncurrent": "32,712",
"Cost of Revenues": "3,380,099",
"Intangible Assets": "40,877",
"Liabilities, Current": "432,384",
"Liabilities, Noncurrent": "366,766",
"Other Assets": "0",
"Other Compr. Net Income": "6,504",
"Other Expenses": "13,393",
"Other Liabilities": "60,082",
"Other Net Income": "-39,729",
"Other Revenues": "3,476,870",
"Property, Plant and Equipment, Net": "708,110",
"Revenues Y+1": "0",
"Revenues Y+2": "0",
"Revenues Y+3": "0",
"Revenues Y+4": "0",
"Revenues Y+5": "0",
"Selling, General and Administrative Expense": "79,019"
},
"output_variables": {
"Liabilities": "859,232",
"Assets": "1,349,734",
"Expenses": "3,472,511",
"Revenues": "3,476,870",
"Stockholders Equity": "490,502",
"Net Income": "-35,370",
"Comprehensive Net Income": "-28,866",
"BaseVar": "204,465,355",
"ECR before LimitedLiability": "36%",
"Economic Capital Ratio": "107%"
}
}
},
"top_rated": false,
"trend": 4.0,
"valuation": {
"past_accumulated_profits": 397306620.0,
"future_profits": 0.0,
"valuation_correction": -0.0,
"limited_liability_put_option": 786107164.29759,
"fair_value": 1183413784.29759,
"market_value": 212486040.37649107
},
"valuation_plot": "https://www.realrate-archive.com/us_chemicals/2012/valuation/valuation_0001309402.svg",
"value": 1.0714640101274442,
"company_index": "https://www.realrate-archive.com/us_chemicals/2012/industry_indexes/0001309402.svg",
"analysing_equity": "https://www.realrate-archive.com/us_chemicals/2012/analytics/equity/0001309402.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_chemicals/2012/analytics/profit_loss/0001309402.svg"
},
{
"company_id": "0000059255",
"feature_distribution_plot": "https://www.realrate-archive.com/us_chemicals/2012/feature_distribution/feature_distribution_0000059255.svg",
"graph_url": "https://www.realrate-archive.com/us_chemicals/2012/graphs/IME_0000059255.svg",
"logo_url": "https://www.realrate-archive.com/us_chemicals/logos/0000059255.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_chemicals/logos/0000059255_256x256.png",
"name": "Valhi INC DE",
"rank": 27,
"regression_plot": "https://www.realrate-archive.com/us_chemicals/2012/backtesting_correlation/regression_0000059255.svg",
"report_text": "The relative strengths and weaknesses of Valhi INC DE are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Valhi INC DE compared to the market average is the variable Assets, increasing the Economic Capital Ratio by 22% points.The greatest weakness of Valhi INC DE is the variable Liabilities, Noncurrent, reducing the Economic Capital Ratio by 40% points.
The company's Economic Capital Ratio, given in the ranking table, is 105%, being 23% points below the market average of 128%.",
"report_url": "https://www.realrate-archive.com/us_chemicals/2012/report/0000059255_2013_Valhi_INC_DE.pdf",
"shrinked_graph_json": {
"2011": {
"Liabilities, Current": "-1.69",
"Liabilities": "-36.8",
"Stockholders Equity": "-9.90",
"ECR before LimitedLiability": "-30.9",
"Other Liabilities": "1.74",
"Liabilities, Noncurrent": "-36.9",
"Property, Plant and Equipment, Net": "1.28",
"Assets": "15.7",
"Intangible Assets": "4.59",
"Other Assets": "-8.93",
"Assets, Noncurrent": "24.6",
"Assets, Current": "-1.46",
"Cost of Revenues": "0",
"Expenses": "0",
"Net Income": "0",
"Other Expenses": "0",
"Selling, General and Administrative Expense": "0",
"Other Revenues": "0",
"Revenues": "0",
"Other Compr. Net Income": "0",
"Comprehensive Net Income": "0",
"Other Net Income": "0",
"Revenues Y+3": "0",
"Economic Capital Ratio": "-29.4",
"Revenues Y+2": "0",
"Revenues Y+1": "0",
"Revenues Y+5": "0",
"Revenues Y+4": "0"
},
"2012": {
"Other Liabilities": "1.39",
"Liabilities": "-32.6",
"Stockholders Equity": "-2.23",
"ECR before LimitedLiability": "-22.8",
"Liabilities, Noncurrent": "-39.5",
"Liabilities, Current": "3.97",
"Property, Plant and Equipment, Net": "0.483",
"Assets": "22.0",
"Intangible Assets": "2.27",
"Other Assets": "-7.39",
"Assets, Current": "10.0",
"Assets, Noncurrent": "16.6",
"Other Expenses": "0",
"Expenses": "0",
"Net Income": "0",
"Cost of Revenues": "0",
"Selling, General and Administrative Expense": "0",
"Other Revenues": "0",
"Revenues": "0",
"Other Net Income": "0",
"Comprehensive Net Income": "0",
"Other Compr. Net Income": "0",
"Revenues Y+4": "0",
"Economic Capital Ratio": "-22.7",
"Revenues Y+1": "0",
"Revenues Y+5": "0",
"Revenues Y+3": "0",
"Revenues Y+2": "0"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2012/plot_over_time/0000059255_strength_weakness.svg",
"table_records": {
"2011": {
"input_variables": {
"Assets, Current": "944,200",
"Assets, Noncurrent": "1,170,000",
"Cost of Revenues": "0",
"Intangible Assets": "402,200",
"Liabilities, Current": "415,600",
"Liabilities, Noncurrent": "1,429,400",
"Other Assets": "-402,200",
"Other Compr. Net Income": "-122,000",
"Other Expenses": "1,567,400",
"Other Liabilities": "0",
"Other Net Income": "0",
"Other Revenues": "2,141,000",
"Property, Plant and Equipment, Net": "723,800",
"Revenues Y+1": "0",
"Revenues Y+2": "0",
"Revenues Y+3": "0",
"Revenues Y+4": "0",
"Revenues Y+5": "0",
"Selling, General and Administrative Expense": "278,600"
},
"output_variables": {
"Liabilities": "1,845,000",
"Assets": "2,838,000",
"Expenses": "1,846,000",
"Revenues": "2,141,000",
"Stockholders Equity": "993,000",
"Net Income": "295,000",
"Comprehensive Net Income": "173,000",
"BaseVar": "106,104,126",
"ECR before LimitedLiability": "34%",
"Economic Capital Ratio": "106%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "1,363,400",
"Assets, Noncurrent": "1,044,000",
"Cost of Revenues": "0",
"Intangible Assets": "379,900",
"Liabilities, Current": "398,500",
"Liabilities, Noncurrent": "1,680,300",
"Other Assets": "-379,900",
"Other Compr. Net Income": "-81,000",
"Other Expenses": "1,688,000",
"Other Liabilities": "0",
"Other Net Income": "25,500",
"Other Revenues": "2,157,900",
"Property, Plant and Equipment, Net": "763,100",
"Revenues Y+1": "0",
"Revenues Y+2": "0",
"Revenues Y+3": "0",
"Revenues Y+4": "0",
"Revenues Y+5": "0",
"Selling, General and Administrative Expense": "273,300"
},
"output_variables": {
"Liabilities": "2,078,800",
"Assets": "3,170,500",
"Expenses": "1,961,300",
"Revenues": "2,157,900",
"Stockholders Equity": "1,091,700",
"Net Income": "222,100",
"Comprehensive Net Income": "141,100",
"BaseVar": "125,464,766",
"ECR before LimitedLiability": "34%",
"Economic Capital Ratio": "105%"
}
}
},
"top_rated": false,
"trend": 4.0,
"valuation": {
"past_accumulated_profits": 884277000.0,
"future_profits": 0.0,
"valuation_correction": 0.0,
"limited_liability_put_option": 1876742734.1438537,
"fair_value": 2761019734.1438537,
"market_value": 3174682566.6037583
},
"valuation_plot": "https://www.realrate-archive.com/us_chemicals/2012/valuation/valuation_0000059255.svg",
"value": 1.0519573025522846,
"company_index": "https://www.realrate-archive.com/us_chemicals/2012/industry_indexes/0000059255.svg",
"analysing_equity": "https://www.realrate-archive.com/us_chemicals/2012/analytics/equity/0000059255.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_chemicals/2012/analytics/profit_loss/0000059255.svg"
},
{
"company_id": "0000778164",
"feature_distribution_plot": "https://www.realrate-archive.com/us_chemicals/2012/feature_distribution/feature_distribution_0000778164.svg",
"graph_url": "https://www.realrate-archive.com/us_chemicals/2012/graphs/IME_0000778164.svg",
"logo_url": "https://www.realrate-archive.com/us_chemicals/logos/0000778164.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_chemicals/logos/0000778164_256x256.png",
"name": "Alto Ingredients Inc",
"rank": 28,
"regression_plot": "https://www.realrate-archive.com/us_chemicals/2012/backtesting_correlation/regression_0000778164.svg",
"report_text": "The relative strengths and weaknesses of Alto Ingredients Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Alto Ingredients Inc compared to the market average is the variable Liabilities, increasing the Economic Capital Ratio by 38% points.The greatest weakness of Alto Ingredients Inc is the variable Stockholders Equity, reducing the Economic Capital Ratio by 125% points.
The company's Economic Capital Ratio, given in the ranking table, is 105%, being 23% points below the market average of 128%.",
"report_url": "https://www.realrate-archive.com/us_chemicals/2012/report/0000778164_2013_Alto_Ingredients_Inc.pdf",
"shrinked_graph_json": {
"2011": {
"Liabilities, Current": "49.7",
"Liabilities": "53.5",
"Stockholders Equity": "-158",
"ECR before LimitedLiability": "-13.2",
"Other Liabilities": "6.67",
"Liabilities, Noncurrent": "49.5",
"Property, Plant and Equipment, Net": "-21.6",
"Assets": "-50.9",
"Intangible Assets": "-16.3",
"Other Assets": "-2.50",
"Assets, Noncurrent": "-23.8",
"Assets, Current": "-39.2",
"Cost of Revenues": "0",
"Expenses": "0",
"Net Income": "0",
"Other Expenses": "0",
"Selling, General and Administrative Expense": "0",
"Other Revenues": "0",
"Revenues": "0",
"Other Compr. Net Income": "0",
"Comprehensive Net Income": "0",
"Other Net Income": "0",
"Revenues Y+3": "0",
"Economic Capital Ratio": "-11.8",
"Revenues Y+2": "0",
"Revenues Y+1": "0",
"Revenues Y+5": "0",
"Revenues Y+4": "0"
},
"2012": {
"Other Liabilities": "2.93",
"Liabilities": "37.6",
"Stockholders Equity": "-125",
"ECR before LimitedLiability": "-23.3",
"Liabilities, Noncurrent": "31.2",
"Liabilities, Current": "33.4",
"Property, Plant and Equipment, Net": "-28.8",
"Assets": "-62.8",
"Intangible Assets": "-23.4",
"Other Assets": "-0.608",
"Assets, Current": "-45.6",
"Assets, Noncurrent": "-29.8",
"Other Expenses": "0",
"Expenses": "0",
"Net Income": "0",
"Cost of Revenues": "0",
"Selling, General and Administrative Expense": "0",
"Other Revenues": "0",
"Revenues": "0",
"Other Net Income": "0",
"Comprehensive Net Income": "0",
"Other Compr. Net Income": "0",
"Revenues Y+4": "0",
"Economic Capital Ratio": "-23.3",
"Revenues Y+1": "0",
"Revenues Y+5": "0",
"Revenues Y+3": "0",
"Revenues Y+2": "0"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2012/plot_over_time/0000778164_strength_weakness.svg",
"table_records": {
"2011": {
"input_variables": {
"Assets, Current": "66,748",
"Assets, Noncurrent": "1,653",
"Cost of Revenues": "0",
"Intangible Assets": "4,458",
"Liabilities, Current": "8,982",
"Liabilities, Noncurrent": "96,915",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "897,343",
"Other Liabilities": "7,315",
"Other Net Income": "7,559",
"Other Revenues": "901,188",
"Property, Plant and Equipment, Net": "159,617",
"Revenues Y+1": "0",
"Revenues Y+2": "0",
"Revenues Y+3": "0",
"Revenues Y+4": "0",
"Revenues Y+5": "0",
"Selling, General and Administrative Expense": "15,427"
},
"output_variables": {
"Liabilities": "113,212",
"Assets": "232,476",
"Expenses": "912,770",
"Revenues": "901,188",
"Stockholders Equity": "119,264",
"Net Income": "-4,023",
"Comprehensive Net Income": "-4,023",
"BaseVar": "46,170,748",
"ECR before LimitedLiability": "56%",
"Economic Capital Ratio": "123%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "57,432",
"Assets, Noncurrent": "3,388",
"Cost of Revenues": "0",
"Intangible Assets": "3,734",
"Liabilities, Current": "12,415",
"Liabilities, Noncurrent": "118,897",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "849,212",
"Other Liabilities": "10,744",
"Other Net Income": "1,954",
"Other Revenues": "816,044",
"Property, Plant and Equipment, Net": "150,409",
"Revenues Y+1": "0",
"Revenues Y+2": "0",
"Revenues Y+3": "0",
"Revenues Y+4": "0",
"Revenues Y+5": "0",
"Selling, General and Administrative Expense": "12,141"
},
"output_variables": {
"Liabilities": "142,056",
"Assets": "214,963",
"Expenses": "861,353",
"Revenues": "816,044",
"Stockholders Equity": "72,907",
"Net Income": "-43,355",
"Comprehensive Net Income": "-43,355",
"BaseVar": "48,996,853",
"ECR before LimitedLiability": "33%",
"Economic Capital Ratio": "105%"
}
}
},
"top_rated": false,
"trend": -6.0,
"valuation": {
"past_accumulated_profits": 59054670.00000001,
"future_profits": 0.0,
"valuation_correction": -0.0,
"limited_liability_put_option": 127793674.6201164,
"fair_value": 186848344.6201164,
"market_value": 48707580.9034479
},
"valuation_plot": "https://www.realrate-archive.com/us_chemicals/2012/valuation/valuation_0000778164.svg",
"value": 1.046713730194283,
"company_index": "https://www.realrate-archive.com/us_chemicals/2012/industry_indexes/0000778164.svg",
"analysing_equity": "https://www.realrate-archive.com/us_chemicals/2012/analytics/equity/0000778164.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_chemicals/2012/analytics/profit_loss/0000778164.svg"
},
{
"company_id": "0000314227",
"feature_distribution_plot": "https://www.realrate-archive.com/us_chemicals/2012/feature_distribution/feature_distribution_0000314227.svg",
"graph_url": "https://www.realrate-archive.com/us_chemicals/2012/graphs/IME_0000314227.svg",
"logo_url": "https://www.realrate-archive.com/us_chemicals/logos/0000314227.jpg",
"logo_url_256x256": "https://www.realrate-archive.com/us_chemicals/logos/0000314227_256x256.png",
"name": "TOMI Environmental Solutions Inc",
"rank": 29,
"regression_plot": "https://www.realrate-archive.com/us_chemicals/2012/backtesting_correlation/regression_0000314227.svg",
"report_text": "The relative strengths and weaknesses of TOMI Environmental Solutions Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of TOMI Environmental Solutions Inc compared to the market average is the variable Liabilities, increasing the Economic Capital Ratio by 35% points.The greatest weakness of TOMI Environmental Solutions Inc is the variable Stockholders Equity, reducing the Economic Capital Ratio by 119% points.
The company's Economic Capital Ratio, given in the ranking table, is 102%, being 26% points below the market average of 128%.",
"report_url": "https://www.realrate-archive.com/us_chemicals/2012/report/0000314227_2013_TOMI_Environmental_Solutions_Inc.pdf",
"shrinked_graph_json": {
"2012": {
"Other Liabilities": "7.42",
"Liabilities": "34.7",
"Stockholders Equity": "-119",
"ECR before LimitedLiability": "-25.6",
"Liabilities, Noncurrent": "32.3",
"Liabilities, Current": "21.5",
"Property, Plant and Equipment, Net": "-41.8",
"Assets": "-63.3",
"Intangible Assets": "-23.9",
"Other Assets": "-0.498",
"Assets, Current": "-33.2",
"Assets, Noncurrent": "-30.1",
"Other Expenses": "0",
"Expenses": "0",
"Net Income": "0",
"Cost of Revenues": "0",
"Selling, General and Administrative Expense": "0",
"Other Revenues": "0",
"Revenues": "0",
"Other Net Income": "0",
"Comprehensive Net Income": "0",
"Other Compr. Net Income": "0",
"Revenues Y+4": "0",
"Economic Capital Ratio": "-25.6",
"Revenues Y+1": "0",
"Revenues Y+5": "0",
"Revenues Y+3": "0",
"Revenues Y+2": "0"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2012/plot_over_time/0000314227_strength_weakness.svg",
"table_records": {
"2012": {
"input_variables": {
"Assets, Current": "294",
"Assets, Noncurrent": "0",
"Cost of Revenues": "0",
"Intangible Assets": "0",
"Liabilities, Current": "234",
"Liabilities, Noncurrent": "0",
"Other Assets": "0.50",
"Other Compr. Net Income": "0",
"Other Expenses": "2,015",
"Other Liabilities": "0",
"Other Net Income": "0",
"Other Revenues": "564",
"Property, Plant and Equipment, Net": "48",
"Revenues Y+1": "0",
"Revenues Y+2": "0",
"Revenues Y+3": "0",
"Revenues Y+4": "0",
"Revenues Y+5": "0",
"Selling, General and Administrative Expense": "0"
},
"output_variables": {
"Liabilities": "234",
"Assets": "343",
"Expenses": "2,015",
"Revenues": "564",
"Stockholders Equity": "108",
"Net Income": "-1,451",
"Comprehensive Net Income": "-1,451",
"BaseVar": "75,262",
"ECR before LimitedLiability": "30%",
"Economic Capital Ratio": "102%"
}
}
},
"top_rated": false,
"trend": null,
"valuation": {
"past_accumulated_profits": 87813.72,
"future_profits": 0.0,
"valuation_correction": -0.0,
"limited_liability_put_option": 207685.45980551685,
"fair_value": 295499.17980551685,
"market_value": 10560606.744961513
},
"valuation_plot": "https://www.realrate-archive.com/us_chemicals/2012/valuation/valuation_0000314227.svg",
"value": 1.0236183877896947,
"company_index": "https://www.realrate-archive.com/us_chemicals/2012/industry_indexes/0000314227.svg",
"analysing_equity": "https://www.realrate-archive.com/us_chemicals/2012/analytics/equity/0000314227.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_chemicals/2012/analytics/profit_loss/0000314227.svg"
},
{
"company_id": "0001122976",
"feature_distribution_plot": "https://www.realrate-archive.com/us_chemicals/2012/feature_distribution/feature_distribution_0001122976.svg",
"graph_url": "https://www.realrate-archive.com/us_chemicals/2012/graphs/IME_0001122976.svg",
"logo_url": "https://www.realrate-archive.com/us_chemicals/logos/0001122976.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_chemicals/logos/0001122976_256x256.png",
"name": "Avient CORP",
"rank": 30,
"regression_plot": "https://www.realrate-archive.com/us_chemicals/2012/backtesting_correlation/regression_0001122976.svg",
"report_text": "The relative strengths and weaknesses of Avient CORP are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Avient CORP compared to the market average is the variable Intangible Assets, increasing the Economic Capital Ratio by 14% points.The greatest weakness of Avient CORP is the variable Stockholders Equity, reducing the Economic Capital Ratio by 36% points.
The company's Economic Capital Ratio, given in the ranking table, is 100%, being 27% points below the market average of 128%.",
"report_url": "https://www.realrate-archive.com/us_chemicals/2012/report/0001122976_2013_Avient_CORP.pdf",
"shrinked_graph_json": {
"2011": {
"Liabilities, Current": "5.31",
"Liabilities": "51.1",
"Stockholders Equity": "-10.2",
"ECR before LimitedLiability": "22.1",
"Other Liabilities": "4.77",
"Liabilities, Noncurrent": "43.7",
"Property, Plant and Equipment, Net": "-6.77",
"Assets": "-11.5",
"Intangible Assets": "8.06",
"Other Assets": "-0.393",
"Assets, Noncurrent": "-5.19",
"Assets, Current": "-7.01",
"Cost of Revenues": "0",
"Expenses": "0",
"Net Income": "0",
"Other Expenses": "0",
"Selling, General and Administrative Expense": "0",
"Other Revenues": "0",
"Revenues": "0",
"Other Compr. Net Income": "0",
"Comprehensive Net Income": "0",
"Other Net Income": "0",
"Revenues Y+3": "0",
"Economic Capital Ratio": "23.6",
"Revenues Y+2": "0",
"Revenues Y+1": "0",
"Revenues Y+5": "0",
"Revenues Y+4": "0"
},
"2012": {
"Other Liabilities": "2.79",
"Liabilities": "5.70",
"Stockholders Equity": "-36.1",
"ECR before LimitedLiability": "-27.6",
"Liabilities, Noncurrent": "-9.91",
"Liabilities, Current": "12.1",
"Property, Plant and Equipment, Net": "-16.6",
"Assets": "-26.2",
"Intangible Assets": "13.5",
"Other Assets": "-0.228",
"Assets, Current": "-12.3",
"Assets, Noncurrent": "-12.0",
"Other Expenses": "0",
"Expenses": "0",
"Net Income": "0",
"Cost of Revenues": "0",
"Selling, General and Administrative Expense": "0",
"Other Revenues": "0",
"Revenues": "0",
"Other Net Income": "0",
"Comprehensive Net Income": "0",
"Other Compr. Net Income": "0",
"Revenues Y+4": "0",
"Economic Capital Ratio": "-27.5",
"Revenues Y+1": "0",
"Revenues Y+5": "0",
"Revenues Y+3": "0",
"Revenues Y+2": "0"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2012/plot_over_time/0001122976_strength_weakness.svg",
"table_records": {
"2011": {
"input_variables": {
"Assets, Current": "843,500",
"Assets, Noncurrent": "95,400",
"Cost of Revenues": "0",
"Intangible Assets": "739,200",
"Liabilities, Current": "442,400",
"Liabilities, Noncurrent": "0",
"Other Assets": "8,800",
"Other Compr. Net Income": "0",
"Other Expenses": "2,460,600",
"Other Liabilities": "0",
"Other Net Income": "151,400",
"Other Revenues": "2,863,500",
"Property, Plant and Equipment, Net": "393,600",
"Revenues Y+1": "0",
"Revenues Y+2": "0",
"Revenues Y+3": "0",
"Revenues Y+4": "0",
"Revenues Y+5": "0",
"Selling, General and Administrative Expense": "381,700"
},
"output_variables": {
"Liabilities": "442,400",
"Assets": "2,080,500",
"Expenses": "2,842,300",
"Revenues": "2,863,500",
"Stockholders Equity": "1,638,100",
"Net Income": "172,600",
"Comprehensive Net Income": "172,600",
"BaseVar": "149,170,541",
"ECR before LimitedLiability": "105%",
"Economic Capital Ratio": "159%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "866,900",
"Assets, Noncurrent": "108,100",
"Cost of Revenues": "0",
"Intangible Assets": "745,500",
"Liabilities, Current": "459,800",
"Liabilities, Noncurrent": "1,036,800",
"Other Assets": "0",
"Other Compr. Net Income": "-9,700",
"Other Expenses": "2,520,300",
"Other Liabilities": "0",
"Other Net Income": "20,100",
"Other Revenues": "2,992,600",
"Property, Plant and Equipment, Net": "407,500",
"Revenues Y+1": "0",
"Revenues Y+2": "0",
"Revenues Y+3": "0",
"Revenues Y+4": "0",
"Revenues Y+5": "0",
"Selling, General and Administrative Expense": "420,600"
},
"output_variables": {
"Liabilities": "1,496,600",
"Assets": "2,128,000",
"Expenses": "2,940,900",
"Revenues": "2,992,600",
"Stockholders Equity": "631,400",
"Net Income": "71,800",
"Comprehensive Net Income": "62,100",
"BaseVar": "175,164,044",
"ECR before LimitedLiability": "28%",
"Economic Capital Ratio": "100%"
}
}
},
"top_rated": false,
"trend": -20.0,
"valuation": {
"past_accumulated_profits": 511434000.00000006,
"future_profits": 0.0,
"valuation_correction": 0.0,
"limited_liability_put_option": 1308728204.046279,
"fair_value": 1820162204.046279,
"market_value": 1367442811.5660524
},
"valuation_plot": "https://www.realrate-archive.com/us_chemicals/2012/valuation/valuation_0001122976.svg",
"value": 1.0043382464527277,
"company_index": "https://www.realrate-archive.com/us_chemicals/2012/industry_indexes/0001122976.svg",
"analysing_equity": "https://www.realrate-archive.com/us_chemicals/2012/analytics/equity/0001122976.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_chemicals/2012/analytics/profit_loss/0001122976.svg"
},
{
"company_id": "0000915389",
"feature_distribution_plot": "https://www.realrate-archive.com/us_chemicals/2012/feature_distribution/feature_distribution_0000915389.svg",
"graph_url": "https://www.realrate-archive.com/us_chemicals/2012/graphs/IME_0000915389.svg",
"logo_url": "https://www.realrate-archive.com/us_chemicals/logos/0000915389.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_chemicals/logos/0000915389_256x256.png",
"name": "Eastman Chemical CO",
"rank": 31,
"regression_plot": "https://www.realrate-archive.com/us_chemicals/2012/backtesting_correlation/regression_0000915389.svg",
"report_text": "The relative strengths and weaknesses of Eastman Chemical CO are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Eastman Chemical CO compared to the market average is the variable Intangible Assets, increasing the Economic Capital Ratio by 23% points.The greatest weakness of Eastman Chemical CO is the variable Liabilities, reducing the Economic Capital Ratio by 40% points.
The company's Economic Capital Ratio, given in the ranking table, is 97%, being 31% points below the market average of 128%.",
"report_url": "https://www.realrate-archive.com/us_chemicals/2012/report/0000915389_2013_Eastman_Chemical_CO.pdf",
"shrinked_graph_json": {
"2011": {
"Liabilities, Current": "1.79",
"Liabilities": "-20.6",
"Stockholders Equity": "-32.0",
"ECR before LimitedLiability": "-35.6",
"Other Liabilities": "-25.3",
"Liabilities, Noncurrent": "2.24",
"Property, Plant and Equipment, Net": "11.0",
"Assets": "-13.0",
"Intangible Assets": "-3.34",
"Other Assets": "-0.914",
"Assets, Noncurrent": "-8.14",
"Assets, Current": "-10.3",
"Cost of Revenues": "0",
"Expenses": "0",
"Net Income": "0",
"Other Expenses": "0",
"Selling, General and Administrative Expense": "0",
"Other Revenues": "0",
"Revenues": "0",
"Other Compr. Net Income": "0",
"Comprehensive Net Income": "0",
"Other Net Income": "0",
"Revenues Y+3": "0",
"Economic Capital Ratio": "-34.2",
"Revenues Y+2": "0",
"Revenues Y+1": "0",
"Revenues Y+5": "0",
"Revenues Y+4": "0"
},
"2012": {
"Other Liabilities": "-15.5",
"Liabilities": "-40.0",
"Stockholders Equity": "-9.59",
"ECR before LimitedLiability": "-31.1",
"Liabilities, Noncurrent": "-27.7",
"Liabilities, Current": "4.84",
"Property, Plant and Equipment, Net": "9.52",
"Assets": "21.6",
"Intangible Assets": "23.1",
"Other Assets": "-0.115",
"Assets, Current": "-5.21",
"Assets, Noncurrent": "-6.17",
"Other Expenses": "0",
"Expenses": "0",
"Net Income": "0",
"Cost of Revenues": "0",
"Selling, General and Administrative Expense": "0",
"Other Revenues": "0",
"Revenues": "0",
"Other Net Income": "0",
"Comprehensive Net Income": "0",
"Other Compr. Net Income": "0",
"Revenues Y+4": "0",
"Economic Capital Ratio": "-31.0",
"Revenues Y+1": "0",
"Revenues Y+5": "0",
"Revenues Y+3": "0",
"Revenues Y+2": "0"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2012/plot_over_time/0000915389_strength_weakness.svg",
"table_records": {
"2011": {
"input_variables": {
"Assets, Current": "2,302,000",
"Assets, Noncurrent": "369,000",
"Cost of Revenues": "0",
"Intangible Assets": "406,000",
"Liabilities, Current": "1,114,000",
"Liabilities, Noncurrent": "1,579,000",
"Other Assets": "0",
"Other Compr. Net Income": "-106,000",
"Other Expenses": "5,837,000",
"Other Liabilities": "1,621,000",
"Other Net Income": "-18,000",
"Other Revenues": "7,178,000",
"Property, Plant and Equipment, Net": "3,107,000",
"Revenues Y+1": "0",
"Revenues Y+2": "0",
"Revenues Y+3": "0",
"Revenues Y+4": "0",
"Revenues Y+5": "0",
"Selling, General and Administrative Expense": "627,000"
},
"output_variables": {
"Liabilities": "4,314,000",
"Assets": "6,184,000",
"Expenses": "6,464,000",
"Revenues": "7,178,000",
"Stockholders Equity": "1,870,000",
"Net Income": "696,000",
"Comprehensive Net Income": "590,000",
"BaseVar": "352,875,263",
"ECR before LimitedLiability": "29%",
"Economic Capital Ratio": "101%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "2,594,000",
"Assets, Noncurrent": "351,000",
"Cost of Revenues": "0",
"Intangible Assets": "4,493,000",
"Liabilities, Current": "1,364,000",
"Liabilities, Noncurrent": "5,280,000",
"Other Assets": "0",
"Other Compr. Net Income": "-22,000",
"Other Expenses": "6,666,000",
"Other Liabilities": "1,947,000",
"Other Net Income": "-150,000",
"Other Revenues": "8,102,000",
"Property, Plant and Equipment, Net": "4,181,000",
"Revenues Y+1": "0",
"Revenues Y+2": "0",
"Revenues Y+3": "0",
"Revenues Y+4": "0",
"Revenues Y+5": "0",
"Selling, General and Administrative Expense": "842,000"
},
"output_variables": {
"Liabilities": "8,591,000",
"Assets": "11,619,000",
"Expenses": "7,508,000",
"Revenues": "8,102,000",
"Stockholders Equity": "3,028,000",
"Net Income": "444,000",
"Comprehensive Net Income": "422,000",
"BaseVar": "468,884,070",
"ECR before LimitedLiability": "24%",
"Economic Capital Ratio": "97%"
}
}
},
"top_rated": false,
"trend": 1.0,
"valuation": {
"past_accumulated_profits": 2452680000.0,
"future_profits": 0.0,
"valuation_correction": 0.0,
"limited_liability_put_option": 7341387311.110967,
"fair_value": 9794067311.110966,
"market_value": 6906699141.868092
},
"valuation_plot": "https://www.realrate-archive.com/us_chemicals/2012/valuation/valuation_0000915389.svg",
"value": 0.9692298180218669,
"company_index": "https://www.realrate-archive.com/us_chemicals/2012/industry_indexes/0000915389.svg",
"analysing_equity": "https://www.realrate-archive.com/us_chemicals/2012/analytics/equity/0000915389.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_chemicals/2012/analytics/profit_loss/0000915389.svg"
},
{
"company_id": "0000007431",
"feature_distribution_plot": "https://www.realrate-archive.com/us_chemicals/2012/feature_distribution/feature_distribution_0000007431.svg",
"graph_url": "https://www.realrate-archive.com/us_chemicals/2012/graphs/IME_0000007431.svg",
"logo_url": "https://www.realrate-archive.com/us_chemicals/logos/0000007431.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_chemicals/logos/0000007431_256x256.png",
"name": "Armstrong World Industries INC",
"rank": 32,
"regression_plot": "https://www.realrate-archive.com/us_chemicals/2012/backtesting_correlation/regression_0000007431.svg",
"report_text": "The relative strengths and weaknesses of Armstrong World Industries INC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Armstrong World Industries INC compared to the market average is the variable Other Assets, increasing the Economic Capital Ratio by 22% points.The greatest weakness of Armstrong World Industries INC is the variable Liabilities, Noncurrent, reducing the Economic Capital Ratio by 38% points.
The company's Economic Capital Ratio, given in the ranking table, is 96%, being 32% points below the market average of 128%.",
"report_url": "https://www.realrate-archive.com/us_chemicals/2012/report/0000007431_2013_Armstrong_World_Industries_INC.pdf",
"shrinked_graph_json": {
"2011": {
"Liabilities, Current": "4.27",
"Liabilities": "-21.1",
"Stockholders Equity": "-19.2",
"ECR before LimitedLiability": "-28.0",
"Other Liabilities": "2.32",
"Liabilities, Noncurrent": "-29.0",
"Property, Plant and Equipment, Net": "-0.540",
"Assets": "-3.13",
"Intangible Assets": "-5.98",
"Other Assets": "20.4",
"Assets, Noncurrent": "-7.77",
"Assets, Current": "-3.84",
"Cost of Revenues": "0",
"Expenses": "0",
"Net Income": "0",
"Other Expenses": "0",
"Selling, General and Administrative Expense": "0",
"Other Revenues": "0",
"Revenues": "0",
"Other Compr. Net Income": "0",
"Comprehensive Net Income": "0",
"Other Net Income": "0",
"Revenues Y+3": "0",
"Economic Capital Ratio": "-26.6",
"Revenues Y+2": "0",
"Revenues Y+1": "0",
"Revenues Y+5": "0",
"Revenues Y+4": "0"
},
"2012": {
"Other Liabilities": "1.80",
"Liabilities": "-25.4",
"Stockholders Equity": "-20.4",
"ECR before LimitedLiability": "-31.9",
"Liabilities, Noncurrent": "-38.5",
"Liabilities, Current": "8.57",
"Property, Plant and Equipment, Net": "2.28",
"Assets": "-0.971",
"Intangible Assets": "-7.80",
"Other Assets": "22.2",
"Assets, Current": "-3.33",
"Assets, Noncurrent": "-8.65",
"Other Expenses": "0",
"Expenses": "0",
"Net Income": "0",
"Cost of Revenues": "0",
"Selling, General and Administrative Expense": "0",
"Other Revenues": "0",
"Revenues": "0",
"Other Net Income": "0",
"Comprehensive Net Income": "0",
"Other Compr. Net Income": "0",
"Revenues Y+4": "0",
"Economic Capital Ratio": "-31.8",
"Revenues Y+1": "0",
"Revenues Y+5": "0",
"Revenues Y+3": "0",
"Revenues Y+2": "0"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2012/plot_over_time/0000007431_strength_weakness.svg",
"table_records": {
"2011": {
"input_variables": {
"Assets, Current": "1,209,300",
"Assets, Noncurrent": "90,500",
"Cost of Revenues": "2,187,900",
"Intangible Assets": "0",
"Liabilities, Current": "386,100",
"Liabilities, Noncurrent": "1,478,400",
"Other Assets": "792,000",
"Other Compr. Net Income": "0",
"Other Expenses": "139,600",
"Other Liabilities": "0",
"Other Net Income": "54,900",
"Other Revenues": "2,863,300",
"Property, Plant and Equipment, Net": "902,900",
"Revenues Y+1": "0",
"Revenues Y+2": "0",
"Revenues Y+3": "0",
"Revenues Y+4": "0",
"Revenues Y+5": "0",
"Selling, General and Administrative Expense": "478,300"
},
"output_variables": {
"Liabilities": "1,864,500",
"Assets": "2,994,700",
"Expenses": "2,805,800",
"Revenues": "2,863,300",
"Stockholders Equity": "1,130,200",
"Net Income": "112,400",
"Comprehensive Net Income": "112,400",
"BaseVar": "146,975,055",
"ECR before LimitedLiability": "38%",
"Economic Capital Ratio": "109%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "1,019,900",
"Assets, Noncurrent": "93,500",
"Cost of Revenues": "1,985,700",
"Intangible Assets": "0",
"Liabilities, Current": "384,700",
"Liabilities, Noncurrent": "1,750,500",
"Other Assets": "735,900",
"Other Compr. Net Income": "-56,400",
"Other Expenses": "129,900",
"Other Liabilities": "0",
"Other Net Income": "42,800",
"Other Revenues": "2,622,400",
"Property, Plant and Equipment, Net": "1,005,000",
"Revenues Y+1": "0",
"Revenues Y+2": "0",
"Revenues Y+3": "0",
"Revenues Y+4": "0",
"Revenues Y+5": "0",
"Selling, General and Administrative Expense": "418,300"
},
"output_variables": {
"Liabilities": "2,135,200",
"Assets": "2,854,300",
"Expenses": "2,533,900",
"Revenues": "2,622,400",
"Stockholders Equity": "719,100",
"Net Income": "131,300",
"Comprehensive Net Income": "74,900",
"BaseVar": "155,270,913",
"ECR before LimitedLiability": "23%",
"Economic Capital Ratio": "96%"
}
}
},
"top_rated": false,
"trend": -4.0,
"valuation": {
"past_accumulated_profits": 582471000.0,
"future_profits": 0.0,
"valuation_correction": 0.0,
"limited_liability_put_option": 1814786998.513456,
"fair_value": 2397257998.5134563,
"market_value": 2729936601.0831337
},
"valuation_plot": "https://www.realrate-archive.com/us_chemicals/2012/valuation/valuation_0000007431.svg",
"value": 0.9609211337863337,
"company_index": "https://www.realrate-archive.com/us_chemicals/2012/industry_indexes/0000007431.svg",
"analysing_equity": "https://www.realrate-archive.com/us_chemicals/2012/analytics/equity/0000007431.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_chemicals/2012/analytics/profit_loss/0000007431.svg"
},
{
"company_id": "0000030554",
"feature_distribution_plot": "https://www.realrate-archive.com/us_chemicals/2012/feature_distribution/feature_distribution_0000030554.svg",
"graph_url": "https://www.realrate-archive.com/us_chemicals/2012/graphs/IME_0000030554.svg",
"logo_url": "https://www.realrate-archive.com/us_chemicals/logos/0000030554.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_chemicals/logos/0000030554_256x256.png",
"name": "EIDP Inc",
"rank": 33,
"regression_plot": "https://www.realrate-archive.com/us_chemicals/2012/backtesting_correlation/regression_0000030554.svg",
"report_text": "The relative strengths and weaknesses of EIDP Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of EIDP Inc compared to the market average is the variable Assets, increasing the Economic Capital Ratio by 18% points.The greatest weakness of EIDP Inc is the variable Liabilities, reducing the Economic Capital Ratio by 45% points.
The company's Economic Capital Ratio, given in the ranking table, is 92%, being 36% points below the market average of 128%.",
"report_url": "https://www.realrate-archive.com/us_chemicals/2012/report/0000030554_2013_EIDP_Inc.pdf",
"shrinked_graph_json": {
"2011": {
"Liabilities, Current": "-8.84",
"Liabilities": "-50.3",
"Stockholders Equity": "-24.1",
"ECR before LimitedLiability": "-46.6",
"Other Liabilities": "-0.235",
"Liabilities, Noncurrent": "-38.4",
"Property, Plant and Equipment, Net": "2.11",
"Assets": "13.2",
"Intangible Assets": "11.9",
"Other Assets": "5.87",
"Assets, Noncurrent": "-6.08",
"Assets, Current": "-0.137",
"Cost of Revenues": "0",
"Expenses": "0",
"Net Income": "0",
"Other Expenses": "0",
"Selling, General and Administrative Expense": "0",
"Other Revenues": "0",
"Revenues": "0",
"Other Compr. Net Income": "0",
"Comprehensive Net Income": "0",
"Other Net Income": "0",
"Revenues Y+3": "0",
"Economic Capital Ratio": "-45.1",
"Revenues Y+2": "0",
"Revenues Y+1": "0",
"Revenues Y+5": "0",
"Revenues Y+4": "0"
},
"2012": {
"Other Liabilities": "-0.276",
"Liabilities": "-44.6",
"Stockholders Equity": "-14.4",
"ECR before LimitedLiability": "-36.4",
"Liabilities, Noncurrent": "-32.1",
"Liabilities, Current": "-9.71",
"Property, Plant and Equipment, Net": "1.08",
"Assets": "17.8",
"Intangible Assets": "8.49",
"Other Assets": "6.06",
"Assets, Current": "9.75",
"Assets, Noncurrent": "-5.71",
"Other Expenses": "0",
"Expenses": "0",
"Net Income": "0",
"Cost of Revenues": "0",
"Selling, General and Administrative Expense": "0",
"Other Revenues": "0",
"Revenues": "0",
"Other Net Income": "0",
"Comprehensive Net Income": "0",
"Other Compr. Net Income": "0",
"Revenues Y+4": "0",
"Economic Capital Ratio": "-36.3",
"Revenues Y+1": "0",
"Revenues Y+5": "0",
"Revenues Y+3": "0",
"Revenues Y+2": "0"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2012/plot_over_time/0000030554_strength_weakness.svg",
"table_records": {
"2011": {
"input_variables": {
"Assets, Current": "18,058,000",
"Assets, Noncurrent": "2,129,000",
"Cost of Revenues": "0",
"Intangible Assets": "10,826,000",
"Liabilities, Current": "11,185,000",
"Liabilities, Noncurrent": "27,244,000",
"Other Assets": "4,067,000",
"Other Compr. Net Income": "0",
"Other Expenses": "29,083,000",
"Other Liabilities": "1,001,000",
"Other Net Income": "758,000",
"Other Revenues": "37,961,000",
"Property, Plant and Equipment, Net": "13,412,000",
"Revenues Y+1": "0",
"Revenues Y+2": "0",
"Revenues Y+3": "0",
"Revenues Y+4": "0",
"Revenues Y+5": "0",
"Selling, General and Administrative Expense": "6,126,000"
},
"output_variables": {
"Liabilities": "39,430,000",
"Assets": "48,492,000",
"Expenses": "35,209,000",
"Revenues": "37,961,000",
"Stockholders Equity": "9,062,000",
"Net Income": "3,510,000",
"Comprehensive Net Income": "3,510,000",
"BaseVar": "1,910,829,687",
"ECR before LimitedLiability": "17%",
"Economic Capital Ratio": "90%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "21,191,000",
"Assets, Noncurrent": "2,123,000",
"Cost of Revenues": "0",
"Intangible Assets": "9,742,000",
"Liabilities, Current": "13,549,000",
"Liabilities, Noncurrent": "25,152,000",
"Other Assets": "3,939,000",
"Other Compr. Net Income": "79,000",
"Other Expenses": "27,183,000",
"Other Liabilities": "856,000",
"Other Net Income": "818,000",
"Other Revenues": "34,812,000",
"Property, Plant and Equipment, Net": "12,741,000",
"Revenues Y+1": "0",
"Revenues Y+2": "0",
"Revenues Y+3": "0",
"Revenues Y+4": "0",
"Revenues Y+5": "0",
"Selling, General and Administrative Expense": "5,634,000"
},
"output_variables": {
"Liabilities": "39,557,000",
"Assets": "49,736,000",
"Expenses": "32,817,000",
"Revenues": "34,812,000",
"Stockholders Equity": "10,179,000",
"Net Income": "2,813,000",
"Comprehensive Net Income": "2,892,000",
"BaseVar": "2,036,681,384",
"ECR before LimitedLiability": "18%",
"Economic Capital Ratio": "92%"
}
}
},
"top_rated": false,
"trend": 2.0,
"valuation": {
"past_accumulated_profits": 8244990000.000001,
"future_profits": 0.0,
"valuation_correction": 0.0,
"limited_liability_put_option": 32671450549.92009,
"fair_value": 40916440549.92009,
"market_value": 51989633476.32599
},
"valuation_plot": "https://www.realrate-archive.com/us_chemicals/2012/valuation/valuation_0000030554.svg",
"value": 0.9164534857137758,
"company_index": "https://www.realrate-archive.com/us_chemicals/2012/industry_indexes/0000030554.svg",
"analysing_equity": "https://www.realrate-archive.com/us_chemicals/2012/analytics/equity/0000030554.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_chemicals/2012/analytics/profit_loss/0000030554.svg"
},
{
"company_id": "0001324759",
"feature_distribution_plot": "https://www.realrate-archive.com/us_chemicals/2012/feature_distribution/feature_distribution_0001324759.svg",
"graph_url": "https://www.realrate-archive.com/us_chemicals/2012/graphs/IME_0001324759.svg",
"logo_url": "https://www.realrate-archive.com/us_chemicals/logos/0000000000.png",
"logo_url_256x256": "https://www.realrate-archive.com/us_chemicals/logos/0000000000_256x256.png",
"name": "HONG YUAN Holding Group",
"rank": 34,
"regression_plot": "https://www.realrate-archive.com/us_chemicals/2012/backtesting_correlation/regression_0001324759.svg",
"report_text": "The relative strengths and weaknesses of HONG YUAN Holding Group are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of HONG YUAN Holding Group compared to the market average is the variable Property, Plant and Equipment, Net, increasing the Economic Capital Ratio by 1.7% points.The greatest weakness of HONG YUAN Holding Group is the variable Liabilities, reducing the Economic Capital Ratio by 46% points.
The company's Economic Capital Ratio, given in the ranking table, is 71%, being 57% points below the market average of 128%.",
"report_url": "https://www.realrate-archive.com/us_chemicals/2012/report/0001324759_2013_HONG_YUAN_Holding_Group.pdf",
"shrinked_graph_json": {
"2011": {
"Liabilities, Current": "-4.33",
"Liabilities": "-43.3",
"Stockholders Equity": "-17.7",
"ECR before LimitedLiability": "-39.0",
"Other Liabilities": "1.71",
"Liabilities, Noncurrent": "-39.9",
"Property, Plant and Equipment, Net": "3.45",
"Assets": "13.7",
"Intangible Assets": "-4.95",
"Other Assets": "-0.991",
"Assets, Noncurrent": "-5.65",
"Assets, Current": "23.7",
"Cost of Revenues": "0",
"Expenses": "0",
"Net Income": "0",
"Other Expenses": "0",
"Selling, General and Administrative Expense": "0",
"Other Revenues": "0",
"Revenues": "0",
"Other Compr. Net Income": "0",
"Comprehensive Net Income": "0",
"Other Net Income": "0",
"Revenues Y+3": "0",
"Economic Capital Ratio": "-37.6",
"Revenues Y+2": "0",
"Revenues Y+1": "0",
"Revenues Y+5": "0",
"Revenues Y+4": "0"
},
"2012": {
"Other Liabilities": "0.153",
"Liabilities": "-46.2",
"Stockholders Equity": "-34.7",
"ECR before LimitedLiability": "-57.2",
"Liabilities, Noncurrent": "-2.58",
"Liabilities, Current": "-8.81",
"Property, Plant and Equipment, Net": "1.74",
"Assets": "-1.01",
"Intangible Assets": "-1.18",
"Other Assets": "-0.207",
"Assets, Current": "0.321",
"Assets, Noncurrent": "-1.17",
"Other Expenses": "0",
"Expenses": "0",
"Net Income": "0",
"Cost of Revenues": "0",
"Selling, General and Administrative Expense": "0",
"Other Revenues": "0",
"Revenues": "0",
"Other Net Income": "0",
"Comprehensive Net Income": "0",
"Other Compr. Net Income": "0",
"Revenues Y+4": "0",
"Economic Capital Ratio": "-57.1",
"Revenues Y+1": "0",
"Revenues Y+5": "0",
"Revenues Y+3": "0",
"Revenues Y+2": "0"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2012/plot_over_time/0001324759_strength_weakness.svg",
"table_records": {
"2011": {
"input_variables": {
"Assets, Current": "24,056",
"Assets, Noncurrent": "1,594",
"Cost of Revenues": "0",
"Intangible Assets": "183",
"Liabilities, Current": "6,501",
"Liabilities, Noncurrent": "20,052",
"Other Assets": "-183",
"Other Compr. Net Income": "14",
"Other Expenses": "18,223",
"Other Liabilities": "0",
"Other Net Income": "-1,590",
"Other Revenues": "20,256",
"Property, Plant and Equipment, Net": "10,601",
"Revenues Y+1": "0",
"Revenues Y+2": "0",
"Revenues Y+3": "0",
"Revenues Y+4": "0",
"Revenues Y+5": "0",
"Selling, General and Administrative Expense": "14,445"
},
"output_variables": {
"Liabilities": "26,553",
"Assets": "36,251",
"Expenses": "32,668",
"Revenues": "20,256",
"Stockholders Equity": "9,698",
"Net Income": "-14,002",
"Comprehensive Net Income": "-13,988",
"BaseVar": "1,408,372",
"ECR before LimitedLiability": "25%",
"Economic Capital Ratio": "98%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "7,500",
"Assets, Noncurrent": "1,085",
"Cost of Revenues": "0",
"Intangible Assets": "245",
"Liabilities, Current": "15,109",
"Liabilities, Noncurrent": "11,096",
"Other Assets": "-245",
"Other Compr. Net Income": "2.0",
"Other Expenses": "975",
"Other Liabilities": "0",
"Other Net Income": "-10,733",
"Other Revenues": "894",
"Property, Plant and Equipment, Net": "7,597",
"Revenues Y+1": "0",
"Revenues Y+2": "0",
"Revenues Y+3": "0",
"Revenues Y+4": "0",
"Revenues Y+5": "0",
"Selling, General and Administrative Expense": "19,348"
},
"output_variables": {
"Liabilities": "26,205",
"Assets": "16,182",
"Expenses": "20,323",
"Revenues": "894",
"Stockholders Equity": "-10,023",
"Net Income": "-30,162",
"Comprehensive Net Income": "-30,160",
"BaseVar": "950,031",
"ECR before LimitedLiability": "-38%",
"Economic Capital Ratio": "71%"
}
}
},
"top_rated": false,
"trend": -1.0,
"valuation": {
"past_accumulated_profits": -8118630.000000001,
"future_profits": 0.0,
"valuation_correction": -0.0,
"limited_liability_put_option": 23126904.208607692,
"fair_value": 15008274.208607692,
"market_value": 1007942.6227383077
},
"valuation_plot": "https://www.realrate-archive.com/us_chemicals/2012/valuation/valuation_0001324759.svg",
"value": 0.7081545855383816,
"company_index": "https://www.realrate-archive.com/us_chemicals/2012/industry_indexes/0001324759.svg",
"analysing_equity": "https://www.realrate-archive.com/us_chemicals/2012/analytics/equity/0001324759.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_chemicals/2012/analytics/profit_loss/0001324759.svg"
},
{
"company_id": "0001308027",
"feature_distribution_plot": "https://www.realrate-archive.com/us_chemicals/2012/feature_distribution/feature_distribution_0001308027.svg",
"graph_url": "https://www.realrate-archive.com/us_chemicals/2012/graphs/IME_0001308027.svg",
"logo_url": "https://www.realrate-archive.com/us_chemicals/logos/0001308027.jpg",
"logo_url_256x256": "https://www.realrate-archive.com/us_chemicals/logos/0001308027_256x256.png",
"name": "Vystar Corp",
"rank": 35,
"regression_plot": "https://www.realrate-archive.com/us_chemicals/2012/backtesting_correlation/regression_0001308027.svg",
"report_text": "The relative strengths and weaknesses of Vystar Corp are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Vystar Corp compared to the market average is the variable Other Assets, increasing the Economic Capital Ratio by 3.5% points.The greatest weakness of Vystar Corp is the variable Liabilities, Current, reducing the Economic Capital Ratio by 65% points.
The company's Economic Capital Ratio, given in the ranking table, is 65%, being 63% points below the market average of 128%.",
"report_url": "https://www.realrate-archive.com/us_chemicals/2012/report/0001308027_2013_Vystar_Corp.pdf",
"shrinked_graph_json": {
"2012": {
"Other Liabilities": "0.229",
"Liabilities": "-19.5",
"Stockholders Equity": "-47.5",
"ECR before LimitedLiability": "-63.5",
"Liabilities, Noncurrent": "2.71",
"Liabilities, Current": "-65.2",
"Property, Plant and Equipment, Net": "-5.03",
"Assets": "-7.92",
"Intangible Assets": "0.852",
"Other Assets": "3.52",
"Assets, Current": "-4.62",
"Assets, Noncurrent": "-4.10",
"Other Expenses": "0",
"Expenses": "0",
"Net Income": "0",
"Cost of Revenues": "0",
"Selling, General and Administrative Expense": "0",
"Other Revenues": "0",
"Revenues": "0",
"Other Net Income": "0",
"Comprehensive Net Income": "0",
"Other Compr. Net Income": "0",
"Revenues Y+4": "0",
"Economic Capital Ratio": "-63.4",
"Revenues Y+1": "0",
"Revenues Y+5": "0",
"Revenues Y+3": "0",
"Revenues Y+2": "0"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_chemicals/2012/plot_over_time/0001308027_strength_weakness.svg",
"table_records": {
"2012": {
"input_variables": {
"Assets, Current": "445",
"Assets, Noncurrent": "0",
"Cost of Revenues": "0",
"Intangible Assets": "306",
"Liabilities, Current": "2,898",
"Liabilities, Noncurrent": "42",
"Other Assets": "223",
"Other Compr. Net Income": "0",
"Other Expenses": "3,253",
"Other Liabilities": "0",
"Other Net Income": "0.53",
"Other Revenues": "545",
"Property, Plant and Equipment, Net": "221",
"Revenues Y+1": "0",
"Revenues Y+2": "0",
"Revenues Y+3": "0",
"Revenues Y+4": "0",
"Revenues Y+5": "0",
"Selling, General and Administrative Expense": "37"
},
"output_variables": {
"Liabilities": "2,940",
"Assets": "1,195",
"Expenses": "3,290",
"Revenues": "545",
"Stockholders Equity": "-1,745",
"Net Income": "-2,744",
"Comprehensive Net Income": "-2,744",
"BaseVar": "113,585",
"ECR before LimitedLiability": "-68%",
"Economic Capital Ratio": "65%"
}
}
},
"top_rated": false,
"trend": null,
"valuation": {
"past_accumulated_profits": -1413421.6500000001,
"future_profits": 0.0,
"valuation_correction": -0.0,
"limited_liability_put_option": 2747081.1690685246,
"fair_value": 1333659.5190685245,
"market_value": 4094737.12
},
"valuation_plot": "https://www.realrate-archive.com/us_chemicals/2012/valuation/valuation_0001308027.svg",
"value": 0.6450114412690354,
"company_index": "https://www.realrate-archive.com/us_chemicals/2012/industry_indexes/0001308027.svg",
"analysing_equity": "https://www.realrate-archive.com/us_chemicals/2012/analytics/equity/0001308027.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_chemicals/2012/analytics/profit_loss/0001308027.svg"
}
],
"feature_distribution_plot": "https://www.realrate-archive.com/us_chemicals/2012/feature_distribution/feature_distribution.svg",
"final_var_label": "Economic Capital Ratio",
"industry_box": [
[
"Revenues",
"102 B"
],
[
"Assets",
"129 B"
],
[
"Expenses",
"96.2 B"
],
[
"Stockholders Equity",
"50.8 B"
]
],
"industry_id": "us_chemicals",
"industry_label": "Plastic & Chemicals",
"num_companies": 35,
"num_top_companies": 8,
"ecr_records": {
"2011": {
"0000084748": {
"rank": 1,
"ecr": "174"
},
"0000915913": {
"rank": 2,
"ecr": "173"
},
"0000310142": {
"rank": 3,
"ecr": "172"
},
"0001101302": {
"rank": 4,
"ecr": "172"
},
"0000038264": {
"rank": 5,
"ecr": "167"
},
"0001306830": {
"rank": 6,
"ecr": "166"
},
"0001282637": {
"rank": 7,
"ecr": "163"
},
"0000060714": {
"rank": 8,
"ecr": "162"
},
"0001200375": {
"rank": 9,
"ecr": "159"
},
"0001122976": {
"rank": 10,
"ecr": "159"
},
"0000896622": {
"rank": 11,
"ecr": "155"
},
"0001337298": {
"rank": 12,
"ecr": "153"
},
"0000069488": {
"rank": 13,
"ecr": "152"
},
"0000744187": {
"rank": 14,
"ecr": "149"
},
"0001392380": {
"rank": 15,
"ecr": "145"
},
"0000891014": {
"rank": 16,
"ecr": "141"
},
"0001120970": {
"rank": 17,
"ecr": "136"
},
"0000717605": {
"rank": 18,
"ecr": "132"
},
"0000072162": {
"rank": 19,
"ecr": "129"
},
"0001262823": {
"rank": 20,
"ecr": "126"
},
"0001026655": {
"rank": 21,
"ecr": "126"
},
"0000778164": {
"rank": 22,
"ecr": "123"
},
"0001257640": {
"rank": 23,
"ecr": "123"
},
"0000790051": {
"rank": 24,
"ecr": "119"
},
"0000105770": {
"rank": 25,
"ecr": "118"
},
"0000002969": {
"rank": 26,
"ecr": "113"
},
"0000110621": {
"rank": 27,
"ecr": "110"
},
"0000007431": {
"rank": 28,
"ecr": "109"
},
"0000051253": {
"rank": 29,
"ecr": "108"
},
"0001309402": {
"rank": 30,
"ecr": "106"
},
"0000059255": {
"rank": 31,
"ecr": "106"
},
"0000915389": {
"rank": 32,
"ecr": "101"
},
"0001324759": {
"rank": 33,
"ecr": "98"
},
"0000079879": {
"rank": 34,
"ecr": "95"
},
"0000030554": {
"rank": 35,
"ecr": "90"
}
},
"2012": {
"0000084748": {
"rank": 1,
"ecr": "175"
},
"0000915913": {
"rank": 2,
"ecr": "175"
},
"0001101302": {
"rank": 3,
"ecr": "174"
},
"0000310142": {
"rank": 4,
"ecr": "174"
},
"0001306830": {
"rank": 5,
"ecr": "168"
},
"0001200375": {
"rank": 6,
"ecr": "166"
},
"0001282637": {
"rank": 7,
"ecr": "165"
},
"0000896622": {
"rank": 8,
"ecr": "161"
},
"0000060714": {
"rank": 9,
"ecr": "160"
},
"0000069488": {
"rank": 10,
"ecr": "155"
},
"0001337298": {
"rank": 11,
"ecr": "151"
},
"0000744187": {
"rank": 12,
"ecr": "139"
},
"0001392380": {
"rank": 13,
"ecr": "137"
},
"0000717605": {
"rank": 14,
"ecr": "136"
},
"0000072162": {
"rank": 15,
"ecr": "130"
},
"0001262823": {
"rank": 16,
"ecr": "128"
},
"0000038264": {
"rank": 17,
"ecr": "126"
},
"0001257640": {
"rank": 18,
"ecr": "125"
},
"0000790051": {
"rank": 19,
"ecr": "124"
},
"0000105770": {
"rank": 20,
"ecr": "118"
},
"0000002969": {
"rank": 21,
"ecr": "112"
},
"0000738214": {
"rank": 22,
"ecr": "111"
},
"0000051253": {
"rank": 23,
"ecr": "109"
},
"0001120970": {
"rank": 24,
"ecr": "109"
},
"0000110621": {
"rank": 25,
"ecr": "108"
},
"0001309402": {
"rank": 26,
"ecr": "107"
},
"0000059255": {
"rank": 27,
"ecr": "105"
},
"0000778164": {
"rank": 28,
"ecr": "105"
},
"0000314227": {
"rank": 29,
"ecr": "102"
},
"0001122976": {
"rank": 30,
"ecr": "100"
},
"0000915389": {
"rank": 31,
"ecr": "97"
},
"0000007431": {
"rank": 32,
"ecr": "96"
},
"0000030554": {
"rank": 33,
"ecr": "92"
},
"0001324759": {
"rank": 34,
"ecr": "71"
},
"0001308027": {
"rank": 35,
"ecr": "65"
}
}
},
"rating_box": [
[
"Top rated",
"8 of 35"
],
[
"Best, worst rating",
"175 %, 64.5 %"
],
[
"New companies",
"3"
]
],
"regression_plot": "https://www.realrate-archive.com/us_chemicals/2012/backtesting_correlation/regression_2012.svg",
"scentences": [
"International Flavors Fragrances INC climbed 6 positions from 29 to 23 due to its excellent Assets, Current.",
"Avient CORP lost 20 positions from 10 to 30 due to its bad Stockholders Equity.",
"Aemetis INC entered the 2013 ranking at rank 22, making it the best newcomer.",
"The biggest company by assets, EIDP Inc, is only ranked at place 33 whereas the smallest company, TOMI Environmental Solutions Inc, is financially stronger at rank 29."
],
"url_segment": "2013-us-chemicals",
"year": 2013,
"feature_importance": "https://www.realrate-archive.com/us_chemicals/2012/feature_importance/feature_importance.svg",
"obs_ecr": {
"0000002969": {
"2011": {
"obs_EconomicCapitalRatio": 1.0976433139205226
},
"2012": {
"obs_EconomicCapitalRatio": 0.9360041817768175
},
"2013": {
"obs_EconomicCapitalRatio": 1.2491579146929779
},
"2014": {
"obs_EconomicCapitalRatio": 1.7222596883155998
},
"2015": {
"obs_EconomicCapitalRatio": 1.614411596429667
},
"2016": {
"obs_EconomicCapitalRatio": 1.7537613281943967
},
"2017": {
"obs_EconomicCapitalRatio": 2.171227339544988
},
"2018": {
"obs_EconomicCapitalRatio": 2.0874340822226483
},
"2019": {
"obs_EconomicCapitalRatio": 3.3496020317351674
},
"2020": {
"obs_EconomicCapitalRatio": 2.7403711674472224
},
"2021": {
"obs_EconomicCapitalRatio": 3.0039816709793827
},
"2022": {
"obs_EconomicCapitalRatio": 3.1205873175604264
},
"2023": {
"obs_EconomicCapitalRatio": 2.349325262988046
},
"2024": {
"obs_EconomicCapitalRatio": 2.082949884472786
},
"2025": {
"obs_EconomicCapitalRatio": 1.6693682249382806
}
},
"0000059255": {
"2011": {
"obs_EconomicCapitalRatio": 2.073078761972932
},
"2012": {
"obs_EconomicCapitalRatio": 1.209564157736749
},
"2013": {
"obs_EconomicCapitalRatio": 1.5558400613187209
},
"2014": {
"obs_EconomicCapitalRatio": 0.6078662556382622
},
"2015": {
"obs_EconomicCapitalRatio": 0.15988577187297812
},
"2016": {
"obs_EconomicCapitalRatio": 0.4372572540647698
},
"2017": {
"obs_EconomicCapitalRatio": 0.6964223823669758
},
"2018": {
"obs_EconomicCapitalRatio": 0.24827569951171105
},
"2019": {
"obs_EconomicCapitalRatio": 0.23945336124774594
},
"2020": {
"obs_EconomicCapitalRatio": 0.17709459114491516
},
"2021": {
"obs_EconomicCapitalRatio": 0.29765217938535704
},
"2022": {
"obs_EconomicCapitalRatio": 0.26938293231858007
}
},
"0000060714": {
"2011": {
"obs_EconomicCapitalRatio": 2.039779842842567
},
"2012": {
"obs_EconomicCapitalRatio": 2.2131807538336474
},
"2013": {
"obs_EconomicCapitalRatio": 1.3904103475977485
},
"2014": {
"obs_EconomicCapitalRatio": 1.100090273020253
},
"2015": {
"obs_EconomicCapitalRatio": 0.2147896339331022
},
"2016": {
"obs_EconomicCapitalRatio": 0.33578161880960755
},
"2017": {
"obs_EconomicCapitalRatio": 0.38654346320293775
},
"2018": {
"obs_EconomicCapitalRatio": 0.25178648371325596
},
"2019": {
"obs_EconomicCapitalRatio": 0.21421590942666746
},
"2020": {
"obs_EconomicCapitalRatio": 0.14095311916560824
},
"2021": {
"obs_EconomicCapitalRatio": 1.5005382738592263
},
"2022": {
"obs_EconomicCapitalRatio": 1.4179856468214125
}
},
"0000072162": {
"2011": {
"obs_EconomicCapitalRatio": 0.7403156161368563
},
"2012": {
"obs_EconomicCapitalRatio": 0.7287485479888595
},
"2013": {
"obs_EconomicCapitalRatio": 0.6551218358570887
},
"2014": {
"obs_EconomicCapitalRatio": 0.7476462291176851
},
"2015": {
"obs_EconomicCapitalRatio": 0.34930765593564356
},
"2016": {
"obs_EconomicCapitalRatio": 0.9169389503100207
},
"2017": {
"obs_EconomicCapitalRatio": 1.1630608354568477
},
"2018": {
"obs_EconomicCapitalRatio": 0.26261518088949715
},
"2019": {
"obs_EconomicCapitalRatio": 0.33335368425682055
},
"2020": {
"obs_EconomicCapitalRatio": 0.4120970293301054
},
"2021": {
"obs_EconomicCapitalRatio": 0.6130774295503331
},
"2022": {
"obs_EconomicCapitalRatio": 0.5925481499725161
},
"2023": {
"obs_EconomicCapitalRatio": 0.5743145631525474
}
},
"0000891014": {
"2011": {
"obs_EconomicCapitalRatio": 1.2196115824660183
},
"2013": {
"obs_EconomicCapitalRatio": 2.520199436562207
},
"2014": {
"obs_EconomicCapitalRatio": 0.8420966963083756
},
"2015": {
"obs_EconomicCapitalRatio": 0.6143094634486403
},
"2016": {
"obs_EconomicCapitalRatio": 1.1387471322001552
},
"2017": {
"obs_EconomicCapitalRatio": 1.0067147927749704
},
"2018": {
"obs_EconomicCapitalRatio": 0.713790728447913
},
"2019": {
"obs_EconomicCapitalRatio": 0.8148959561065288
},
"2020": {
"obs_EconomicCapitalRatio": 0.8259022739519024
},
"2021": {
"obs_EconomicCapitalRatio": 0.9152018595823116
},
"2022": {
"obs_EconomicCapitalRatio": 0.7347855440009189
},
"2023": {
"obs_EconomicCapitalRatio": 0.8828261150921283
},
"2025": {
"obs_EconomicCapitalRatio": 0.7425037708810072
}
},
"0001257640": {
"2011": {
"obs_EconomicCapitalRatio": 0.7473627284404054
},
"2012": {
"obs_EconomicCapitalRatio": 0.6784490985651526
},
"2013": {
"obs_EconomicCapitalRatio": 0.8805912426344558
},
"2014": {
"obs_EconomicCapitalRatio": 0.6555238315485933
},
"2015": {
"obs_EconomicCapitalRatio": 0.37668667016523305
},
"2016": {
"obs_EconomicCapitalRatio": 0.9018899129986416
},
"2017": {
"obs_EconomicCapitalRatio": 1.3553910892526544
},
"2018": {
"obs_EconomicCapitalRatio": 0.5905285629816391
},
"2019": {
"obs_EconomicCapitalRatio": 0.720346960805854
},
"2020": {
"obs_EconomicCapitalRatio": 0.8043646522558651
},
"2021": {
"obs_EconomicCapitalRatio": 0.8621361629256152
},
"2022": {
"obs_EconomicCapitalRatio": 0.6234165514756979
},
"2023": {
"obs_EconomicCapitalRatio": 0.728712524845626
}
},
"0000030554": {
"2011": {
"obs_EconomicCapitalRatio": 1.1192517322544968
},
"2012": {
"obs_EconomicCapitalRatio": 1.1644727688917607
},
"2013": {
"obs_EconomicCapitalRatio": 1.027381948932993
},
"2014": {
"obs_EconomicCapitalRatio": 1.2739813525244739
},
"2019": {
"obs_EconomicCapitalRatio": 2.552382093764655e-07
}
},
"0001306830": {
"2011": {
"obs_EconomicCapitalRatio": 1.0795597199260327
},
"2012": {
"obs_EconomicCapitalRatio": 1.0744864508371528
},
"2013": {
"obs_EconomicCapitalRatio": 1.3036505709409618
},
"2014": {
"obs_EconomicCapitalRatio": 1.4697469921508195
},
"2015": {
"obs_EconomicCapitalRatio": 1.6010258802276929
},
"2016": {
"obs_EconomicCapitalRatio": 2.057300801619153
},
"2017": {
"obs_EconomicCapitalRatio": 2.239159736487357
},
"2018": {
"obs_EconomicCapitalRatio": 1.8384708779103238
},
"2019": {
"obs_EconomicCapitalRatio": 2.3659780082061137
},
"2020": {
"obs_EconomicCapitalRatio": 2.157741512673283
},
"2021": {
"obs_EconomicCapitalRatio": 2.279367529348738
},
"2022": {
"obs_EconomicCapitalRatio": 0.6944971645678013
},
"2023": {
"obs_EconomicCapitalRatio": 1.0739815375961428
},
"2024": {
"obs_EconomicCapitalRatio": 0.5579499137385675
},
"2025": {
"obs_EconomicCapitalRatio": 0.3664347948729315
}
},
"0000084748": {
"2011": {
"obs_EconomicCapitalRatio": 1.6297295665504372
},
"2012": {
"obs_EconomicCapitalRatio": 1.8904466957321773
},
"2013": {
"obs_EconomicCapitalRatio": 2.425311183376347
},
"2014": {
"obs_EconomicCapitalRatio": 3.046291777606733
},
"2015": {
"obs_EconomicCapitalRatio": 1.8365238040624734
},
"2016": {
"obs_EconomicCapitalRatio": 2.379857635941588
},
"2017": {
"obs_EconomicCapitalRatio": 4.753068625237965
},
"2018": {
"obs_EconomicCapitalRatio": 2.59132319937647
},
"2019": {
"obs_EconomicCapitalRatio": 3.452130088367989
},
"2020": {
"obs_EconomicCapitalRatio": 4.1357883963222495
},
"2021": {
"obs_EconomicCapitalRatio": 5.8018013174325835
},
"2022": {
"obs_EconomicCapitalRatio": 2.4047635348526097
},
"2023": {
"obs_EconomicCapitalRatio": 3.063132968303847
},
"2024": {
"obs_EconomicCapitalRatio": 2.3743773454577464
},
"2025": {
"obs_EconomicCapitalRatio": 2.1636878503383694
}
},
"0000717605": {
"2011": {
"obs_EconomicCapitalRatio": 2.281347992582869
},
"2012": {
"obs_EconomicCapitalRatio": 2.2192405747567965
},
"2013": {
"obs_EconomicCapitalRatio": 3.209541640316984
},
"2014": {
"obs_EconomicCapitalRatio": 2.4933060760420447
},
"2015": {
"obs_EconomicCapitalRatio": 2.5496131888159073
},
"2016": {
"obs_EconomicCapitalRatio": 2.496343317905908
},
"2017": {
"obs_EconomicCapitalRatio": 2.5883077593417965
},
"2018": {
"obs_EconomicCapitalRatio": 2.146719610664719
},
"2019": {
"obs_EconomicCapitalRatio": 2.48439144215883
},
"2020": {
"obs_EconomicCapitalRatio": 1.7943395236961057
},
"2021": {
"obs_EconomicCapitalRatio": 2.0045481673369747
},
"2022": {
"obs_EconomicCapitalRatio": 2.2887256198873067
}
},
"0000915389": {
"2011": {
"obs_EconomicCapitalRatio": 0.6709218129987479
},
"2012": {
"obs_EconomicCapitalRatio": 0.6834932352170303
},
"2013": {
"obs_EconomicCapitalRatio": 0.8195622048968719
},
"2014": {
"obs_EconomicCapitalRatio": 0.5554081691455909
},
"2015": {
"obs_EconomicCapitalRatio": 0.5252123383130736
},
"2016": {
"obs_EconomicCapitalRatio": 0.621956571767049
},
"2017": {
"obs_EconomicCapitalRatio": 0.7513459147065986
},
"2018": {
"obs_EconomicCapitalRatio": 0.5844692773095668
},
"2019": {
"obs_EconomicCapitalRatio": 0.6584777372063563
},
"2020": {
"obs_EconomicCapitalRatio": 0.8733381760757748
},
"2021": {
"obs_EconomicCapitalRatio": 1.031958712937266
},
"2022": {
"obs_EconomicCapitalRatio": 0.7069622897019276
},
"2023": {
"obs_EconomicCapitalRatio": 0.8077733875946396
},
"2024": {
"obs_EconomicCapitalRatio": 0.809239617135343
},
"2025": {
"obs_EconomicCapitalRatio": 0.605949714833355
}
},
"0000915913": {
"2011": {
"obs_EconomicCapitalRatio": 2.0184129066034515
},
"2012": {
"obs_EconomicCapitalRatio": 2.373913132013944
},
"2013": {
"obs_EconomicCapitalRatio": 2.1436593371926302
},
"2015": {
"obs_EconomicCapitalRatio": 0.9724727715974824
},
"2016": {
"obs_EconomicCapitalRatio": 1.8999779820103766
},
"2017": {
"obs_EconomicCapitalRatio": 2.8487015464464203
},
"2018": {
"obs_EconomicCapitalRatio": 1.6884521774474757
},
"2019": {
"obs_EconomicCapitalRatio": 1.25209266376253
},
"2020": {
"obs_EconomicCapitalRatio": 2.3998706851196427
},
"2021": {
"obs_EconomicCapitalRatio": 3.990187329969337
},
"2022": {
"obs_EconomicCapitalRatio": 2.781862601586399
},
"2023": {
"obs_EconomicCapitalRatio": 1.531133521605186
},
"2024": {
"obs_EconomicCapitalRatio": 1.1011056823531262
},
"2025": {
"obs_EconomicCapitalRatio": 1.873363806000487
}
},
"0001122976": {
"2011": {
"obs_EconomicCapitalRatio": 0.6272134290483431
},
"2012": {
"obs_EconomicCapitalRatio": 0.7545344653567579
},
"2013": {
"obs_EconomicCapitalRatio": 1.0662668309104917
},
"2014": {
"obs_EconomicCapitalRatio": 1.1662324035706073
},
"2015": {
"obs_EconomicCapitalRatio": 0.9742841724695139
},
"2016": {
"obs_EconomicCapitalRatio": 0.9514273808087566
},
"2017": {
"obs_EconomicCapitalRatio": 1.2011187447303786
},
"2018": {
"obs_EconomicCapitalRatio": 0.7550477309898862
},
"2019": {
"obs_EconomicCapitalRatio": 0.8798567137767184
},
"2020": {
"obs_EconomicCapitalRatio": 0.8056744819399897
},
"2021": {
"obs_EconomicCapitalRatio": 1.101977209972516
},
"2022": {
"obs_EconomicCapitalRatio": 0.5699142791320071
},
"2023": {
"obs_EconomicCapitalRatio": 0.729904863778972
},
"2024": {
"obs_EconomicCapitalRatio": 0.7827805402958028
},
"2025": {
"obs_EconomicCapitalRatio": 0.5881259150778726
}
},
"0001324759": {
"2011": {
"obs_EconomicCapitalRatio": 0.47779999203872364
},
"2012": {
"obs_EconomicCapitalRatio": 0.047559045119414334
}
},
"0000079879": {
"2011": {
"obs_EconomicCapitalRatio": 0.7780557806919013
},
"2013": {
"obs_EconomicCapitalRatio": 1.6064372334261137
},
"2014": {
"obs_EconomicCapitalRatio": 1.7237761886140508
},
"2015": {
"obs_EconomicCapitalRatio": 1.5136259329059834
},
"2016": {
"obs_EconomicCapitalRatio": 1.5831715636878736
},
"2017": {
"obs_EconomicCapitalRatio": 1.833809153344714
},
"2018": {
"obs_EconomicCapitalRatio": 1.474343674528762
},
"2019": {
"obs_EconomicCapitalRatio": 1.8422184602158846
},
"2020": {
"obs_EconomicCapitalRatio": 1.8322627153315263
},
"2021": {
"obs_EconomicCapitalRatio": 2.0006301399744304
},
"2022": {
"obs_EconomicCapitalRatio": 1.5757084148865124
},
"2023": {
"obs_EconomicCapitalRatio": 1.8797816372672098
},
"2024": {
"obs_EconomicCapitalRatio": 1.6837665860129216
},
"2025": {
"obs_EconomicCapitalRatio": 1.270629832342974
}
},
"0000110621": {
"2011": {
"obs_EconomicCapitalRatio": 0.8159663229707331
},
"2012": {
"obs_EconomicCapitalRatio": 1.0066182219866078
},
"2013": {
"obs_EconomicCapitalRatio": 1.2216735778718413
},
"2015": {
"obs_EconomicCapitalRatio": 1.1638598491154066
},
"2016": {
"obs_EconomicCapitalRatio": 1.4613265756957852
},
"2017": {
"obs_EconomicCapitalRatio": 1.3537489806535472
},
"2018": {
"obs_EconomicCapitalRatio": 1.5170070287157547
},
"2019": {
"obs_EconomicCapitalRatio": 1.829926329902574
},
"2020": {
"obs_EconomicCapitalRatio": 2.107611524772258
},
"2021": {
"obs_EconomicCapitalRatio": 2.1859728332722064
},
"2022": {
"obs_EconomicCapitalRatio": 2.085361518544056
}
},
"0000051253": {
"2011": {
"obs_EconomicCapitalRatio": 1.2608278857531472
},
"2012": {
"obs_EconomicCapitalRatio": 1.5363533135328669
},
"2013": {
"obs_EconomicCapitalRatio": 2.021741772063451
},
"2014": {
"obs_EconomicCapitalRatio": 2.3279305904331866
},
"2015": {
"obs_EconomicCapitalRatio": 2.5597560327190485
},
"2016": {
"obs_EconomicCapitalRatio": 2.326927655454232
},
"2017": {
"obs_EconomicCapitalRatio": 2.597342315071224
},
"2018": {
"obs_EconomicCapitalRatio": 1.1756510004685328
},
"2019": {
"obs_EconomicCapitalRatio": 1.1049896983456262
},
"2020": {
"obs_EconomicCapitalRatio": 0.998970229835377
},
"2023": {
"obs_EconomicCapitalRatio": 0.8217695801085897
},
"2024": {
"obs_EconomicCapitalRatio": 0.9717487368226513
}
},
"0000310142": {
"2011": {
"obs_EconomicCapitalRatio": 1.522182749884351
},
"2012": {
"obs_EconomicCapitalRatio": 1.380788739979202
},
"2013": {
"obs_EconomicCapitalRatio": 1.8011106108510149
},
"2014": {
"obs_EconomicCapitalRatio": 2.377168760470051
},
"2015": {
"obs_EconomicCapitalRatio": 2.396036404800919
},
"2016": {
"obs_EconomicCapitalRatio": 3.053576044118711
},
"2017": {
"obs_EconomicCapitalRatio": 2.751030025767579
},
"2018": {
"obs_EconomicCapitalRatio": 1.9611832938641327
},
"2019": {
"obs_EconomicCapitalRatio": 2.4788120703710677
},
"2020": {
"obs_EconomicCapitalRatio": 2.845625772836302
},
"2021": {
"obs_EconomicCapitalRatio": 3.79854741418168
},
"2022": {
"obs_EconomicCapitalRatio": 2.5230849182210866
},
"2023": {
"obs_EconomicCapitalRatio": 2.364913118243379
}
},
"0000744187": {
"2011": {
"obs_EconomicCapitalRatio": 0.7615255644911764
},
"2012": {
"obs_EconomicCapitalRatio": 0.520796967073116
},
"2013": {
"obs_EconomicCapitalRatio": 1.379480373664334
},
"2014": {
"obs_EconomicCapitalRatio": 1.84300106749189
},
"2015": {
"obs_EconomicCapitalRatio": 1.4191783872826655
},
"2022": {
"obs_EconomicCapitalRatio": 1.6974681588556615
},
"2023": {
"obs_EconomicCapitalRatio": 2.5633258097042937
},
"2024": {
"obs_EconomicCapitalRatio": 1.9548599073579234
},
"2025": {
"obs_EconomicCapitalRatio": 2.8110715440300837
}
},
"0000778164": {
"2011": {
"obs_EconomicCapitalRatio": 0.40795113728905225
},
"2012": {
"obs_EconomicCapitalRatio": 0.2728570798946157
},
"2013": {
"obs_EconomicCapitalRatio": 0.36362282639273047
},
"2014": {
"obs_EconomicCapitalRatio": 1.3918790530834066
},
"2015": {
"obs_EconomicCapitalRatio": 0.3655962213896531
},
"2016": {
"obs_EconomicCapitalRatio": 0.7762319237434837
},
"2017": {
"obs_EconomicCapitalRatio": 0.37859807101733556
},
"2018": {
"obs_EconomicCapitalRatio": 0.083610793643223
},
"2019": {
"obs_EconomicCapitalRatio": 0.06983055159676796
},
"2020": {
"obs_EconomicCapitalRatio": 1.231532502989717
},
"2021": {
"obs_EconomicCapitalRatio": 1.1234128589452403
},
"2022": {
"obs_EconomicCapitalRatio": 0.6534061213973273
},
"2023": {
"obs_EconomicCapitalRatio": 0.6807491182966778
}
},
"0001120970": {
"2011": {
"obs_EconomicCapitalRatio": 2.8391047315428075
},
"2012": {
"obs_EconomicCapitalRatio": 2.5685277934327084
},
"2013": {
"obs_EconomicCapitalRatio": 3.351650078773552
},
"2014": {
"obs_EconomicCapitalRatio": 1.7062441861998598
},
"2015": {
"obs_EconomicCapitalRatio": 1.8413967718530309
},
"2016": {
"obs_EconomicCapitalRatio": 1.8009656495006061
},
"2017": {
"obs_EconomicCapitalRatio": 3.0311041975400186
},
"2018": {
"obs_EconomicCapitalRatio": 0.39989217753849887
},
"2019": {
"obs_EconomicCapitalRatio": 1.7797252585639252
},
"2020": {
"obs_EconomicCapitalRatio": 1.308887645808208
},
"2021": {
"obs_EconomicCapitalRatio": 1.1198050566573303
},
"2022": {
"obs_EconomicCapitalRatio": 0.3352557132069845
},
"2024": {
"obs_EconomicCapitalRatio": 1.37967500703654
},
"2025": {
"obs_EconomicCapitalRatio": 1.742427165853982
}
},
"0001200375": {
"2011": {
"obs_EconomicCapitalRatio": 2.342334864170049
},
"2012": {
"obs_EconomicCapitalRatio": 1.4278133680149394
},
"2013": {
"obs_EconomicCapitalRatio": 1.4036789453415757
},
"2015": {
"obs_EconomicCapitalRatio": 5.461171189376292
},
"2016": {
"obs_EconomicCapitalRatio": 7.462700171233544
},
"2017": {
"obs_EconomicCapitalRatio": 9.499492838832932
},
"2018": {
"obs_EconomicCapitalRatio": 17.558137963859057
},
"2020": {
"obs_EconomicCapitalRatio": 9.615236147466042
},
"2021": {
"obs_EconomicCapitalRatio": 12.452497348721183
},
"2022": {
"obs_EconomicCapitalRatio": 1.7252599263898558
},
"2023": {
"obs_EconomicCapitalRatio": 2.3101133818505715
},
"2024": {
"obs_EconomicCapitalRatio": 3.5178811866292525
},
"2025": {
"obs_EconomicCapitalRatio": 1.2089199749282789
}
},
"0001262823": {
"2011": {
"obs_EconomicCapitalRatio": 0.8632654186815746
},
"2012": {
"obs_EconomicCapitalRatio": 1.7673872630528977
},
"2013": {
"obs_EconomicCapitalRatio": 2.313519828661935
},
"2014": {
"obs_EconomicCapitalRatio": 1.9211037148664771
},
"2018": {
"obs_EconomicCapitalRatio": 0.8578468481324052
},
"2019": {
"obs_EconomicCapitalRatio": 0.8041790501234812
},
"2020": {
"obs_EconomicCapitalRatio": 0.906469497835784
},
"2021": {
"obs_EconomicCapitalRatio": 0.7947629410142738
},
"2022": {
"obs_EconomicCapitalRatio": 0.8106507231202377
},
"2023": {
"obs_EconomicCapitalRatio": 1.1011409475588807
},
"2024": {
"obs_EconomicCapitalRatio": 0.9378427733083907
},
"2025": {
"obs_EconomicCapitalRatio": 0.6164497377130742
}
},
"0001282637": {
"2011": {
"obs_EconomicCapitalRatio": 2.945613299177136
},
"2012": {
"obs_EconomicCapitalRatio": 3.7842976687580396
},
"2014": {
"obs_EconomicCapitalRatio": 3.9853441761546184
},
"2015": {
"obs_EconomicCapitalRatio": 3.4180730158113795
},
"2016": {
"obs_EconomicCapitalRatio": 3.5874127897345804
},
"2017": {
"obs_EconomicCapitalRatio": 2.8054521566265405
},
"2018": {
"obs_EconomicCapitalRatio": 2.6330556176793882
},
"2019": {
"obs_EconomicCapitalRatio": 3.078758201505581
},
"2020": {
"obs_EconomicCapitalRatio": 2.507320755560595
},
"2021": {
"obs_EconomicCapitalRatio": 1.535501106844712
},
"2022": {
"obs_EconomicCapitalRatio": 1.412219500459358
},
"2023": {
"obs_EconomicCapitalRatio": 2.8822000219737256
},
"2024": {
"obs_EconomicCapitalRatio": 2.0696616176006044
},
"2025": {
"obs_EconomicCapitalRatio": 2.5524203409778674
}
},
"0001309402": {
"2011": {
"obs_EconomicCapitalRatio": 0.24542500073271054
},
"2012": {
"obs_EconomicCapitalRatio": 0.19238507100289554
},
"2013": {
"obs_EconomicCapitalRatio": 0.414950096399585
},
"2014": {
"obs_EconomicCapitalRatio": 0.5919243332848719
},
"2015": {
"obs_EconomicCapitalRatio": 0.526190605613486
},
"2016": {
"obs_EconomicCapitalRatio": 0.5113655037386442
},
"2017": {
"obs_EconomicCapitalRatio": 0.29438501518347043
},
"2018": {
"obs_EconomicCapitalRatio": 0.31175079761499724
},
"2019": {
"obs_EconomicCapitalRatio": 0.4416364891279984
},
"2020": {
"obs_EconomicCapitalRatio": 0.39848768672446727
},
"2021": {
"obs_EconomicCapitalRatio": 1.18169673379572
},
"2022": {
"obs_EconomicCapitalRatio": 1.1035543591345094
},
"2023": {
"obs_EconomicCapitalRatio": 1.0552459342477385
},
"2024": {
"obs_EconomicCapitalRatio": 0.4456197592893155
},
"2025": {
"obs_EconomicCapitalRatio": 0.5727781878908101
}
},
"0001337298": {
"2011": {
"obs_EconomicCapitalRatio": 0.46873569923790753
},
"2012": {
"obs_EconomicCapitalRatio": 0.5531606051966987
},
"2013": {
"obs_EconomicCapitalRatio": 0.7269469611578753
},
"2014": {
"obs_EconomicCapitalRatio": 0.5579156407705856
},
"2015": {
"obs_EconomicCapitalRatio": 0.5934897624288799
},
"2016": {
"obs_EconomicCapitalRatio": 0.5699786573542159
},
"2017": {
"obs_EconomicCapitalRatio": 0.853033731385962
}
},
"0001392380": {
"2011": {
"obs_EconomicCapitalRatio": 0.0
},
"2012": {
"obs_EconomicCapitalRatio": 0.0
},
"2014": {
"obs_EconomicCapitalRatio": 0.0
},
"2015": {
"obs_EconomicCapitalRatio": 0.17514504542518838
},
"2016": {
"obs_EconomicCapitalRatio": 0.42150170519487207
},
"2017": {
"obs_EconomicCapitalRatio": 0.2311431373943365
},
"2018": {
"obs_EconomicCapitalRatio": 0.2903524117363617
},
"2019": {
"obs_EconomicCapitalRatio": 0.5941894466599246
},
"2020": {
"obs_EconomicCapitalRatio": 5.010438779881309
},
"2021": {
"obs_EconomicCapitalRatio": 2.4717995124336034
},
"2022": {
"obs_EconomicCapitalRatio": 1.0698563696583818
},
"2023": {
"obs_EconomicCapitalRatio": 0.782419865367601
}
},
"0000105770": {
"2011": {
"obs_EconomicCapitalRatio": 1.080723686133535
},
"2012": {
"obs_EconomicCapitalRatio": 1.440159978777089
},
"2013": {
"obs_EconomicCapitalRatio": 2.6496866280130673
},
"2014": {
"obs_EconomicCapitalRatio": 3.059297770910497
},
"2015": {
"obs_EconomicCapitalRatio": 3.5870309029396745
},
"2016": {
"obs_EconomicCapitalRatio": 5.178962101238499
},
"2017": {
"obs_EconomicCapitalRatio": 5.862622367745658
},
"2018": {
"obs_EconomicCapitalRatio": 5.491642513593138
},
"2019": {
"obs_EconomicCapitalRatio": 7.0518141617419206
},
"2020": {
"obs_EconomicCapitalRatio": 10.901516162358838
},
"2021": {
"obs_EconomicCapitalRatio": 15.768601871582161
},
"2022": {
"obs_EconomicCapitalRatio": 7.57316787604098
},
"2023": {
"obs_EconomicCapitalRatio": 10.927242645615857
},
"2024": {
"obs_EconomicCapitalRatio": 10.345191482060887
},
"2025": {
"obs_EconomicCapitalRatio": 7.364852694707018
}
},
"0000790051": {
"2011": {
"obs_EconomicCapitalRatio": 0.9523473743187331
},
"2012": {
"obs_EconomicCapitalRatio": 1.2193531456019637
},
"2013": {
"obs_EconomicCapitalRatio": 1.732226348910334
},
"2014": {
"obs_EconomicCapitalRatio": 1.9079869226387787
},
"2015": {
"obs_EconomicCapitalRatio": 1.828545613276869
},
"2016": {
"obs_EconomicCapitalRatio": 2.358918001627138
},
"2017": {
"obs_EconomicCapitalRatio": 1.5745695391359638
},
"2018": {
"obs_EconomicCapitalRatio": 1.3226849068140094
},
"2019": {
"obs_EconomicCapitalRatio": 2.042954206220577
},
"2020": {
"obs_EconomicCapitalRatio": 1.7131727756966508
},
"2021": {
"obs_EconomicCapitalRatio": 2.044524036269128
},
"2022": {
"obs_EconomicCapitalRatio": 2.074178187080066
},
"2023": {
"obs_EconomicCapitalRatio": 2.863749524996848
},
"2024": {
"obs_EconomicCapitalRatio": 3.676042519977833
},
"2025": {
"obs_EconomicCapitalRatio": 3.9241709221128183
}
},
"0000007431": {
"2011": {
"obs_EconomicCapitalRatio": 0.818467771051719
},
"2012": {
"obs_EconomicCapitalRatio": 1.0942726129203864
},
"2013": {
"obs_EconomicCapitalRatio": 1.1052119585170082
},
"2014": {
"obs_EconomicCapitalRatio": 1.1115494146880482
},
"2015": {
"obs_EconomicCapitalRatio": 1.02166103708548
},
"2016": {
"obs_EconomicCapitalRatio": 1.3476740008616848
},
"2017": {
"obs_EconomicCapitalRatio": 1.760306037970634
},
"2018": {
"obs_EconomicCapitalRatio": 1.5305498421864336
},
"2019": {
"obs_EconomicCapitalRatio": 3.2566368202830485
},
"2020": {
"obs_EconomicCapitalRatio": 2.264030605291642
},
"2021": {
"obs_EconomicCapitalRatio": 3.58771001699517
},
"2022": {
"obs_EconomicCapitalRatio": 2.135376522868203
}
},
"0000038264": {
"2011": {
"obs_EconomicCapitalRatio": 1.0329806069578091
},
"2012": {
"obs_EconomicCapitalRatio": 0.7899398737508551
},
"2016": {
"obs_EconomicCapitalRatio": 1.3369658225594734
},
"2017": {
"obs_EconomicCapitalRatio": 1.2936573782377594
},
"2018": {
"obs_EconomicCapitalRatio": 0.9061225493935785
},
"2019": {
"obs_EconomicCapitalRatio": 0.7789919723924983
},
"2020": {
"obs_EconomicCapitalRatio": 1.1538884137625203
},
"2021": {
"obs_EconomicCapitalRatio": 0.9853013703608507
},
"2022": {
"obs_EconomicCapitalRatio": 0.6187307762078627
},
"2023": {
"obs_EconomicCapitalRatio": 0.4505565261038733
},
"2024": {
"obs_EconomicCapitalRatio": 0.37213846234683806
},
"2025": {
"obs_EconomicCapitalRatio": 0.8080596209243718
}
},
"0000069488": {
"2011": {
"obs_EconomicCapitalRatio": 1.0381389514900297
},
"2012": {
"obs_EconomicCapitalRatio": 1.0982471614752694
},
"2013": {
"obs_EconomicCapitalRatio": 1.5779663442097482
},
"2014": {
"obs_EconomicCapitalRatio": 1.0448340654628014
},
"2015": {
"obs_EconomicCapitalRatio": 1.1050712104667275
},
"2016": {
"obs_EconomicCapitalRatio": 1.3997384538756348
},
"2017": {
"obs_EconomicCapitalRatio": 2.0145122323067755
},
"2018": {
"obs_EconomicCapitalRatio": 1.8813426470530377
},
"2019": {
"obs_EconomicCapitalRatio": 2.2670171914412007
},
"2020": {
"obs_EconomicCapitalRatio": 2.234243587527368
},
"2021": {
"obs_EconomicCapitalRatio": 1.6533807558683955
},
"2022": {
"obs_EconomicCapitalRatio": 1.797531523930188
}
},
"0000896622": {
"2011": {
"obs_EconomicCapitalRatio": 2.0868313337444193
},
"2012": {
"obs_EconomicCapitalRatio": 1.8807246688006947
},
"2013": {
"obs_EconomicCapitalRatio": 2.4029125499934576
},
"2014": {
"obs_EconomicCapitalRatio": 2.443567442826526
},
"2015": {
"obs_EconomicCapitalRatio": 2.7764854165641975
},
"2016": {
"obs_EconomicCapitalRatio": 2.5878406030054495
},
"2017": {
"obs_EconomicCapitalRatio": 2.630067440589336
},
"2018": {
"obs_EconomicCapitalRatio": 2.6343679023770394
},
"2019": {
"obs_EconomicCapitalRatio": 3.1855125134954276
},
"2020": {
"obs_EconomicCapitalRatio": 3.4171371120052183
},
"2021": {
"obs_EconomicCapitalRatio": 2.8601027138624455
},
"2022": {
"obs_EconomicCapitalRatio": 2.6705535243713014
},
"2023": {
"obs_EconomicCapitalRatio": 2.812157464710154
},
"2024": {
"obs_EconomicCapitalRatio": 3.755227885156863
},
"2025": {
"obs_EconomicCapitalRatio": 2.489893782678988
}
},
"0001026655": {
"2011": {
"obs_EconomicCapitalRatio": 0.8608604132301414
},
"2015": {
"obs_EconomicCapitalRatio": 1.0261225432597354
},
"2016": {
"obs_EconomicCapitalRatio": 1.5457069662038585
},
"2017": {
"obs_EconomicCapitalRatio": 2.038686180000626
},
"2018": {
"obs_EconomicCapitalRatio": 0.3811072540913451
},
"2019": {
"obs_EconomicCapitalRatio": 0.1860788744114522
},
"2020": {
"obs_EconomicCapitalRatio": 0.9665552273279091
},
"2021": {
"obs_EconomicCapitalRatio": 0.5463679132715609
},
"2022": {
"obs_EconomicCapitalRatio": 0.8060269557536746
},
"2023": {
"obs_EconomicCapitalRatio": 1.1817584887595467
},
"2024": {
"obs_EconomicCapitalRatio": 1.0829256568468935
},
"2025": {
"obs_EconomicCapitalRatio": 1.2340741543649976
}
},
"0001101302": {
"2011": {
"obs_EconomicCapitalRatio": 2.7491165994593594
},
"2012": {
"obs_EconomicCapitalRatio": 2.6653627657446073
},
"2013": {
"obs_EconomicCapitalRatio": 3.113402676837307
},
"2014": {
"obs_EconomicCapitalRatio": 1.7470382204545611
},
"2015": {
"obs_EconomicCapitalRatio": 2.001756544086691
},
"2016": {
"obs_EconomicCapitalRatio": 2.499761364933779
},
"2017": {
"obs_EconomicCapitalRatio": 3.6869056226990087
},
"2018": {
"obs_EconomicCapitalRatio": 2.734074355112706
},
"2019": {
"obs_EconomicCapitalRatio": 4.824371067308623
},
"2020": {
"obs_EconomicCapitalRatio": 7.899749187595021
},
"2021": {
"obs_EconomicCapitalRatio": 10.252528829437917
},
"2022": {
"obs_EconomicCapitalRatio": 1.7535183737791016
},
"2023": {
"obs_EconomicCapitalRatio": 3.819572157423702
},
"2024": {
"obs_EconomicCapitalRatio": 3.432771056072382
},
"2025": {
"obs_EconomicCapitalRatio": 2.9138159001120774
}
},
"0000314227": {
"2012": {
"obs_EconomicCapitalRatio": 36.58227159030734
},
"2013": {
"obs_EconomicCapitalRatio": 4.878952832500941
},
"2014": {
"obs_EconomicCapitalRatio": 5.24015335098959
},
"2015": {
"obs_EconomicCapitalRatio": 10.893902688960509
},
"2016": {
"obs_EconomicCapitalRatio": 6.300286207146806
},
"2017": {
"obs_EconomicCapitalRatio": 1.5030478789208082
},
"2018": {
"obs_EconomicCapitalRatio": 1.5930927533821764
},
"2019": {
"obs_EconomicCapitalRatio": 1.8430933154497675
},
"2020": {
"obs_EconomicCapitalRatio": 6.922906717251226
},
"2021": {
"obs_EconomicCapitalRatio": 3.987960578296863
},
"2022": {
"obs_EconomicCapitalRatio": 1.0411978255748624
},
"2023": {
"obs_EconomicCapitalRatio": 1.96551223898017
},
"2024": {
"obs_EconomicCapitalRatio": 2.1470292359354066
},
"2025": {
"obs_EconomicCapitalRatio": 2.3255815191838423
}
},
"0000738214": {
"2012": {
"obs_EconomicCapitalRatio": 1.0239116004500597
},
"2013": {
"obs_EconomicCapitalRatio": 0.6238452133492072
},
"2014": {
"obs_EconomicCapitalRatio": 2.130359197315785
},
"2015": {
"obs_EconomicCapitalRatio": 0.4274014796768218
},
"2016": {
"obs_EconomicCapitalRatio": 0.3047847609156527
},
"2017": {
"obs_EconomicCapitalRatio": 0.09043221222247719
},
"2018": {
"obs_EconomicCapitalRatio": 0.07622127473757176
},
"2019": {
"obs_EconomicCapitalRatio": 0.10855332519939714
},
"2020": {
"obs_EconomicCapitalRatio": 0.26127311485613125
},
"2022": {
"obs_EconomicCapitalRatio": 0.4536326588554047
},
"2023": {
"obs_EconomicCapitalRatio": 0.6065208266688298
},
"2024": {
"obs_EconomicCapitalRatio": 0.3432021715219472
},
"2025": {
"obs_EconomicCapitalRatio": 0.2197483404246265
}
},
"0001308027": {
"2012": {
"obs_EconomicCapitalRatio": 1.9803797398257204
},
"2015": {
"obs_EconomicCapitalRatio": 2.778919231593189
},
"2016": {
"obs_EconomicCapitalRatio": 10.351619765303129
},
"2017": {
"obs_EconomicCapitalRatio": 3.7308811857383533
},
"2018": {
"obs_EconomicCapitalRatio": 0.08714768625160174
},
"2020": {
"obs_EconomicCapitalRatio": 1.3387441772805952
},
"2021": {
"obs_EconomicCapitalRatio": 0.5700547146774205
},
"2022": {
"obs_EconomicCapitalRatio": 0.14721267296450652
},
"2023": {
"obs_EconomicCapitalRatio": 0.14346362598664772
},
"2024": {
"obs_EconomicCapitalRatio": 0.23698738818540735
},
"2025": {
"obs_EconomicCapitalRatio": 0.35054254006651825
}
},
"0001489393": {
"2013": {
"obs_EconomicCapitalRatio": 1.4151084027441547
},
"2014": {
"obs_EconomicCapitalRatio": 1.4900382362139972
},
"2015": {
"obs_EconomicCapitalRatio": 1.6300225505579853
},
"2016": {
"obs_EconomicCapitalRatio": 1.4926247052183903
},
"2017": {
"obs_EconomicCapitalRatio": 1.7026727710448146
},
"2018": {
"obs_EconomicCapitalRatio": 1.1735237199637458
},
"2019": {
"obs_EconomicCapitalRatio": 1.1746692422602985
},
"2020": {
"obs_EconomicCapitalRatio": 1.039160334370416
},
"2021": {
"obs_EconomicCapitalRatio": 1.0115527984501795
},
"2022": {
"obs_EconomicCapitalRatio": 1.001507933051565
},
"2023": {
"obs_EconomicCapitalRatio": 1.1989866656327328
},
"2024": {
"obs_EconomicCapitalRatio": 1.0201268420034355
},
"2025": {
"obs_EconomicCapitalRatio": 0.6858348113544311
}
},
"0001042187": {
"2013": {
"obs_EconomicCapitalRatio": 0.5714296705166615
},
"2014": {
"obs_EconomicCapitalRatio": 0.3391814297044462
},
"2015": {
"obs_EconomicCapitalRatio": 0.4583016602403627
},
"2016": {
"obs_EconomicCapitalRatio": 0.5278406481008625
},
"2017": {
"obs_EconomicCapitalRatio": 0.4309951786881203
},
"2018": {
"obs_EconomicCapitalRatio": 0.33238633083898383
},
"2021": {
"obs_EconomicCapitalRatio": 0.5428482214821214
},
"2022": {
"obs_EconomicCapitalRatio": 1.2123118520382488
},
"2023": {
"obs_EconomicCapitalRatio": 2.8157146744889916
},
"2024": {
"obs_EconomicCapitalRatio": 0.6517477133212607
},
"2025": {
"obs_EconomicCapitalRatio": 0.6078884785899927
}
},
"0001325964": {
"2013": {
"obs_EconomicCapitalRatio": 22.493014273125006
},
"2022": {
"obs_EconomicCapitalRatio": 34.89205016257957
},
"2023": {
"obs_EconomicCapitalRatio": 26.28715222376341
},
"2024": {
"obs_EconomicCapitalRatio": 12.036573744155438
},
"2025": {
"obs_EconomicCapitalRatio": 10.167232094101845
}
},
"0001530804": {
"2014": {
"obs_EconomicCapitalRatio": 0.23216984985374312
},
"2015": {
"obs_EconomicCapitalRatio": 0.041862906284199475
},
"2016": {
"obs_EconomicCapitalRatio": 0.12247701906359186
},
"2017": {
"obs_EconomicCapitalRatio": 0.3243116789167706
},
"2018": {
"obs_EconomicCapitalRatio": 0.1282515917643454
},
"2019": {
"obs_EconomicCapitalRatio": 0.26738229447865736
},
"2020": {
"obs_EconomicCapitalRatio": 0.2980248750707583
},
"2021": {
"obs_EconomicCapitalRatio": 0.5991924965793767
},
"2022": {
"obs_EconomicCapitalRatio": 0.34669182047987734
},
"2023": {
"obs_EconomicCapitalRatio": 0.38428424149732565
},
"2024": {
"obs_EconomicCapitalRatio": 0.29016321773794146
},
"2025": {
"obs_EconomicCapitalRatio": 0.12252377761438202
}
},
"0001519061": {
"2015": {
"obs_EconomicCapitalRatio": 0.5082545963516538
},
"2016": {
"obs_EconomicCapitalRatio": 0.9822707398812356
},
"2017": {
"obs_EconomicCapitalRatio": 1.0603699225812344
},
"2018": {
"obs_EconomicCapitalRatio": 0.6694580389125863
},
"2019": {
"obs_EconomicCapitalRatio": 0.6442858173008269
},
"2020": {
"obs_EconomicCapitalRatio": 0.6933794015667445
},
"2021": {
"obs_EconomicCapitalRatio": 0.44773102673168885
},
"2022": {
"obs_EconomicCapitalRatio": 0.2159810544712253
},
"2023": {
"obs_EconomicCapitalRatio": 0.09109949903062606
},
"2024": {
"obs_EconomicCapitalRatio": 0.060660047162396515
}
},
"0001604028": {
"2015": {
"obs_EconomicCapitalRatio": 1.273025974598838
},
"2016": {
"obs_EconomicCapitalRatio": 1.162661883696283
},
"2020": {
"obs_EconomicCapitalRatio": 2.842591008013679
},
"2022": {
"obs_EconomicCapitalRatio": 3.22180346425185
},
"2023": {
"obs_EconomicCapitalRatio": 4.5099881471076415
},
"2024": {
"obs_EconomicCapitalRatio": 3.3874661614584705
}
},
"0001413119": {
"2016": {
"obs_EconomicCapitalRatio": 24.683469858060686
}
},
"0001616862": {
"2016": {
"obs_EconomicCapitalRatio": 1.249245022511231
},
"2017": {
"obs_EconomicCapitalRatio": 1.2709666433083144
},
"2018": {
"obs_EconomicCapitalRatio": 0.8988817379751548
},
"2019": {
"obs_EconomicCapitalRatio": 1.1628496816891973
},
"2020": {
"obs_EconomicCapitalRatio": 1.0477989830362657
},
"2021": {
"obs_EconomicCapitalRatio": 1.1375315368339611
},
"2022": {
"obs_EconomicCapitalRatio": 0.8928272863027281
},
"2023": {
"obs_EconomicCapitalRatio": 1.1738772868758283
},
"2024": {
"obs_EconomicCapitalRatio": 1.1968963283554306
},
"2025": {
"obs_EconomicCapitalRatio": 1.07578092243606
}
},
"0001532595": {
"2017": {
"obs_EconomicCapitalRatio": 0.0
},
"2018": {
"obs_EconomicCapitalRatio": 0.0
},
"2021": {
"obs_EconomicCapitalRatio": 0.0
}
},
"0001666700": {
"2017": {
"obs_EconomicCapitalRatio": 1.2982724922533362
},
"2018": {
"obs_EconomicCapitalRatio": 0.9766770954550188
},
"2019": {
"obs_EconomicCapitalRatio": 1.0763840926952941
},
"2020": {
"obs_EconomicCapitalRatio": 1.2281886255149852
},
"2021": {
"obs_EconomicCapitalRatio": 1.1716964643545753
},
"2022": {
"obs_EconomicCapitalRatio": 1.1391746058297987
},
"2023": {
"obs_EconomicCapitalRatio": 1.1769393384782991
},
"2024": {
"obs_EconomicCapitalRatio": 1.269255252759582
},
"2025": {
"obs_EconomicCapitalRatio": 1.177039000282219
}
},
"0001549145": {
"2017": {
"obs_EconomicCapitalRatio": 0.5747342547575599
}
},
"0001604665": {
"2017": {
"obs_EconomicCapitalRatio": 0.38596753102315345
},
"2018": {
"obs_EconomicCapitalRatio": 0.37561511361862315
},
"2019": {
"obs_EconomicCapitalRatio": 0.5626102527641046
},
"2020": {
"obs_EconomicCapitalRatio": 0.5786108953382062
},
"2021": {
"obs_EconomicCapitalRatio": 0.625922748853383
},
"2022": {
"obs_EconomicCapitalRatio": 0.6358639836543026
},
"2023": {
"obs_EconomicCapitalRatio": 0.7241530877769992
},
"2024": {
"obs_EconomicCapitalRatio": 0.8379790013918492
},
"2025": {
"obs_EconomicCapitalRatio": 0.7668585509621723
}
},
"0000814453": {
"2017": {
"obs_EconomicCapitalRatio": 0.3945245827290697
},
"2018": {
"obs_EconomicCapitalRatio": 0.41354941300898324
},
"2019": {
"obs_EconomicCapitalRatio": 0.4622826850929423
},
"2020": {
"obs_EconomicCapitalRatio": 0.554973166701373
},
"2021": {
"obs_EconomicCapitalRatio": 0.6222570787388074
},
"2022": {
"obs_EconomicCapitalRatio": 0.4021645428351386
},
"2023": {
"obs_EconomicCapitalRatio": 0.30508941801619077
},
"2024": {
"obs_EconomicCapitalRatio": 0.40608427926573776
},
"2025": {
"obs_EconomicCapitalRatio": 0.16284952532863772
}
},
"0001096056": {
"2018": {
"obs_EconomicCapitalRatio": 1.2084172700636033
},
"2019": {
"obs_EconomicCapitalRatio": 1.3399983762345555
},
"2020": {
"obs_EconomicCapitalRatio": 1.3587499237343874
},
"2021": {
"obs_EconomicCapitalRatio": 1.6715663477419418
},
"2022": {
"obs_EconomicCapitalRatio": 1.0053153019909002
},
"2023": {
"obs_EconomicCapitalRatio": 0.8248803824588569
},
"2024": {
"obs_EconomicCapitalRatio": 1.2139487963598101
},
"2025": {
"obs_EconomicCapitalRatio": 1.4140802578124703
}
},
"0001707925": {
"2018": {
"obs_EconomicCapitalRatio": 1.1893866129197774
},
"2019": {
"obs_EconomicCapitalRatio": 1.7107372512106584
},
"2020": {
"obs_EconomicCapitalRatio": 1.9789271383123104
},
"2021": {
"obs_EconomicCapitalRatio": 2.803679476386629
},
"2022": {
"obs_EconomicCapitalRatio": 2.641834020623559
},
"2023": {
"obs_EconomicCapitalRatio": 3.2039390092777027
},
"2024": {
"obs_EconomicCapitalRatio": 3.276524672647183
},
"2025": {
"obs_EconomicCapitalRatio": 2.9532857569105055
}
},
"0001673985": {
"2018": {
"obs_EconomicCapitalRatio": 0.7908073461168124
},
"2019": {
"obs_EconomicCapitalRatio": 0.5012501390818038
},
"2020": {
"obs_EconomicCapitalRatio": 0.4845788000628009
},
"2021": {
"obs_EconomicCapitalRatio": 1.1487852416389563
},
"2022": {
"obs_EconomicCapitalRatio": 0.8656004837284976
},
"2023": {
"obs_EconomicCapitalRatio": 0.6833615329193509
},
"2024": {
"obs_EconomicCapitalRatio": 0.6025210438163165
},
"2025": {
"obs_EconomicCapitalRatio": 0.34841400786738524
}
},
"0001758021": {
"2021": {
"obs_EconomicCapitalRatio": 2.23009434292126
},
"2022": {
"obs_EconomicCapitalRatio": 1.2779871240295437
},
"2023": {
"obs_EconomicCapitalRatio": 2.1494705882572824
},
"2024": {
"obs_EconomicCapitalRatio": 2.5946291453927186
},
"2025": {
"obs_EconomicCapitalRatio": 2.1540554003132124
}
},
"0001833197": {
"2021": {
"obs_EconomicCapitalRatio": 4.733556344493112
},
"2022": {
"obs_EconomicCapitalRatio": 0.5439158340845507
},
"2023": {
"obs_EconomicCapitalRatio": 0.491241265280765
},
"2025": {
"obs_EconomicCapitalRatio": 1.1848142238337869
}
},
"0001648087": {
"2022": {
"obs_EconomicCapitalRatio": 0.0
},
"2023": {
"obs_EconomicCapitalRatio": 0.0
},
"2024": {
"obs_EconomicCapitalRatio": 0.0
},
"2025": {
"obs_EconomicCapitalRatio": 0.0
}
}
}
}